Form 8-K

8-K — Boost Run Inc.

Accession: 0001493152-26-023208

Filed: 2026-05-14

Period: 2026-05-08

CIK: 0002090646

SIC: 7374 (SERVICES-COMPUTER PROCESSING & DATA PREPARATION)

Item: Entry into a Material Definitive Agreement

Item: Termination of a Material Definitive Agreement

Item: Completion of Acquisition or Disposition of Assets

Item: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item: Unregistered Sales of Equity Securities

Item: Material Modifications to Rights of Security Holders

Item: Changes in Registrant's Certifying Accountant

Item: Changes in Control of Registrant

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Change in Shell Company Status

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-3.1 (ex3-1.htm)

EX-3.2 (ex3-2.htm)

EX-10.1 (ex10-1.htm)

EX-10.2 (ex10-2.htm)

EX-10.3 (ex10-3.htm)

EX-10.6 (ex10-6.htm)

EX-10.7 (ex10-7.htm)

EX-16.1 (ex16-1.htm)

EX-99.1 (ex99-1.htm)

EX-99.2 (ex99-2.htm)

EX-99.3 (ex99-3.htm)

EX-99.4 (ex99-4.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

--12-31

0002090646

2026-05-08

0002090646

BRUN:ClassCommonStock0.0001ParValuePerShareMember

2026-05-08

0002090646

BRUN:WarrantsEachWholeWarrantIsExercisableForOneShareOfClassOrdinaryShareAtExercisePriceOf11.50PerShareMember

2026-05-08

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported): May 8, 2026

BOOST

RUN INC.

(Exact Name of Registrant as Specified in Charter)

Delaware

001-43277

39-4824850

(State

or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS

Employer

Identification No.)

Revere Drive, Suite 200

Northbrook, IL 60062

(Address of Principal Executive Offices) (Zip Code)

(847)

489-3367

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions (see General Instruction A.2. below):

☐

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Class A Common Stock, $0.0001 par value per

BRUN

The Nasdaq Stock Market LLC

Warrants, each whole warrant is exercisable

for one share of Class A Common Stock at an exercise price of $11.50 per share

BRUNW

The Nasdaq Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Introductory

Note

As previously disclosed, on September 15, 2025, Willow

Lane Acquisition Corp., a Cayman Islands exempted company (“SPAC” or “Willow Lane”), entered into

a Business Combination Agreement (the “Business Combination Agreement,” as amended by Amendment No. 1 to the

Business Combination Agreement, dated January 13, 2026 “Amendment No 1. To the Business Combination Agreement”),

with Boost Run Inc., a Delaware corporation (“Pubco”), Benchmark Merger Sub I Inc., a Delaware corporation and wholly-owned

subsidiary of Pubco (“SPAC Merger Sub”), Boost Run Holdings, LLC, a Delaware limited liability company (the “Company”

or “Boost Run”), Benchmark Merger Sub II LLC, a Delaware limited liability company and wholly-owned subsidiary of

Pubco (“Company Merger Sub”), Andrew Karos, solely in his capacity as the representative of the holders of Boost

Run’s issued and outstanding membership interests, and George Peng, solely in his capacity as the representative of Willow

Lane shareholders. Terms used herein but not defined herein shall be defined in the Proxy Statement/Prospectus (as defined below).

April 30, 2026, Willow Lane held an extraordinary general meeting of its shareholders (the “Meeting”), in connection

with the Business Combination. At the Meeting, Willow Lane shareholders voted to approve the Business Combination and the other related

proposals. In connection with the Meeting, no Willow Lane shareholders exercised their rights to redeem any ordinary shares for a pro

rata portion of the approximately 134.5 million in the trust account of Willow Lane (the “Trust Account”).

May 8, 2026 (the “Closing Date”), the parties consummated the transactions contemplated by the Business Combination

Agreement (the “Business Combination”), as follows:

The

Conversion

the Closing Date, among other things, SPAC caused the continuation and the domestication of SPAC as a corporation incorporated under

the laws of the State of Delaware (the “Conversion”), immediately followed by the deregistration of SPAC as an

exempted company in the Cayman Islands. . The Conversion occurred in accordance with the Delaware General Corporation Law (the “DGCL”)

and Part XII of the Companies Act (As Revised) of the Cayman Islands (the “Act”). Upon the Conversion, each issued

and outstanding SPAC security remained outstanding and became a substantially identical security of SPAC as a Delaware corporation.

The

Mergers

Following

the Conversion, and on the Closing Date, SPAC Merger Sub merged with and into SPAC, with SPAC surviving as a wholly-owned subsidiary

of Pubco (the “SPAC Merger”). Simultaenously with the SPAC Merger, Company Merger Sub merged with and into

Boost Run, with, pursuant to the Certificate of Merger, the surviving entity continuing as Boost Run Services, LLC and

a wholly-owned subsidiary of Pubco (the “Company Merger”, and together with the SPAC Merger, the “Mergers”).

As a result of the Business Combination, SPAC and Boost Run became wholly-owned subsidiaries of Pubco and Pubco became a publicly traded

company.

Pursuant

to the terms of the Business Combination Agreement, at 5:00 p.m. New York City Time on the Closing Date (the “Effective Time”),

by virtue of the Mergers, without any action on the part of any party or any other person:

● Each

share of capital stock of SPAC Merger Sub issued and outstanding immediately prior to the

completion of the SPAC Merger (the “SPAC Merger Effective Time”)

was automatically cancelled and converted into one share of common stock of Willow Lane,

with the same rights, powers and privileges as the shares so converted.

● Each

Willow Lane Public Unit that was issued and outstanding immediately prior to the SPAC Merger

Effective Time was automatically separated, and the holder was deemed to hold one Willow

Lane Ordinary Share and one-half of one Willow Lane Public Warrant. Each Willow Lane Ordinary

Share that was issued and outstanding immediately prior to the SPAC Merger Effective Time

was automatically cancelled and converted into the right to receive one share of Pubco Class

A Common Stock, par value $0.0001 per share (“Pubco Class A Common Stock”).

Each Willow Lane Public Warrant was converted into one Pubco Public Warrant and each Willow

Lane Private Warrant was converted into one Pubco Private Warrant.

● Each

membership interest of Company Merger Sub outstanding immediately prior to the completion

of the Company Merger (the “Company Merger Effective Time”)

was converted into an equal number of membership interests of Boost Run.

● Each

issued and outstanding membership interest of Boost Run (“Company Interest”)

issued and outstanding immediately prior to the Company Merger Effective Time was automatically

cancelled and ceased to exist in exchange for the right to receive (i) to the holder of the

Class A Units, an installment note in the initial principal amount of $8,500,000 (the “Note”),

and (ii) a number of newly issued shares of Pubco Common Stock (defined below) equal to $441,500,000

divided by $10.00 per share (the “Merger Consideration”), consisting of

14,616,982 shares of Pubco Class A Common Stock and 29,533,018 shares of Pubco Class B Common

Stock, par value $0.0001 per share (“Pubco Class B Common Stock”, and

together with the Pubco Class A Common Stock, the “Pubco Common Stock”),

plus (iii) the contingent right to receive up to 7,875,000 Karos Earnout Shares (as

defined below) as described below.

the Closing Date, Pubco issued an aggregate of 44,150,000 shares of Pubco Common Stock to the former holders of Company Interests of

Boost Run (collectively, the “Sellers”) in exchange for their equity interests in Boost Run, consisting of 14,616,982

shares of Pubco Class A Common Stock and 29,533,018 shares of Pubco Class B Common Stock, representing aggregate merger consideration

with a value of $441,500,000 based on a per share value of $10.00. In addition, Pubco issued the Note in the initial principal amount

of $8,500,000 to Andrew Karos, Chief Executive Officer of Boost Run.

Earnout

connection with the Business Combination, the holder of Class A Units of Boost Run (“Andrew Karos”) has the contingent

right to receive up to 7,875,000 newly issued shares of Pubco Class A Common Stock (the “Karos Earnout Shares”), based

on the performance of the Pubco Class A Common Stock during the three-year period following the Closing (the “Earnout Period”),

as follows: (i) if the VWAP of the Pubco Class A Common Stock equals or exceeds $12.50 per share for any 20 trading days within any consecutive

30 trading days during the Earnout Period, 2,625,000 Karos Earnout Shares; (ii) if the VWAP equals or exceeds $15.00 per share under

the same conditions, an additional 2,625,000 Karos Earnout Shares; and (iii) if the VWAP equals or exceeds $17.50 per share under the

same conditions, an additional 2,625,000 Karos Earnout Shares.

addition, pursuant to the Earnout Agreement (as defined below), Willow Lane Sponsor, LLC (the “Sponsor”) may

earn up to 1,125,000 newly issued shares of Pubco Class A Common Stock (the “Sponsor Earnout Shares”) and Goodrich

ILMJS LLC (the “SPV”) may earn up to 1,968,750 newly issued shares of Pubco Class A Common Stock (the “SPV

Earnout Shares”), for a total of 3,093,750 shares, based on the performance of the Pubco Class A Common Stock during the Earnout

Period, with the same VWAP thresholds of $12.50, $15.00 and $17.50 per share described above.

Assumption

of Warrants

connection with the SPAC Merger, each outstanding Willow Lane Public Warrant was converted into one Pubco Public Warrant and each outstanding

Willow Lane Private Warrant was converted into one Pubco Private Warrant. Each Pubco Public Warrant entitles the holder thereof to purchase

one share of Pubco Class A Common Stock at an exercise price of $11.50 per share, subject to adjustment. The Pubco Private Warrants have

substantially the same terms as the Pubco Public Warrants, subject to certain limited exceptions. As of the Closing Date, Pubco had 6,325,000

Pubco Public Warrants and 5,145,722 Pubco Private Warrants issued and outstanding.

Listing

of Securities

Prior

to the Closing Date, the Willow Lane units (the “Willow Lane Units”), Willow Lane Class A Ordinary Shares and

Willow Lane Public Warrants were listed on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “WLACU,”

“WLAC” and “WLACW,” respectively. In connection with the Business Combination, on May 8, 2026, the

Willow Lane Units, Willow Lane Class A Ordinary Shares and Willow Lane Public Warrants ceased trading on Nasdaq.

of the open of trading on May 11, 2026, the Pubco Class A Common Stock and Pubco Public Warrants began trading on Nasdaq under

the symbols “BRUN” and “BRUNW,” respectively.

The descriptions

of the Business Combination Agreement and Amendment No. 1 to the Business Combination Agreement

contained in this Current Report on Form 8-K does not purport to be complete and is qualified in its entirety by the text of the Business

Combination Agreement and the Amendment No. 1 to the Business Combination Agreement, copies

of which are attached as Exhibit 2.1 and Exhibit 2.2,

respectively, to this Current Report on Form 8-K and is incorporated herein by reference.

The

Business Combination Agreement is also described in detail in the definitive proxy statement/prospectus for the Business Combination

filed by Pubco, SPAC and the Company (the “Proxy Statement/Prospectus”).

Item

1.01 Entry into a Material Definitive Agreement

The

information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference.

Lock-up

Agreement

connection with the Business Combination, on the Closing Date, Pubco entered into Lock-Up Agreements (the “Lock-Up Agreements”)

with certain stockholders of Boost Run, pursuant to which each of the parties to the Lock-Up Agreements agreed not to effect any

sale or distribution of any equity securities of Pubco held by any of them during the lock-up period set forth therein.

The

foregoing description of the Lock-Up Agreement is qualified in its entirety by reference to the full text of the agreement, a copy of

which is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Registration

Rights Agreement

connection with the Business Combination, on the Closing Date, Pubco entered into an Amended and Restated Registration Rights Agreement

(the “Registration Rights Agreement”) pursuant to which it agreed to register for resale shares of Pubco Common Stock

and other securities held by the Sellers, the Sponsor, and certain other stockholders, subject to the terms and conditions described

therein.

The

foregoing description of the Registration Rights Agreement is qualified in its entirety by reference to the full text of the agreement,

a copy of which is attached as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference.

Indemnification

Agreements

connection with the Business Combination, on the Closing Date, Pubco entered into indemnification agreements (the “Indemnification

Agreements”) with each of its directors and executive officers. Subject to certain exceptions, the Indemnification Agreements

provide that Pubco will indemnify each of its directors and executive officers for certain expenses, which may include attorneys’

fees, judgments, fines and settlement amounts, incurred by a director or officer in any action or proceeding arising out of their services

as one of Pubco’s directors or officers or any other company or enterprise to which the person provides services at Pubco’s

request.

The

foregoing description of the Indemnification Agreements is qualified in its entirety by reference to the form of Indemnification Agreement,

a copy of which is attached as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.

Earnout

Agreement

In connection with the Business Combination, on September

15, 2025, Pubco, the Sponsor and the SPV entered into an Earnout Agreement (the “Earnout Agreement” as amended

on January 13, 2026, “Amendment to the Earnout Agreement”), providing that the Sponsor may earn up to 1,125,000

Sponsor Earnout Shares and the SPV may earn up to 1,968,750 SPV Earnout Shares based on the performance of the Pubco Class A Common Stock

during the Earnout Period.

The foregoing descriptions

of the Earnout Agreement and Amendment to the Earnout Agreement are qualified in their

entirety by reference to the full text of the agreements, copies of which are

attached as Exhibit 10.4 and Exhibit 10.5, respectively, to this Current Report on Form 8-K

and is incorporated herein by reference.

Weil

Consulting Agreement

January 13, 2026, Pubco entered into a consulting services agreement (the “Weil Consulting Agreement”) with B. Luke

Weil, Chairman and Chief Executive Officer of SPAC, pursuant to which Mr. Weil will provide advice as needed with respect to business

strategy and corporate governance and use his reasonable efforts to introduce Pubco to clients and investors, commencing on the first

business day following the Closing. In consideration for such future services, Pubco has agreed to grant up to 336,000 shares

of Pubco Class A Common Stock to Mr. Weil or his assignees, subject to price-based vesting conditions.

Employment

Agreements

connection with the Business Combination, on the Closing Date, Pubco entered into an employment agreement with Andrew Karos (the “Karos

Employment Agreement”), pursuant to which Mr. Karos serves as Chief Executive Officer of Pubco. Under the Karos Employment

Agreement, Mr. Karos receives a base salary of $1.00 per year, subject to annual review by the Pubco Board (or a duly authorized committee

thereof). Mr. Karos’s employment may be terminated by either party at any time and for any reason in accordance with applicable

law. The Karos Employment Agreement contains customary confidentiality, intellectual property assignment and non-disparagement covenants.

The Karos Employment Agreement is governed by the laws of the State of Illinois.

connection with the Business Combination, on the Closing Date, Pubco entered into an employment agreement with Erik Guckel (the

“Guckel Employment Agreement”), pursuant to which Mr. Guckel serves as Chief Financial Officer of Pubco. Under

the Guckel Employment Agreement, Mr. Guckel receives an annual base salary of $400,000, subject to annual review by the Pubco Board

or its compensation committee. Mr. Guckel is eligible to earn an annual cash bonus with a target of 75% of his base salary, with the

ability to earn between 0% and 150% of such target based on Company and individual performance metrics determined by the Pubco Board

or the compensation committee.

addition, Mr. Guckel is eligible to receive a one-time long-term incentive award under the Incentive Plan consisting of 1,156,304 time-based

restricted stock units, 722,691 performance-based restricted stock units and a nonqualified stock option to purchase 1,011,766 shares

of Pubco Class A Common Stock, subject to the terms and conditions of the Incentive Plan and applicable award agreements.

Mr. Guckel’s employment is terminated by Pubco without cause or by Mr. Guckel for good reason (other than in connection with a

change in control), Mr. Guckel is entitled to, among other things, receive (i) 12 months of base salary continuation, (ii) any

earned but unpaid annual bonus for the prior fiscal year, (iii) a pro-rata annual bonus for the year of termination based on actual performance

and (iv) treatment of outstanding equity in accordance with the Incentive Plan and applicable award agreements, in each case subject

to his execution and non-revocation of a release of claims. If such termination occurs within 12 months following a change in control,

Mr. Guckel is entitled to enhanced severance consisting of, among other things, (i) 18 months of base salary payable in a lump sum, (ii)

any earned but unpaid annual bonus for the prior fiscal year, (iii) 100% of the higher of his target bonus or the prior year’s

actual bonus and (iv) 100% acceleration of outstanding unvested equity awards, in each case subject to his execution and non-revocation

of a release of claims.

The

Guckel Employment Agreement also contains customary confidentiality, intellectual property assignment, non-competition, non-solicitation

and non-disparagement covenants. The non-competition and non-solicitation covenants apply during employment and for 12 months following

termination of employment. The Guckel Employment Agreement is governed by the laws of the State of Illinois.

The

foregoing descriptions of the Karos Employment Agreement and the Guckel Employment Agreement are qualified in their entirety by reference

to the full text of such agreements, copies of which are attached as Exhibits 10.5 and 10.6, respectively, to this Current Report on

Form 8-K and are incorporated herein by reference.

Each

of the above-referenced agreements are described in the Proxy Statement/Prospectus.

Item

1.02 Termination of a Material Definitive Agreement.

The

information set forth in the Introductory Note of this Current Report on Form 8-K and Item 1.01 is incorporated herein by reference.

the Closing Date, in connection with the consummation of the Business Combination, that certain Investment Management Trust Agreement,

dated as of November 12, 2024, between SPAC and Continental Stock Transfer & Trust Company (“CST”), pursuant to

which CST held certain of the proceeds of SPAC’s initial public offering in the Trust Account and facilitated the redemption

of SPAC public shares, was terminated.

Item

2.01 Completion of Acquisition or Disposition of Assets.

The

disclosure set forth in the Introductory Note of this Current Report on Form 8-K and Item 1.01 are incorporated into this Item 2.01 by

reference.

The

Business Combination and each of the other proposals in the Proxy Statement/Prospectus were approved by SPAC’s shareholders at Meeting on April 30, 2026. As indicated above, Pubco issued 44,150,000 shares of Pubco

Common Stock to the Sellers on the Closing Date.

connection with the Meeting, no SPAC Ordinary Shares were redeemed by shareholders of SPAC.

of the Closing Date and following the completion of the Business Combination, Pubco had 61,428,674 shares of Pubco Common Stock

issued and outstanding, consisting of 31,895,656 shares of Pubco Class A Common Stock and 29,533,018 shares of Pubco Class B Common

Stock. In addition, as of the Closing Date, Pubco had 6,325,000 Pubco Public Warrants and 5,145,722 Pubco Private Warrants issued and

outstanding, each Pubco Public Warrant and Pubco Private Warrant entitling the holder thereof to purchase one share of Pubco Class A

Common Stock at an exercise price of $11.50 per share.

FORM

10 INFORMATION

Item

2.01(f) of Form 8-K states that if the predecessor registrant was a shell company, as Pubco was immediately before the consummation of

the Business Combination, then the registrant must disclose the information that would be required if the registrant were filing a general

form for registration of securities on Form 10. Accordingly, Pubco is providing below the information that would be included in the Form

10 if it were to file a Form 10. Please note that the information provided below relates to Pubco following the consummation of the Business

Combination, unless otherwise specifically indicated or the context otherwise requires.

of the Closing Date, Boost Run became Pubco’s wholly-owned subsidiary.

Cautionary

Note Regarding Forward-Looking Statements

This

document and the information incorporated by reference herein include “forward-looking statements” within the meaning of

the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements

of present or historical fact included in or incorporated by reference in this Current Report on Form 8-K, regarding Pubco’s future

financial performance, as well as Pubco’s strategy, future operations, financial position, estimated revenues, and losses, projected

costs, prospects, plans and objectives of management are forward-looking statements. When used in this Current Report on Form 8-K, the

words “could,” “should,” “will,” “may,” “believe,” “anticipate,”

“intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar

expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying

words. These forward-looking statements are based on management’s current expectations and assumptions about future events and

are based on currently available information as to the outcome and timing of future events. Pubco cautions you that these forward-looking

statements are subject to all of the risks and uncertainties, most of which are difficult to predict and many of which are beyond the

control of Pubco, incident to its business.

These

forward-looking statements are based on information available as of the date of this Current Report on Form 8-K, and current expectations,

forecasts and assumptions, and involve a number of risks and uncertainties. Accordingly, forward-looking statements should not be relied

upon as representing Pubco’s views as of any subsequent date, and Pubco does not undertake any obligation to update forward-looking

statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or

otherwise, except as may be required under applicable securities laws.

a result of a number of known and unknown risks and uncertainties, Pubco’s actual results or performance may be materially different

from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:

● Pubco’s

ability to recognize the anticipated benefits of the Business Combination, which may be affected

by, among other things, competition and the ability of Boost Run to grow and manage growth

profitably following the Closing Date;

● the

ability to maintain the listing of the Pubco Common Stock and Pubco Public Warrants

on The Nasdaq Stock Market LLC following the Closing Date;

● the

business, operations and financial performance of the Company following the Business Combination;

● expansion

plans and opportunities, including future acquisitions or additional business combinations;

● Boost

Run’s success in retaining or recruiting, or changes required in, its officers, key

employees or directors following the Business Combination;

● consequences

from the diversion of management’s time from ongoing business operations due to the

Business Combination;

● litigation,

complaints, product liability claims and/or adverse publicity;

● the

impact of changes in consumer spending patterns, consumer preferences, local, regional and

national economic conditions, crime, weather, demographic trends and employee availability;

● privacy

and data protection laws, privacy or data breaches, or the loss of data; and

● other

risks and uncertainties set forth in the Proxy Statement/Prospectus in the section titled

“Risk Factors” beginning on page 58 of the Proxy Statement/Prospectus.

Business

and Facilities

The

information set forth in the section of the Proxy Statement/Prospectus entitled “Information About Boost Run” is incorporated

herein by reference.

Risk

Factors

The

risks associated with Pubco’s business and operations following the Closing Date are described in the Proxy Statement/Prospectus

in the section entitled “Risk Factors” beginning on page 58, which is incorporated herein by reference.

Financial

Information

Audited

Condensed Consolidated Financial Statements

The

following historical financial statements of SPAC and the related notes are incorporated herein by reference from the Proxy Statement/Prospectus:

(i) audited financial statements of Willow Lane as of and for the period ended December 31, 2025; and (ii) audited

financial statements of Willow Lane as of and for the period from July 3, 2024 (inception) through December 31, 2024.

The

following historical financial statements of Boost Run and the related notes are incorporated herein by reference from the Proxy Statement/Prospectus:

the audited financial statements of Boost Run Holdings, LLC as of and for the year ended December 31, 2025.

The

historical financial statements of Pubco, SPAC and Boost Run, and the related notes as of and for the period ended December 31, 2025

are included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

Unaudited

Pro Forma Condensed Combined Financial Information

The

information set forth in Exhibit 99.2 to this Current Report on Form 8-K is incorporated by reference herein.

Management’s

Discussion and Analysis of Financial Condition and Results of Operations

Management’s

discussion and analysis of the financial condition and results of operations prior to the Closing Date is included in the Proxy Statement/Prospectus

in the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations of

Willow Lane” and “ Management’s Discussion and Analysis of Financial Condition and Results of Operations of

Boost Run,” which are incorporated herein by reference.

Boost

Run’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the year ended December 31,

2025 is included as Exhibit 99.3 to this Current Report on Form 8-K and incorporated by reference herein.

Security

Ownership of Certain Beneficial Owners and Management

The

following table sets forth information regarding the beneficial ownership of the Pubco Common Stock as of the Closing Date by:

● each

person who is known to be the beneficial owner of more than 5% of the Pubco Common Stock;

● each

executive officer and director of Pubco; and

● all

executive officers and directors of Pubco as a group.

Beneficial

ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security

if he, she or it possesses sole or shared voting or investment power over that security, including options, rights and convertible notes

that are currently exercisable or exercisable within 60 days.

The

beneficial ownership of Pubco Common Stock is based on 61,428,674 shares of Pubco Common Stock issued and outstanding immediately

following the Closing Date, consisting of 31,895,656 shares of Pubco Class A Common Stock and 29,533,018 shares of Pubco Class

B Common Stock. Each share of Pubco Class B Common Stock is entitled to ten (10) votes per share.

Name

and Address of Beneficial Owner(1)

of Class A Common Stock

of Class

of Class B Common Stock

of Class

Voting

Power

Directors

and Officers

Andrew

Karos

29,533,018

(2)

48.08

29,533,018

100

90.25

Erik

Guckel

Harry

Georgakopoulos

8,016,095

25.13

2.45

Sean

Goodrich(3)(5)

2,065,385

6.48

Luke Weil(4)

4,628,674

14.51

1.41

Ryan

Burke

792,500

2.48

Jeffrey

Kleinops

All

directors and officers as a group (seven individuals)

43,762,787

71.24

29,533,018

100

94.60

Other

5% Shareholders

Willow

Lane Sponsor, LLC(4)

4,628,674

14.51

1.41

Goodrich

ILMJS LLC(5)

2,563,289

4.90

Magnetar

Financial LLC(6)

1,250,000

3.92

Islet

Management, LP(7)

1,153,200

3.62

Daniel

Gormley-Rahn

2,531,397

7.94

Tynan

Wilke

2,109,492

6.61

TOMS

Capital Investment Management LP(8)

3,902,300

12.23

1.19

*Less

than 1%

(1) Unless

otherwise noted, the business address of each of the following entities or individuals is

c/o Boost Run Inc., 5 Revere Drive, Suite 200, Northbrook, IL 60062.

(2) Consists

of 29,533,018 shares of Pubco Class A Common Stock which may be issued upon the conversion

of 29,533,018 shares of Pubco Class B Common Stock.

(3) Includes

792,500 shares of Pubco Class A Common Stock which are directly held by Mr. Goodrich.

(4) Willow

Lane Sponsor, LLC is the record holder of such securities. Mr. Weil is the sole managing

member of the Sponsor and holds voting and investment discretion with respect to the shares

of Pubco Class A Common Stock held of record by the Sponsor. Mr. Weil disclaims any beneficial

ownership of the securities held by Willow Lane’s Sponsor other than to the extent

of any pecuniary interest he may have therein, directly or indirectly. Includes 1,272,885

shares of Pubco Class A Common Stock which may be transferred to the SPV pursuant to the

Transfer Agreement (as defined in the Proxy Statement/Prospectus). Excludes (i) 4,007,222

shares of Pubco Class A Common Stock which are issuable upon the exercise of 4,007,222 Pubco

Private Warrants and (ii) 336,000 shares of Pubco Class A Common Stock to Mr. Weil and/or

his affiliates pursuant to the Weil Consulting Agreement.

(5) Goodrich

ILMJS LLC is the record hold of such securities. Mr. Goodrich is the managing member of Goodrich

ILMJS LLC and holds and holds voting and investment discretion with respect to the shares

of Pubco Class A Common Stock held of record by Goodrich ILMJS LLC. Mr. Goodrich disclaims

any beneficial ownership of the securities held by Goodrich ILMJS LLC other than to the extent

of any pecuniary interest he may have therein, directly or indirectly. Includes 1,272,885

shares of Pubco Class A Common Stock and excludes 1,101,986 shares of Pubco Class A Common

Stocks which are issuable upon the exercise of 1,101,986 Pubco Warrants.

(6) The

reported position is according to a Schedule 13G filed with the SEC on January 29, 2025 by

(i) Magnetar Financial LLC, a Delaware limited liability company (“Magnetar Financial”),

(ii) Magnetar Capital Partners LP, a Delaware limited partnership (“Magnetar Capital

Partners”), (iii) Supernova Management LLC, a Delaware limited liability company

(“Supernova Management”), and (iv) David J. Snyderman, a citizen of the

United States (“Mr. Snyderman,” collectively with Magnetar Financial,

Magnetar Capital Partners and Supernova Management, the “Magnetar Parties”),

in connection with Public Shares held for the following funds (collectively, the “Magnetar

Funds”): (a) Magnetar Constellation Master Fund, Ltd, Magnetar Xing He Master Fund

Ltd, Magnetar SC Fund Ltd, Purpose Alternative Credit Fund Ltd, all Cayman Islands exempted

companies and (b) Magnetar Structured Credit Fund, LP, a Delaware limited partnership and

Magnetar Alpha Star Fund LLC, Magnetar Lake Credit Fund LLC, Purpose Alternative Credit Fund-T

LLC, all Delaware limited liability companies. Magnetar Financial serves as the investment

adviser to the Magnetar Funds, and as such, Magnetar Financial exercises voting and investment

power over the Public Shares held for the Magnetar Funds’ accounts. Magnetar Capital

Partners serves as the sole member and parent holding company of Magnetar Financial. Supernova

Management is the general partner of Magnetar Capital Partners. The manager of Supernova

Management is Mr. Snyderman. The principal business address of each of the Magnetar Parties

is 1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201.

(7) The

reported position is according to a Schedule 13G filed with the SEC on December 2, 2025 by

(i) islet Management LP, organized under the laws of the State of Delaware (“Islet”)

and (ii) Joseph Samuels, a citizen of the United States. Joseph Samuels is the Chief Executive

Officer and Chief Investment Officer of Islet. The principal business address of each of

the parties above is 590 Madison Avenue, 27th Floor, New York, New York 10022.

(8) The

reported position is according to a Schedule 13G filed with the SEC on May 7, 2026 by TOMS

Capital Investment Management LP, organized under the laws of the State of Delaware (“TCIM”).

TCIM Management GP LLC (“TCIM GP”) is the General Partner of TCIM, and

Noam Gottesman is the Senior Member of TCIM GP. Each of TCIM and TCIM GP have established

a management board which has been delegated responsibility for all aspects of the management

and operation of TCIM and TCIM GP.The principal business address of each of the parties above

is 590 Madison Avenue, 27th Floor, New York, New York 10022. 450 West 14th Street, 13th Floor,

New York, NY 10014.

Information

about Directors and Executive Officers

Name

Age

Position

Held

Andrew Karos

Chief Executive Officer, Chair

and Director

Erik Guckel

Chief Financial Officer

Harry Georgakopoulos

Chief Operating Officer, Secretary and Director

Sean Goodrich

Director

B. Luke Weil

Director

Ryan Burke

Director

Rayne Steinberg

Director

Jeffrey Kleinops

Director

Resignations

and Appointments

connection with the closing of the Business Combination, Mr. Weil and George Peng will resign from their positions as Chief Executive

Officer of SPAC and Chief Financial Officer of SPAC, respectively, in connection with the filing of SPAC’s Form 10-Q for

the quarterly period ended March 31, 2026, and each of Marjorie (Maya) Hernandez, Rayne Steinberg, Mauricio Orellana,

Robert Stevens and Simón Gaviria Muñoz resigned from their respective positions as an officer or director

of SPAC, in each case effective as of the Effective Time on the Closing Date. Effective as of the Closing Date, each of Sean Goodrich,

B. Luke Weil, Ryan Burke, Rayne Steinberg and Jeffrey Kleinops were appointed as directors of Pubco. Andrew Karos serves as Chair

of the Pubco Board, Harry Georgakopoulos serves as Chief Operating Officer, Secretary and a director of Pubco, and Erik

Guckel serves as Chief Financial Officer of Pubco.

Information

with respect to Pubco’s directors and officers appointed as of the Closing Date, including biographical information regarding these

individuals, is set forth in the Proxy Statement/Prospectus in the section entitled “Management of Pubco Following the Business

Combination,” which information is incorporated herein by reference.

Risk

Oversight

The

Pubco Board will have extensive involvement in the oversight of risk management related to Pubco and its business and will accomplish

this oversight through the regular reporting to the Pubco Board by the audit committee. The audit committee will represent the Pubco

Board by periodically reviewing Pubco’s accounting, reporting and financial practices, including the integrity of its financial

statements, the surveillance of administrative and financial controls and its compliance with legal and regulatory requirements. Through

its regular meetings with management, including the finance, legal, internal audit and information technology functions, the audit committee

will review and discuss all significant areas of our business and summarize for the Pubco Board all areas of risk and the appropriate

mitigating factors. In addition, the Pubco Board will receive periodic detailed operating performance reviews from management.

Director

Independence

The

Pubco Board consists of seven members, three of whom qualify as independent within the meaning of the independent director guidelines

of Nasdaq. Upon the Closing, Pubco’s majority stockholder, Andrew Karos, holds a majority of the voting power of Pubco Common Stock

and Pubco is a “controlled company” within the meaning of applicable rules of Nasdaq. Under these rules, a company of which

more than 50% of the voting power for the election of directors is held by an individual, group or another company is a “controlled

company” and may elect not to comply with certain corporate governance requirements. Pubco intends to rely on certain of these

exemptions.

Under

the rules of Nasdaq, independent directors must comprise a majority of a listed company’s board of directors. In addition, the

rules of Nasdaq require that, subject to specified exceptions, each member of a listed company’s audit and compensation committees

be independent. Under the rules of Nasdaq, a director will only qualify as an “independent director” if, in the opinion of

that company’s board of directors, that person does not have a relationship that would interfere with the exercise of independent

judgment in carrying out the responsibilities of a director. Audit committee members must also satisfy the additional independence criteria

set forth in Rule 10A-3 of the Exchange Act and the rules of Nasdaq. Compensation committee members must also satisfy the additional

independence criteria set forth in Rule 10C-1 under the Exchange Act and the rules of Nasdaq.

order to be considered independent for purposes of Rule 10A-3 under the Exchange Act and under the rules of Nasdaq, a member of an audit

committee of a listed company may not, other than in his or her capacity as a member of the committee, the board of directors, or any

other board committee: (1) accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company

or any of its subsidiaries; or (2) be an affiliated person of the listed company or any of its subsidiaries.

be considered independent for purposes of Rule 10C-1 under the Exchange Act and under the rules of Nasdaq, the board of directors must

affirmatively determine that the member of the compensation committee is independent, including a consideration of all factors specifically

relevant to determining whether the director has a relationship to the company which is material to that director’s ability to

be independent from management in connection with the duties of a compensation committee member, including, but not limited to: (i) the

source of compensation of such director, including any consulting, advisory or other compensatory fee paid by the company to such director;

and (ii) whether such director is affiliated with the company, a subsidiary of the company or an affiliate of a subsidiary of the company.

The

Pubco Board has undertaken a review of the independence of each director and considered whether each director has a material relationship

that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. As a result of

this review, each of Rayne Steinberg, Ryan Burke and Jeffrey Kleinops has been deemed an “independent director” as defined

under the listing requirements and rules of Nasdaq and the applicable rules of the Exchange Act.

Committees

of the Board of Directors

The

Pubco Board has a standing Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. All of the committees

will comply with all applicable requirements of the Sarbanes-Oxley Act, Nasdaq and SEC rules and regulations as further described below.

The responsibilities of each of the committees of the Pubco Board are described below. Members will serve on these committees until their

resignation or until as otherwise determined by the Pubco Board.

Audit

Committee

Pubco’s

audit committee is responsible for, among other things:

● appointing,

approving the fees of, retaining and overseeing Pubco’s independent registered public

accounting firm;

● discussing

with Pubco’s independent registered public accounting firm their independence from

management;

● discussing

with Pubco’s independent registered public accounting firm any audit problems or difficulties

and management’s response;

● approving

all audit and permissible non-audit services to be performed by Pubco’s independent

registered public accounting firm;

● overseeing

the financial reporting process and discussing with management and Pubco’s independent

registered public accounting firm the interim and annual financial statements that Pubco

files with the SEC;

● reviewing

Pubco’s policies on risk assessment and risk management;

● reviewing

related person transactions; and

● establishing

procedures for the confidential, anonymous submission of complaints regarding questionable

accounting, internal controls or auditing matters.

Pubco’s

Audit Committee currently consists of Rayne Steinberg, Ryan Burke and Jeffrey Kleinops, with Ryan Burke serving as Chairperson. The Pubco

Board has affirmatively determined that Rayne Steinberg, Ryan Burke and Jeffrey Kleinops each meet the definition of “independent

director” for purposes of serving on the Audit Committee under the Nasdaq rules and the independence standards under Rule 10A-3

of the Exchange Act. Each member of the Audit Committee meets the financial literacy requirements of the Nasdaq rules. In addition, the

Pubco Board has determined that Ryan Burke qualifies as an “audit committee financial expert,” as such term is defined in

Item 407(d)(5) of Regulation S-K. The written charter for the Audit Committee will be available on Pubco’s corporate website at

boostrun.com. The information on Pubco’s website is deemed not to be incorporated in this Current Report on Form 8-K.

Compensation

Committee

Pubco’s

Compensation Committee is responsible for, among other things:

● reviewing

and approving, or recommending that the Pubco Board approve, the compensation of Pubco’s

Chief Executive Officer and other executive officers;

● making

recommendations to the Pubco Board regarding director compensation; and

● reviewing

and approving incentive compensation and equity-based plans and arrangements and making grants

of cash-based and equity-based awards under such plans.

Pubco’s

Compensation Committee consists of Andrew Karos, Harry Georgakopoulos and Ryan Burke, with Andrew Karos serving as Chairperson. Ryan

Burke is an independent director. The written charter for the Compensation Committee will be available on Pubco’s corporate website

at boostrun.com. The information on Pubco’s website is deemed not to be incorporated in this Current Report on Form 8-K.

Nominating

and Corporate Governance Committee

Pubco’s

Nominating and Corporate Governance Committee consists of Harry Georgakopoulos, B. Luke Weil and Ryan Burke, with Ryan Burke serving

as Chairperson. Ryan Burke is an independent director under Nasdaq’s listing standards. The Nominating and Corporate Governance

Committee is responsible for overseeing the selection of persons to be nominated to serve on the Pubco Board. The written charter for

the Nominating and Corporate Governance Committee will be available on Pubco’s corporate website at boostrun.com. The information

on Pubco’s website is deemed not to be incorporated in this Current Report on Form 8-K.

Code

of Business Conduct and Ethics

Pubco

has adopted a written code of business conduct and ethics that applies to its directors, officers and employees, including its principal

executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.

A copy of the code is posted on Pubco’s website at boostrun.com. In addition, Pubco intends to post on its website all disclosures

that are required by law or the Nasdaq rules concerning any amendments to, or waivers from, any provision of the code. The information

on Pubco’s website is deemed not to be incorporated in this Current Report on Form 8-K.

Executive

Compensation

connection with the closing of the Business Combination, Pubco entered into employment agreements with Andrew Karos, as Chief Executive

Officer, and Erik Guckel, as Chief Financial Officer. The material terms of the Karos Employment Agreement and the Guckel Employment

Agreement are described above in Item 1.01 of this Current Report on Form 8-K and are incorporated herein by reference.

Overview

of Anticipated Executive Compensation Program

Following

the Closing Date, decisions with respect to the compensation of Pubco’s executive officers, including its named executive officers,

will be made by the Compensation Committee of the Pubco Board. Pubco anticipates that compensation for its executive officers

will have the following components: base salary, cash bonus opportunities, equity compensation, employee benefits and severance protections.

Base salaries, employee benefits and severance protections will be designed to attract and retain senior management talent. Pubco will

also use annual cash bonuses and equity awards to promote performance-based pay that aligns the interests of its executive officers with

the long-term interests of its stockholders and enhances executive retention.

Certain

Relationships and Related Transactions

Certain

relationships and related party transactions are described in the Proxy Statement/Prospectus in the section titled “Certain

Relationships and Related Person Transactions” beginning on page 228 of the Proxy Statement/Prospectus, which is incorporated

herein by reference.

Legal

Proceedings

From

time to time, Pubco and its subsidiaries may become involved in additional legal proceedings arising in the ordinary course of its business.

Market

Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters

Market

Information and Holders

Immediately

prior to the closing of the Business Combination, the Willow Lane Units, Willow Lane Class A Ordinary Shares and Willow Lane Public

Warrants were listed on Nasdaq under the symbols “WLACU,” “WLAC” and “WLACW,” respectively.

of the Closing Date, the Willow Lane Units were separated into Willow Lane Class A Ordinary Shares and Willow Lane Public

Warrants, and the Willow Lane Class A Ordinary Shares were converted into shares of Pubco Class A Common Stock and the Willow Lane

Public Warrants were converted into Pubco Public Warrants. As a result, the Willow Lane Units, Willow Lane Class A Ordinary

Shares and Willow Lane Public Warrants no longer trade.

May 11, 2026, the Pubco Class A Common Stock and Pubco Public Warrants began trading on Nasdaq under the new trading symbols

“BRUN” and “BRUNW,” respectively.

of the Closing Date and following the completion of the Business Combination, Pubco had 61,428,674 shares of Pubco Common Stock

issued and outstanding, consisting of 31,895,656 shares of Pubco Class A Common Stock and 29,533,018 shares of Pubco Class B Common

Stock, held of record by 9 holders. Such numbers do not include Depository Trust Company participants or beneficial owners holding

shares through nominee names.

Dividends

Pubco

has not paid any cash dividends on its Common Stock to date. Pubco may retain future earnings, if any, for future operations, expansion

and debt repayment and has no current plans to pay cash dividends for the foreseeable future. Any decision to declare and pay dividends

in the future will be made at the discretion of the board of directors and will depend on, among other things, Pubco’s results

of operations, financial condition, cash requirements, contractual restrictions and other factors that the board of directors may deem

relevant. In addition, Pubco’s ability to pay dividends may be limited by any Pubco’s outstanding preferred stock and covenants

of any existing and future outstanding indebtedness Pubco or its subsidiaries incur. Pubco does not anticipate declaring any cash dividends

to holders of Common Stock in the foreseeable future.

Recent

Sales of Unregistered Securities

Information

regarding unregistered sales of securities by SPAC is set forth in Part II, Item 2 of SPAC’s Annual Report on Form 10-K filed with

the SEC on March 20, 2026.

Description

of Registrant’s Securities

The

description of Pubco’s securities is set forth in the section of the Proxy Statement/Prospectus entitled “Description

of Pubco Securities” beginning on page 236.

Indemnification

of Directors and Officers

The

DGCL authorizes corporations to limit or eliminate, subject to certain conditions, the personal liability of directors and officers to

corporations and their stockholders for monetary damages for breach of their fiduciary duties. The Pubco organizational documents limit

the liability of Pubco’s directors and officers to the fullest extent permitted by Delaware law.

Pubco

expects to purchase director and officer liability insurance to cover liabilities its directors and officers may incur in connection

with their services to the combined company, including matters arising under the Securities Act. The Pubco organizational documents also

provide that Pubco will indemnify its directors and officers to the fullest extent permitted by Delaware law. In addition, Pubco has

entered into customary indemnification agreements with each of its officers and directors, as described above in Item 1.01 of this

Current Report on Form 8-K.

There

is no pending litigation or proceeding involving any of Pubco’s directors, officers, employees or agents in which indemnification

will be required or permitted. Pubco is not aware of any threatened litigation or proceedings that may result in a claim for such indemnification.

Insofar

as indemnification for liabilities arising under the Securities Act may be permitted to directors, executive officers or persons controlling

the combined company, Pubco has been informed that in the opinion of the SEC such indemnification is against public policy as

expressed in the Securities Act and is therefore unenforceable.

Financial

Statements and Supplementary Data

The

information set forth under Item 9.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item

3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Prior

to the consummation of the Business Combination, the Willow Lane Units, Willow Lane Class A Ordinary Shares and Willow Lane Public

Warrants were listed on Nasdaq under the symbols “WLACU,” “WLAC” and “WLACW,” respectively.

On the Closing Date, the Willow Lane Units, Willow Lane Class A Ordinary Shares and Willow Lane Public Warrants ceased trading

on Nasdaq.

connection with the Business Combination, the Pubco Class A Common Stock and Pubco Public Warrants were approved for listing on Nasdaq.

The Pubco Class A Common Stock and Pubco Public Warrants began trading on Nasdaq under the symbols “BRUN” and “BRUNW,”

respectively, on May 11, 2026.

Item

3.02. Unregistered Sales of Equity Securities.

The

information provided in Item 1.01 of this Form 8-K is incorporated by reference into this Item 3.02.

Item

3.03 Material Modification to Rights of Security Holders.

The

material terms of the organizational documents of Pubco and the general effect upon the rights of holders of Pubco’s capital stock

are described in the sections of the Proxy Statement/Prospectus entitled “The Conversion Proposal” beginning on page

123 of the Proxy Statement/Prospectus, “Description of Pubco Securities” beginning on page 236 of the Proxy Statement/Prospectus

and “Comparison of Corporate Governance and Shareholder Rights” beginning on page 232 of the Proxy Statement/Prospectus,

which information is incorporated herein by reference.

the Closing Date, Pubco filed the Amended and Restated Certificate of Incorporation and adopted new Bylaws. Copies of the Amended

and Restated Certificate of Incorporation and Bylaws are filed as Exhibits 3.1 and 3.2 to this Current Report on Form 8-K, respectively,

and are incorporated herein by reference.

Item

4.01 Changes in Registrant’s Certifying Accountant

Upon

the consummation of the Business Combination, Pubco appointed Elliott Davis, PLLC as Pubco’s independent registered public

accounting firm to audit Pubco’s consolidated financial statements as of and for the year ending December 31, 2026.

Accordingly,

WithumSmith+Brown, PC, the independent registered public accounting firm for Willow Lane prior to the Business

Combination, was dismissed as of the date of the consummation of the Business Combination.

There

were no “disagreements” (as such term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) with

the prior auditor on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures,

which disagreements, if not resolved to the satisfaction of the prior auditor, would have caused the prior auditor to make reference

thereto in its report on the pre-merger financial statements for such periods. There have been no “reportable events” (as

such term is defined in Item 304(a)(1)(v) of Regulation S-K).

Pubco

provided the prior auditor with a copy of the foregoing disclosures and has requested that the prior auditor furnish Pubco with

a letter addressed to the SEC stating whether it agrees with the statements made by Pubco set forth above. A copy of the prior

auditor’s letter, dated May 14, 2026, is filed as Exhibit 16.1 to this Current Report on Form 8-K.

Item

5.01 Changes in Control of Registrant.

The

information set forth in the Introductory Note of this Current Report on Form 8-K and in the section entitled “Security Ownership

of Certain Beneficial Owners and Management” in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of

Certain Officers.

The

information set forth in the Introductory Note of this Current Report on Form 8-K and in the section entitled “Information about

Directors and Executive Officers” in Item 2.01 of this Current Report on Form 8-K is incorporated by reference herein.

Incentive

Plan

connection with the Business Combination, Pubco adopted the Boost Run Inc. 2026 Omnibus Incentive Plan (the “Incentive Plan”).

The Incentive Plan reserves 9,214,301 shares of Pubco Class A Common Stock for issuance. The Incentive Plan permits the grant of options

(including incentive stock options and nonqualified stock options), stock appreciation rights, restricted stock, restricted stock units,

performance-based awards, other share-based awards and other cash-based awards. The material terms of the Incentive Plan are discussed

in the section of the Proxy Statement/Prospectus entitled “The Incentive Plan Proposal,” which information is incorporated

herein by reference.

The

information regarding the Karos Employment Agreement and the Guckel Employment Agreement set forth in Item 1.01 of this Current Report

on Form 8-K is incorporated herein by reference.

Directors

and Executive Officers

The

information regarding Pubco’s directors and executive officers set forth under the headings “Directors and Executive Officers”

and “Executive Compensation” in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item

5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The

information set forth in Item 3.03 of this Current Report on Form 8-K is incorporated herein by reference.

Item

5.06 Change in Shell Company Status

a result of the Business Combination, which fulfilled the definition of a business combination as required by SPAC’s organizational

documents, the SPAC ceased to be a shell company (as defined in Rule 12b-2 of the Exchange Act) as of the Closing Date. The material

terms of the Business Combination are described in the Proxy Statement/Prospectus in the section entitled “The Business Combination

Proposal” beginning on page 85 of the Proxy Statement/Prospectus, which is incorporated herein by reference.

Item

7.01. Regulation FD Disclosure.

May 8, 2026, Pubco issued a press release announcing the consummation of the Business Combination, which is included in this Current

Report on Form 8-K as Exhibit 99.4.

Item

9.01 Financial Statements and Exhibits.

(a)

Financial Statements of Business Acquired

The

following historical financial statements of SPAC and the related notes are incorporated herein by reference from the Proxy Statement/Prospectus:

(i) audited financial statements of Willow Lane as of and for the period ended December 31, 2025; and (ii) audited

financial statements of Willow Lane as of and for the period from July 3, 2024 (inception) through December 31, 2024.

The

following historical financial statements of Boost Run and the related notes are incorporated herein by reference from the Proxy Statement/Prospectus:

the audited financial statements of Boost Run Holdings, LLC as of and for the year ended December 31, 2025.

The

historical financial statements of Pubco, SPAC and Boost Run, and the related notes as of and for the period ended December 31, 2025,

are included as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

(b)

Pro Forma Financial Information

The

unaudited pro forma condensed combined financial information of SPAC, Pubco and Boost Run as of December 31, 2025, are set forth in Exhibit

99.2 hereto and are incorporated by reference herein.

(d)

Exhibits

Exhibit

Index

Exhibit

No.

Description

2.1+

Business Combination Agreement, dated as of September 15, 2025, by and among (i) Boost Run Inc. (f/k/a Pubco), (ii) Benchmark Merger Sub I Inc., (iii) Benchmark Merger Sub II LLC, (iv) Willow Lane Acquisition Corp., (v) Boost Run Holdings, LLC, (vi) Andrew Karos, and (vii) George Peng (incorporated by reference to Exhibit 2.1 to the Registration Statement on Form S-4, as amended (File No. 333-292712) filed on January 13, 2026).

2.2

Amendment No. 1 to the Business Combination Agreement (incorporated by reference to Exhibit 2.1 to Willow Lane’s Current Report on Form 8-K, filed with the SEC on January 13, 2026).

3.1

Amended and Restated Certificate of Incorporation of Boost Run Inc., effective upon the Closing.

3.2

Amended and Restated Bylaws of Boost Run Inc., effective upon the Closing.

10.1

Form of Lock-Up Agreement.

10.2

Amended and Restated Registration Rights Agreement.

10.3

Form of Indemnification Agreement.

10.4

Earnout Agreement, dated as of September 15, 2025, by and among Willow Lane Sponsor, LLC, Goodrich ILMJS LLC and Boost Run Inc (incorporated by reference to Exhibit 10.7 to Willow Lane’s Current Report on Form 8-K, filed with the SEC on September 19, 2025).

10.5

Amendment to the Earnout Agreement, dated January 13, 2026, by and among Boost Run, Inc., Willow Lane Sponsor LLC and Goodrich ILMJS LLC (incorporated by reference to Exhibit 99.1 to Willow Lane’s Current Report on Form 8-K, filed with the SEC on January 13, 2026).

10.6

Employment Agreement, dated as of May 8, 2026, between Boost Run Inc. and Andrew Karos.

10.7

Employment Agreement, dated as of May 8, 2026, by and between Boost Run Inc. and Erik Guckel.

16.1

Letter from WithumSmith+Brown, PC to the Securities and Exchange Commission, dated May 14, 2026.

99.1

Audited financial statements of Pubco, SPAC and Boost Run for the period ended December 31, 2025.

99.2

Unaudited Pro Forma Condensed Combined Financial Information of SPAC, Pubco and Boost Run.

99.3

Boost Run’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the year ended December 31, 2025.

99.4

Press Release.

104

Cover Page Interactive Data File (formatted

as Inline XBRL and contained in Exhibit 101).

+ Schedule

and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). Pubco agrees

to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.

SIGNATURE

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Dated:

May 14, 2026

BOOST

RUN INC.

By:

/s/

Andrew Karos

Name:

Andrew

Karos

Title:

Chief

Executive Officer

EX-3.1

Filename: ex3-1.htm · Sequence: 2

Exhibit

3.1

AMENDED

AND RESTATED

CERTIFICATE

OF INCORPORATION

BOOST

RUN INC.

Pursuant

to Sections 242 and 245 of the

Delaware

General Corporation Law

Boost

Run Inc., a corporation existing under the laws of the State of Delaware (the “Corporation”), by its Chief

Executive Officer, hereby certifies as follows:

The name of the Corporation is “Boost Run Inc.”.

The Corporation’s original Certificate of Incorporation was filed in the office of the Secretary of State of the State of Delaware

on September 5, 2025.

This Amended Restated Certificate of Incorporation (this “Certificate”) restates, integrates and amends the

Certificate of Incorporation of the Corporation.

This Amended and Restated Certificate of Incorporation was duly adopted by the directors and stockholders of the Corporation in accordance

with the applicable provisions of Sections 141(f), 228, 242 and 245 of the General Corporation Law of the State of Delaware (“DGCL”).

The text of the Certificate of Incorporation of the Corporation is hereby amended and restated to read in full as follows:

FIRST:

The name of the corporation is “Boost Run Inc.” (hereinafter sometimes referred to as the “Corporation”).

SECOND:

The registered office of the Corporation in the State of Delaware is to be located at Corporation Trust Center, 1209 Orange Street, Wilmington

(New Castle County), Delaware 19801. The name of its registered agent at that address is The Corporation Trust Company.

THIRD:

The purpose of the Corporation shall be to engage in any lawful act or activity for which corporations may be organized under the DGCL.

In addition to the powers and privileges conferred upon the Corporation by law and those incidental thereto, the Corporation shall possess

and may exercise all the powers and privileges that are necessary or convenient to the conduct, promotion or attainment of the business

or purposes of the Corporation.

FOURTH:

The total number of shares of all classes of capital stock which the Corporation shall have authority to issue is 1,000,000,000 of which

(i) 700,000,000 shares shall be Common Stock of the par value of $0.0001 per share (“Common Stock”), representing

(a) 500,000,000 shares of Class A Common Stock (“Class A Common Stock”) and (b) 200,000,000 shares of Class

B Common Stock (“Class B Common Stock”), and (ii) 300,000,000 shares shall be Preferred Stock of the par value

of $0.0001 per share (“Preferred Stock”).

Preferred Stock. The Board of Directors is expressly granted authority to issue shares of the Preferred Stock, in one or more

series, and to fix for each such series such voting powers, full or limited, and such designations, preferences and relative, participating,

optional or other special rights and such qualifications, limitations or restrictions thereof as shall be stated and expressed in the

resolution or resolutions adopted by the Board of Directors providing for the issue of such series (a “Preferred Stock Designation”)

and as may be permitted by the DGCL. The number of authorized shares of Preferred Stock may be increased or decreased (but not below

the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the voting power of all of the

then outstanding shares of the capital stock of the Corporation entitled to vote generally in the election of directors, voting together

as a single class, without a separate vote of the holders of the Preferred Stock, or any series thereof, unless a vote of any such holders

is required pursuant to any Preferred Stock Designation.

Rights of Class A Common Stock and Class B Common Stock.

(1)

Voting. Except as otherwise required by law or this Certificate of Incorporation (including any Preferred Stock Designation),

the holders of shares of Class A Common Stock and Class B Common Stock shall (a) at all times vote together as a single class on all

matters (including the election of directors) submitted to a vote or for the consent (if action by written consent of the stockholders

is permitted at such time under this Certificate of Incorporation) of the stockholders of the corporation, (b) be entitled to notice

of any stockholders’ meeting in accordance with the Bylaws of the corporation and (c) be entitled to vote upon such matters and

in such manner as may be provided by the DGCL. Except as otherwise expressly provided herein or required by the DGCL, each holder of

Class B Common Stock shall have the right to ten (10) votes per share of Class B Common Stock held of record by such holder and each

holder of Class A Common Stock shall have the right to one (1) vote per share of Class A Common Stock held of record by such holder.

(2)

Dividend and Distribution Rights. Shares of Class A Common Stock and Class B Common Stock shall be treated equally, identically

and ratably, on a per share basis, with respect to any dividends or distributions as may be declared and paid from time to time by the

Board of Directors out of any assets of the corporation legally available therefor; provided, however, that in the event a dividend is

paid in the form of shares of Class A Common Stock or Class B Common Stock (or rights to acquire such shares), then holders of Class

A Common Stock shall receive shares of Class A Common Stock (or rights to acquire such shares, as the case may be) and holders of Class

B Common Stock shall receive shares of Class B Common Stock (or rights to acquire such shares, as the case may be), with holders of shares

of Class A Common Stock and Class B Common Stock receiving, on a per share basis, an identical number of shares of Class A Common Stock

or Class B Common Stock, as applicable. Notwithstanding the foregoing, the Board of Directors may pay or make a disparate dividend or

distribution per share of Class A Common Stock or Class B Common Stock (whether in the amount of such dividend or distribution payable

per share, the form in which such dividend or distribution is payable, the timing of the payment, or otherwise) if such disparate dividend

or distribution is approved in advance by the affirmative vote (or written consent if action by written consent of stockholders is permitted

at such time under this Certificate of Incorporation) of the holders of a majority of the outstanding shares of Class A Common Stock

and Class B Common Stock, each voting separately as a class.

(3)

Subdivisions, Combinations or Reclassifications. Shares of Class A Common Stock or Class B Common Stock may not be subdivided,

combined or reclassified unless the shares of the other class are concurrently therewith proportionately subdivided, combined or reclassified

in a manner that maintains the same proportionate equity ownership between the holders of the outstanding Class A Common Stock and Class

B Common Stock on the record date for such subdivision, combination or reclassification; provided, however, that shares of one such class

may be subdivided, combined or reclassified in a different or disproportionate manner if such subdivision, combination or reclassification

is approved in advance by the affirmative vote (or written consent if action by written consent of stockholders is permitted at such

time under this Certificate of Incorporation) of the holders of a majority of the outstanding shares of Class A Common Stock and Class

B Common Stock, each voting separately as a class.

(4)

Liquidation, Dissolution or Winding Up of the Corporation. Subject to the preferential or other rights of any holders of Preferred

Stock then outstanding, upon the dissolution, liquidation or winding up of the corporation, whether voluntary or involuntary, holders

of Class A Common Stock and Class B Common Stock will be entitled to receive ratably all assets of the corporation available for distribution

to its stockholders unless disparate or different treatment of the shares of each such class with respect to distributions upon any such

liquidation, dissolution or winding up is approved in advance by the affirmative vote (or written consent if action by written consent

of stockholders is permitted at such time under this Certificate of Incorporation) of the holders of a majority of the outstanding shares

of Class A Common Stock and Class B Common Stock, each voting separately as a class.

Conversion of Class B Common Stock.

(1)

Automatic

Conversion. Each share of Class B Common Stock shall automatically be converted into one fully paid and nonassessable share of

Class A Common Stock upon any sale, assignment, transfer, conveyance, hypothecation or other transfer or disposition of such share

or any legal or beneficial interest in such share, whether or not for value and whether voluntary or involuntary or by operation

of law, including, without limitation, a transfer of a share of Class B Common Stock to a broker or other nominee (regardless of

whether there is a corresponding change in beneficial ownership), or the transfer of, or entering into a binding agreement with respect

to voting control over such share by proxy or otherwise (each a “Transfer”), other than a Permitted Transfer

(as defined below), of such share of Class B Common Stock. In addition, each share of Class B Common Stock shall automatically be

converted into one fully paid and nonassessable share of Class A Common Stock upon the holder of such share ceasing to serve as an

executive officer or director of the Company, or upon the holder owning less than forty percent (40%) of the Class B shares that

he initially owned at the closing of the initial business combination transactions contemplated by that certain Business Combination

Agreement, dated as of September 15, 2025, by and among Willow Lane Acquisition Corp., Boost Run Holdings, LLC, and other parties

thereto, as the same may be amended, restated, supplemented or waived from time to time (the “Business Combination”).

Such conversion shall occur automatically without the need for any further action by the holders of such shares and whether or not

the certificates representing such shares (if any) are surrendered to the Company or its transfer agent; provided, however, that

the Company shall not be obligated to issue certificates evidencing the shares of Class A Common Stock issuable upon such conversion

unless the certificates evidencing such shares of Class B Common Stock are either delivered to the Company or its transfer agent

as provided below, or the holder notifies the Company or its transfer agent that such certificates have been lost, stolen or destroyed

and executes an agreement satisfactory to the Company to indemnify the Company from any loss incurred by it in connection with such

certificates. Upon the occurrence of such automatic conversion of shares of Class B Common Stock, the holders of shares of Class

B Common Stock so converted shall surrender the certificates representing such shares (if any) at the office of the Company or any

transfer agent for the shares of Class A Common Stock.

(2)

Permitted

Transfers. The following shall not be considered a Transfer: (i) the granting of a revocable proxy to officers or directors of

the Company at the request of the Board of Directors in connection with actions to be taken at an annual or special meeting of stockholders;

(ii) the existence of any proxy granted prior to the effective time of the Business Combination or the amendment or expiration of

any such proxy; (iii) entering into a voting trust, agreement or arrangement (with or without granting a proxy) solely with stockholders

who are holders of shares of Class B Common Stock that (A) is disclosed either in a Schedule 13D filed with the Securities and Exchange

Commission or in writing to the Secretary of the Company, (B) either has a term not exceeding one year or is terminable by the holder

of the shares subject thereto at any time and (C) does not involve any payment of cash, securities, property or other consideration

to the holder of the shares subject thereto other than the mutual promise to vote shares in a designated manner; (iv) the pledge

of shares of Class B Common Stock by a stockholder that creates a mere security interest in such shares pursuant to a bona fide loan

or indebtedness transaction for so long as such stockholder continues to exercise exclusive voting control over such pledged shares;

provided, however, that a foreclosure on such shares or other similar action by the pledgee shall constitute a Transfer unless such

foreclosure or similar action qualifies as a Permitted Transfer; or (v) entering into, or reaching an agreement, arrangement or understanding

regarding, a support or similar voting or tender agreement (with or without granting a proxy) in connection with a liquidation of

the Company, business combination, or acquisition that has been approved by the Board of Directors.

FIFTH:

The number of members of the entire Board shall be fixed, from time to time, exclusively by the Board, in accordance with the bylaws

of the Corporation (as amended from time to time in accordance with the provisions hereof and thereof, the “Bylaws”),

subject to the rights of holders of any series of Preferred Stock with respect to the election of directors, if any.

The Board shall consist of directors whose number shall be fixed exclusively by the Board. All directors shall be elected at each annual

meeting of stockholders for a term expiring at the next annual meeting of stockholders and until their successors shall have been elected

and qualified. Except as the DGCL may otherwise require, in the interim between annual meetings of stockholders or special meetings of

stockholders called for the election of directors and/or the removal of one or more directors and the filling of any vacancy in that

connection, newly created directorships and any vacancies in the Board, including unfilled vacancies resulting from the removal of directors,

may be filled only by the vote of a majority of the remaining directors then in office, although less than a quorum (as defined in the

Bylaws), or by the sole remaining director. All directors shall hold office until the expiration of their respective terms of office

and until their successors shall have been elected and qualified. A director elected to fill a vacancy resulting from the death, resignation

or removal of a director shall serve for the remainder of the term and until his successor shall have been elected and qualified. Directors

may be removed from office at any time, but only for cause and only by the affirmative vote of holders of 66-2/3% of the voting power

of all then-outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors, voting together

as a single class.

SIXTH:

The following provisions are inserted for the management of the business and for the conduct of the affairs of the Corporation, and for

further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders:

Election of directors need not be by ballot unless the Bylaws so provide.

In furtherance and not in limitation of the powers conferred by the laws of the State of Delaware, the Board is expressly authorized

to make, alter and repeal the Bylaws without the consent of the stockholders in any manner not inconsistent with the laws of the State

of Delaware or this Certificate. Notwithstanding anything to the contrary contained in this Certificate or any provision of law which

might otherwise permit a lesser vote of the stockholders, the stockholders may adopt, amend, alter or repeal the Bylaws only with the

affirmative vote of the holders of not less than 66-2/3% of the voting power of all outstanding securities of the Corporation generally

entitled to vote in the election of directors, voting together as a single class.

Any action required or permitted to be taken by the stockholders of the Corporation at a annual or special meeting of the stockholders

of the Corporation may be effected by written consent in lieu of a meeting.

Except as otherwise expressly provided by the terms of any series of Preferred Stock permitting the holders of such series of Preferred

Stock to call a special meeting of the holders of such series, special meetings of the stockholders of the Corporation may be called

only by the chairperson of the Board, the chief executive officer of the Corporation or the Board, and the ability of the stockholders

to call a special meeting of the stockholders is hereby specifically denied.

Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting

of the stockholders of the Corporation shall be given in the manner provided in the Bylaws.

The directors in their discretion may submit any contract or act for approval or ratification at any annual meeting of the stockholders

or at any special meeting of the stockholders called for the purpose of considering any such act or contract, and any contract or act

that shall be approved or be ratified by the vote of the holders of a majority of the stock of the Corporation which is represented in

person or by proxy at such meeting and entitled to vote thereat (provided that a lawful quorum of stockholders be there represented in

person or by proxy), unless a higher vote is required by applicable law, shall be as valid and binding upon the Corporation and upon

all the stockholders as though it had been approved or ratified by every stockholder of the Corporation, whether or not the contract

or act would otherwise be open to legal attack because of directors’ interests, or for any other reason.

In addition to the powers and authorities hereinbefore or by statute expressly conferred upon them, the directors are hereby empowered

to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation; subject, nevertheless, to

the provisions of the statutes of the State of Delaware and of this Certificate.

SEVENTH:

A director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for

breach of fiduciary duty as a director or officer, except to the extent such exemption from liability or limitation thereof is not permitted

under the DGCL, as it presently exists or may hereafter be amended from time to time. If the DGCL is amended to authorize corporate action

further eliminating or limiting the personal liability of directors or officers, then the liability of a director or officer of the Corporation

shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. Neither the repeal or modification of this

paragraph A nor, to the fullest extent permitted by the DGCL, any modification of law shall adversely affect any right or protection

of a director of the Corporation with respect to events occurring prior to the time of such repeal or modification.

The Corporation, to the full extent permitted by Section 145 of the DGCL, as amended from time to time, shall indemnify all persons whom

it may indemnify pursuant thereto, and such right to indemnification shall continue as to a person who has ceased to be a director or

officer of the Corporation and shall inure to the benefit of such person’s heirs, executors and personal and legal representatives.

Expenses (including attorneys’ fees) incurred by an officer or director in defending any civil, criminal, administrative, or investigative

action, suit or proceeding for which such officer or director may be entitled to indemnification hereunder shall be paid by the Corporation

in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director

or officer to repay such amount if it shall ultimately be determined that he or she is not entitled to be indemnified by the Corporation

as authorized hereby.

The rights to indemnification and advancement of expenses conferred in this Article Seventh of this Certificate shall neither be exclusive

of, nor be deemed in limitation of, any rights to which any person may otherwise be or become entitled or permitted under this Certificate,

the Bylaws, any statute, agreement, vote of stockholders or disinterested directors or otherwise.

EIGHTH:

Whenever a compromise or arrangement is proposed between this Corporation and its creditors or any class of them and/or between this

Corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application

in a summary way of this Corporation or of any creditor or stockholder thereof or on the application of any receiver or receivers appointed

for this Corporation under Section 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of any receiver

or receivers appointed for this Corporation under Section 279 of Title 8 of the Delaware Code order a meeting of the creditors or class

of creditors, and/or of the stockholders or class of stockholders of this Corporation, as the case may be, to be summoned in such manner

as the said court directs. If a majority in number representing three fourths in value of the creditors or class of creditors, and/or

of the stockholders or class of stockholders of this Corporation, as the case may be, agree to any compromise or arrangement and to any

reorganization of this Corporation as a consequence of such compromise or arrangement, the said compromise or arrangement and the said

reorganization shall, if sanctioned by the court to which the said application has been made, be binding on all the creditors or class

of creditors, and/or on all the stockholders or class of stockholders, of this Corporation, as the case may be, and also on this Corporation.

NINTH:

Unless a majority of the Board, acting on behalf of the Corporation, consents in writing to the selection of an alternative forum, the

Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for any stockholder

(including a beneficial owner) to bring (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action

asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation

or the Corporation’s stockholders, (iii) any action asserting a claim against the Corporation, its directors, officers or employees

arising pursuant to any provision of the DGCL or this Certificate or the Bylaws, or (iv) any action asserting a claim against the Corporation,

its directors, officers or employees governed by the internal affairs doctrine and, if brought outside of Delaware, the stockholder bringing

the suit will be deemed to have consented to service of process on such stockholder’s counsel. Notwithstanding the foregoing, the

Court of Chancery of the State of Delaware shall not be the sole and exclusive forum for any of the following actions: (A) as to which

the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the

Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days

following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery,

(C) for which the Court of Chancery does not have subject matter jurisdiction, or (D) any action arising under the Securities Act of

1933, as amended, or the Securities Exchange Act of 1934, as amended, or, in each case, rules and regulations promulgated thereunder,

for which there is exclusive federal or concurrent federal and state jurisdiction.

If any action the subject matter of which is within the scope of paragraph A immediately above is filed in a court other than a court

located within the State of Delaware (a “Foreign Action”) in the name of any stockholder, such stockholder

shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware

in connection with any action brought in any such court to enforce paragraph A immediately above (an “Enforcement Action”)

and (ii) having service of process made upon such stockholder in any such Enforcement Action by service upon such stockholder’s

counsel in the Foreign Action as agent for such stockholder.

If any provision or provisions of this Article Ninth shall be held to be invalid, illegal or unenforceable as applied to any person or

entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability

of such provisions in any other circumstance and of the remaining provisions of this Article Ninth (including, without limitation, each

portion of any sentence of this Article Ninth containing any such provision held to be invalid, illegal or unenforceable that is not

itself held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and circumstances

shall not in any way be affected or impaired thereby. Any person or entity purchasing or otherwise acquiring any interest in shares of

capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article Ninth.

TENTH:

The doctrine of corporate opportunity, or any other analogous doctrine, shall not apply with respect to the Corporation or any of its

officers or directors in circumstances where the application of any such doctrine would conflict with any fiduciary duties or contractual

obligations they may have as of the date of this Certificate or in the future, and the Corporation renounces any expectancy that any

of the directors or officers of the Corporation will offer any such corporate opportunity of which he or she may become aware to the

Corporation. In addition to the foregoing, the doctrine of corporate opportunity shall not apply to any other corporate opportunity with

respect to any of the directors or officers of the Corporation unless such corporate opportunity is offered to such person solely in

his or her capacity as a director or officer of the Corporation and such opportunity is one the Corporation is legally and contractually

permitted to undertake and would otherwise be reasonable for the Corporation to pursue.

ELEVENTH:

The Corporation reserves the right to amend, alter or repeal any provision contained in this Certificate, in the manner now or hereafter

prescribed by this Certificate and the DGCL, and all rights, preferences and privileges herein conferred upon stockholders of the Corporation

by and pursuant to this Certificate in its present form or as hereafter amended are granted subject to the right reserved in this Article

Eleventh. Notwithstanding any other provisions of this Certificate or any provision of law which might otherwise permit a lesser vote

or no vote, but in addition to any other vote that may be required by law, applicable stock exchange rule or the terms of any series

of Preferred Stock, the stockholders may amend, alter, or repeal, or adopt any provision inconsistent with, any provision of Article

Fifth, Sixth or Eleventh of this Certificate only with the affirmative vote of the holders of not less than 66-2/3% of the voting power

of all outstanding securities of the Corporation generally entitled to vote in the election of directors, voting together as a single

class.

TWELFTH:

The Corporation will not be subject to Section 203 of the DGCL.

[Signature

Page Follows]

WITNESS WHEREOF, the Corporation has caused this Amended and Restated Certificate of Incorporation to be signed by its , as of the day

of , 2025.

Chief Executive Officer

EX-3.2

Filename: ex3-2.htm · Sequence: 3

Exhibit

3.2

Adopted

as of , 2026

BYLAWS

BOOST

RUN INC.

ARTICLE

OFFICES

1.1

Registered Office. The registered office of Boost Run Inc. (the “Corporation”) in the State of Delaware shall be established

and maintained at Corporation Trust Center, 1209 Orange Street, Wilmington (New Castle County), Delaware 19801 and The Corporation Trust

Company. shall be the registered agent of the corporation in charge thereof.

1.2

Other Offices. The Corporation may also have offices at such other places both within and without the State of Delaware as the

board of directors of the Corporation (the “Board of Directors”) may from time to time determine or the business

of the Corporation may require.

ARTICLE

MEETINGS

OF STOCKHOLDERS

2.1

Place of Meetings. All meetings of the stockholders shall be held at such time and place, either within or without the State of

Delaware, as shall be designated from time to time by the Board of Directors and stated in the notice of the meeting or in a duly executed

waiver of notice thereof.

2.2

Annual Meetings.

(a)

The annual meeting of stockholders shall be held on such date and at such time as may be fixed by the Board of Directors and stated in

the notice of the meeting, for the purpose of electing directors and for the transaction of only such other business as is properly brought

before the meeting in accordance with these Bylaws (the “Bylaws”).

(b)

Written notice of an annual meeting stating the place, date and hour of the meeting, shall be given to each stockholder entitled to vote

at such meeting not less than ten (10) nor more than sixty (60) days before the date of the annual meeting.

(c)

To be properly brought before the annual meeting, business must be either (i) specified in the notice of annual meeting (or any supplement

or amendment thereto) given by or at the direction of the Board of Directors, (ii) otherwise brought before the annual meeting by or

at the direction of the Board of Directors, or (iii) otherwise properly brought before the annual meeting by a stockholder. In addition

to any other applicable requirements, for business to be properly brought before an annual meeting by a stockholder, the stockholder

must have given timely notice thereof in writing to the Secretary of the Corporation. To be timely, a stockholder’s notice must

be delivered to or mailed and received at the principal executive offices of the Corporation not less than sixty (60) days nor more than

ninety (90) days prior to the meeting; provided, however, that in the event that less than seventy (70) days’ notice or prior public

disclosure of the date of the annual meeting is given or made to stockholders, notice by a stockholder, to be timely, must be received

no later than the close of business on the tenth (10th) day following the day on which such notice of the date of the annual

meeting was mailed or such public disclosure was made, whichever first occurs. A stockholder’s notice to the Secretary shall set

forth (a) as to each matter the stockholder proposes to bring before the annual meeting (i) a brief description of the business desired

to be brought before the annual meeting and the reasons for conducting such business at the annual meeting, and (ii) any material interest

of the stockholder in such business, and (b) as to the stockholder giving the notice (i) the name and record address of the stockholder

and (ii) the class, series and number of shares of capital stock of the Corporation which are beneficially owned by the stockholder.

Notwithstanding anything in these Bylaws to the contrary, no business shall be conducted at the annual meeting except in accordance with

the procedures set forth in this Article II, Section 2. The officer of the Corporation presiding at an annual meeting shall, if the facts

warrant, determine and declare to the annual meeting that business was not properly brought before the annual meeting in accordance with

the provisions of this Article II, Section 2, and if such officer should so determine, such officer shall so declare to the annual meeting

and any such business not properly brought before the meeting shall not be transacted.

2.3

Special Meetings.

(a)

Special meetings of the stockholders, for any purpose or purposes, unless otherwise prescribed by statute or by the Certificate of Incorporation

of the Corporation (the “Certificate of Incorporation”), may only be called by the chairperson of the Board,

the chief executive officer of the Corporation or the Board of Directors. Such request shall state the purpose or purposes of the proposed

meeting.

(b)

Unless otherwise provided by law, written notice of a special meeting of stockholders, stating the time, place and purpose or purposes

thereof, shall be given to each stockholder entitled to vote at such meeting, not less than ten (10) or more than sixty (60) days before

the date fixed for the meeting. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in

the notice.

2.4

Quorum. The holders of a majority of the voting power of the capital stock issued and outstanding and entitled to vote thereat,

present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business

except as otherwise provided by statute or by the Certificate of Incorporation. If, however, such quorum shall not be present or represented

at any meeting of the stockholders, the holders of a majority of the votes entitled to be cast by the stockholders entitled to vote thereat,

present in person or represented by proxy, shall have power to adjourn the meeting from time to time, without notice other than announcement

at the meeting, until a quorum shall be present or represented. At such adjourned meeting at which a quorum shall be present or represented,

any business may be transacted which might have been transacted at the meeting as originally noticed. If the adjournment is for more

than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting

shall be given to each stockholder entitled to vote at the meeting.

2.5

Organization.

(a)

The Chairman of the Board of Directors shall act as chairman of meetings of the stockholders. The Board of Directors may designate any

other officer or director of the Corporation to act as chairman of any meeting in the absence of the Chairman of the Board of Directors,

and the Board of Directors may further provide for determining who shall act as chairman of any stockholders meeting in the absence of

the Chairman of the Board of Directors and such designee.

(b)

The Secretary of the Corporation shall act as secretary of all meetings of the stockholders, but in the absence of the Secretary the

presiding officer may appoint any other person to act as secretary of any meeting.

2.6

Voting. Unless otherwise required by law, the Certificate of Incorporation or these Bylaws, any question (other than the election

of directors) brought before any meeting of stockholders shall be decided by the vote of the holders of a majority of the stock represented

and entitled to vote on such question. At all meetings of stockholders for the election of directors, a plurality of the votes cast shall

be sufficient to elect each director. Each stockholder represented at a meeting of stockholders shall be entitled to cast one vote for

each share of the capital stock entitled to vote thereat held by such stockholder, unless otherwise provided by the Certificate of Incorporation.

Each stockholder entitled to vote at a meeting of stockholders or to express consent or dissent to corporate action in writing without

a meeting may authorize any person or persons to act for him by proxy. All proxies shall be executed in writing and shall be filed with

the Secretary of the Corporation not later than the day on which exercised. No proxy shall be voted or acted upon after three (3) years

from its date, unless the proxy provides for a longer period. The Board of Directors, in its discretion, or the officer of the Corporation

presiding at a meeting of stockholders, in his or her discretion, may require that any votes cast at such meeting shall be cast by written

ballot.

2.7

2.8

Voting List. The officer who has charge of the stock ledger of the corporation shall prepare and make, at least ten (10) days

before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order,

showing the address of each stockholder and the class and number of shares registered in the name of each stockholder. Such list shall

be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of

at least ten (10) days prior to the election, either at a place within the city, town or village where the election is to be held, which

place shall be specified in the notice of the meeting, or, if not specified, at the place where said meeting is to be held.

2.9

Stock Ledger. The stock ledger of the Corporation shall be the only evidence as to who are the stockholders entitled to examine

the stock ledger, the list required by Section 2.8 or the books of the Corporation, or to vote in person or by proxy at any meeting of

stockholders.

2.10

Adjournment. Any meeting of the stockholders, including one at which directors are to be elected, may be adjourned for such periods

as the presiding officer of the meeting or the stockholders present in person or by proxy and entitled to vote shall direct.

2.11

Ratification. Any transaction questioned in any stockholders’ derivative suit, or any other suit to enforce alleged rights

of the Corporation or any of its stockholders, on the ground of lack of authority, defective or irregular execution, adverse interest

of any director, officer or stockholder, nondisclosure, miscomputation or the application of improper principles or practices of accounting

may be approved, ratified and confirmed before or after judgment by the Board of Directors or by the holders of Common Stock and, if

so approved, ratified or confirmed, shall have the same force and effect as if the questioned transaction had been originally duly authorized,

and said approval, ratification or confirmation shall be binding upon the Corporation and all of its stockholders and shall constitute

a bar to any claim or execution of any judgment in respect of such questioned transaction.

2.12

Inspectors. The election of directors and any other vote by ballot at any meeting of the stockholders shall be supervised by at

least one inspector. Such inspectors shall be appointed by the Board of Directors in advance of the meeting. If the inspector so appointed

shall refuse to serve or shall not be present, such appointment shall be made by the officer presiding at the meeting.

ARTICLE

III

DIRECTORS

3.1

Powers; Number; Qualifications. The business and affairs of the Corporation shall be managed by or under the direction of the

Board of Directors, except as may be otherwise provided by law or in the Certificate of Incorporation. The number of directors which

shall constitute the Board of Directors shall be not less than one (1) nor more than nine (9). The exact number of directors shall be

fixed from time to time, within the limits specified in this Section 3.1 or in the Certificate of Incorporation, by the Board of Directors.

Directors need not be stockholders of the Corporation. The Board may be divided into classes as more fully described in the Certificate

of Incorporation.

3.2

Election; Term of Office; Resignation; Removal; Vacancies. Each director shall hold office until the next annual meeting of stockholders

(or if the Board is divided in classes, the next annual meeting at which such director’s class stands for election) or until such

director’s earlier resignation, removal from office, death or incapacity. Unless otherwise provided in the Certificate of Incorporation,

vacancies and newly created directorships resulting from any increase in the authorized number of directors or from any other cause may

be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director and each director

so chosen shall hold office until the next election of the class for which such director shall have been chosen, and until his or her

successor shall be elected and qualified, or until such director’s earlier resignation, removal from office, death or incapacity.

3.3

Nominations. Unless otherwise provided in the Certificate of Incorporation or any Preferred Stock Designation (as defined in the

Certificate of Incorporation), nominations of persons for election to the Board of Directors of the Corporation at a meeting of stockholders

of the Corporation may be made at such meeting by or at the direction of the Board of Directors, by any committee or persons appointed

by the Board of Directors or by any stockholder of the Corporation entitled to vote for the election of directors at the meeting who

complies with the notice procedures set forth in this Section 3.3. Such nominations by any stockholder shall be made pursuant to timely

notice in writing to the Secretary of the Corporation. To be timely, a stockholder’s notice shall be delivered to or mailed and

received at the principal executive offices of the Corporation not less than sixty (60) days nor more than ninety (90) days prior to

the meeting; provided however, that in the event that less than seventy (70) days’ notice or prior public disclosure of the date

of the meeting is given or made to stockholders, notice by the stockholder, to be timely, must be received no later than the close of

business on the tenth (10th) day following the day on which such notice of the date of the meeting was mailed or such public

disclosure was made, whichever first occurs. Such stockholder’s notice to the Secretary shall set forth (i) as to each person whom

the stockholder proposes to nominate for election or reelection as a director, (a) the name, age, business address and residence address

of the person, (b) the principal occupation or employment of the person, (c) the class and number of shares of capital stock of the Corporation

which are beneficially owned by the person, and (d) any other information relating to the person that is required to be disclosed in

solicitations for proxies for election of directors pursuant to the Rules and Regulations of the Securities and Exchange Commission under

Section 14 of the Securities Exchange Act of 1934, as amended, and (ii) as to the stockholder giving the notice (a) the name and record

address of the stockholder and (b) the class and number of shares of capital stock of the Corporation which are beneficially owned by

the stockholder. The Corporation may require any proposed nominee to furnish such other information as may reasonably be required by

the Corporation to determine the eligibility of such proposed nominee to serve as a director of the Corporation. No person shall be eligible

for election as a director of the Corporation unless nominated in accordance with the procedures set forth herein. The officer of the

Corporation presiding at an annual meeting shall, if the facts warrant, determine and declare to the meeting that a nomination was not

made in accordance with the foregoing procedure, and if he should so determine, he shall so declare to the meeting and the defective

nomination shall be disregarded.

3.4

Meetings. The Board of Directors of the Corporation may hold meetings, both regular and special, either within or without the

State of Delaware. The first meeting of each newly elected Board of Directors shall be held immediately after and at the same place as

the meeting of the stockholders at which it is elected and no notice of such meeting shall be necessary to the newly elected directors

in order to legally constitute the meeting, provided a quorum shall be present. Regular meetings of the Board of Directors may be held

without notice at such time and place as shall from time to time be determined by the Board of Directors. Special meetings of the Board

of Directors may be called by the Chairman or a majority of the entire Board of Directors. Notice thereof stating the place, date and

hour of the meeting shall be given to each director either by mail not less than forty-eight (48) hours before the date of the meeting,

by telephone, facsimile, telegram or e-mail on twenty-four (24) hours’ notice, or on such shorter notice as the person or persons

calling such meeting may deem necessary or appropriate in the circumstances.

3.5

Quorum. Except as may be otherwise specifically provided by law, the Certificate of Incorporation or these Bylaws, at all meetings

of the Board of Directors or any committee thereof, a majority of the entire Board of Directors or such committee, as the case may be,

shall constitute a quorum for the transaction of business and the act of a majority of the directors present at any meeting at which

there is a quorum shall be the act of the Board of Directors. If a quorum shall not be present at any meeting of the Board of Directors

or of any committee thereof, a majority of the directors present thereat may adjourn the meeting from time to time, without notice other

than announcement at the meeting, until a quorum shall be present.

3.6

Organization of Meetings.

(a)

The Board of Directors shall elect one of its members to be Chairman of the Board of Directors. The Chairman of the Board of Directors

shall lead the Board of Directors in fulfilling its responsibilities as set forth in these By-Laws, including its responsibility to oversee

the performance of the Corporation, and shall determine the agenda and perform all other duties and exercise all other powers which are

or from time to time may be delegated to him or her by the Board of Directors.

(b)

Meetings of the Board of Directors shall be presided over by the Chairman of the Board of Directors, or in his or her absence, by the

Chief Executive Officer, or in the absence of the Chairman of the Board of Directors and the Chief Executive Officer by such other person

as the Board of Directors may designate or the members present may select.

3.7

Actions of Board of Directors Without Meeting. Unless otherwise restricted by the Certificate of Incorporation or these Bylaws,

any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without

a meeting, if all members of the Board of Directors or of such committee, as the case may be, consent thereto in writing or by electronic

transmission, and the writing or writings or electronic transmission or transmissions are filled with the minutes of proceedings of the

Board of Directors or committee.

3.8

Removal of Directors by Stockholders. Directors of the Board of Directors may be removed from office at any time, but only for

cause and only by the affirmative vote of holders of 66-2/3% of the voting power of all then-outstanding shares of capital stock of the

Corporation entitled to vote generally in the election of directors, voting together as a single class.

3.9

Resignations. Any Director may resign at any time by submitting his or her written resignation to the Board of Directors or Secretary

of the Corporation. Such resignation shall take effect at the time of its receipt by the Corporation unless another time be fixed in

the resignation, in which case it shall become effective at the time so fixed. The acceptance of a resignation shall not be required

to make it effective.

3.10

Committees. The Board of Directors may designate one or more committees, each committee to consist of one or more of the directors

of the Corporation. In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting

and not disqualified from voting, whether or not he or they constitute a quorum, may unanimously appoint another member of the Board

of Directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided

by law and in the resolution of the Board of Directors establishing such committee, shall have and may exercise all the powers and authority

of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation

to be affixed to all papers which may require it; but no such committee shall have the power or authority in reference to amending the

Certificate of Incorporation, adopting an agreement of merger or consolidation, recommending to the stockholders the sale, lease or exchange

of all or substantially all of the Corporation’s property and assets, recommending to the stockholders a dissolution of the Corporation

or a revocation of a dissolution or amending the Bylaws of the Corporation; and, unless the resolution expressly so provides, no such

committee shall have the power or authority to declare a dividend or to authorize the issuance of stock or to adopt a certificate of

ownership and merger. Each committee shall keep regular minutes of its meetings and report the same to the Board of Directors when required.

3.11

Compensation. The Board of Directors shall have the authority to fix the compensation of directors. Without limiting the foregoing,

the directors shall be paid their reasonable expenses, if any, of attendance at each meeting of the Board or any committee thereof and

may be paid a fixed sum for attendance at each such meeting and an annual retainer or salary for service as director or committee member,

payable in cash or securities. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving

compensation therefor. Directors who are full-time employees of the Corporation shall not receive any compensation for their service

as director or as a member of any committee of the Board of Directors.

3.12

Interested Directors. No contract or transaction between the Corporation and one or more of its directors or officers, or between

the Corporation and any other corporation, partnership, association, or other organization in which one or more of its directors or officers

are directors or officers, or have a financial interest, shall be void or voidable solely for this reason, or solely because the director

or officer is present at or participates in the meeting of the Board of Directors or committee thereof which authorizes the contract

or transaction, or solely because his, her or their votes are counted for such purpose, if (i) the material facts as to his, her or their

relationship or interest and as to the contract or transaction are disclosed or are known to the Board of Directors or the committee,

and the Board of Directors or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of

the disinterested directors, even though the disinterested directors be less than a quorum; or (ii) the material facts as to his, her

or their relationship or interest and as to the contract or transaction are disclosed or are known to the stockholders entitled to vote

thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or (iii) the contract or

transaction is fair as to the Corporation as of the time it is authorized, approved or ratified, by the Board of Directors, a committee

thereof or the stockholders. Common or interested directors may be counted in determining the presence of a quorum at a meeting of the

Board of Directors or of a committee which authorizes the contract or transaction.

3.13

Meetings by Means of Conference Telephone. Members of the Board of Directors or any committee designed by the Board of Directors

may participate in a meeting of the Board of Directors or of a committee of the Board of Directors by means of conference telephone or

similar communications equipment by means of which all persons participating in the meeting can hear each other, and participation in

a meeting pursuant to this subsection shall constitute presence in person at such meeting.

ARTICLE

OFFICERS

4.1

General. The officers of the Corporation shall be elected or appointed by the Board of Directors and may consist of: a Chairman

of the Board, Vice Chairman of the Board, Chief Executive Officer, President, Chief Financial Officer, Secretary and Treasurer. The Board

of Directors, in its discretion, may also elect or appoint one or more Vice Presidents (including Executive Vice Presidents and Senior

Vice Presidents), Assistant Secretaries, Assistant Treasurers, a Controller and or desirable. Any number of offices may be held by the

same person and more than one person may hold the same office, unless otherwise prohibited by law, the Certificate of Incorporation or

these Bylaws. The officers of the Corporation need not be stockholders of the Corporation, nor need such officers be directors of the

Corporation.

4.2

Election. The Board of Directors at its first meeting held after each annual meeting of stockholders shall elect the officers

of the Corporation who shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined

from time to time by the Board of Directors; and all officers of the Corporation shall hold office until their successors are chosen

and qualified, or until their earlier resignation or removal. Except as otherwise provided in this ARTICLE IV, any officer elected by

the Board of Directors may be removed at any time by the affirmative vote of a majority of the Board of Directors. Any vacancy occurring

in any office of the Corporation shall be filled by the Board of Directors. The salaries of all officers who are directors of the Corporation

shall be fixed by the Board of Directors.

4.3

Voting Securities Owned by the Corporation. Powers of attorney, proxies, waivers of notice of meeting, consents and other instruments

relating to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the Chief Executive

Officer, President or any Vice President, and any such officer may, in the name and on behalf of the Corporation, take all such action

as any such officer may deem advisable to vote in person or by proxy at any meeting of security holders of any corporation in which the

Corporation may own securities and at any such meeting shall possess and may exercise any and all rights and powers incident to the ownership

of such securities and which, as the owner thereof, the Corporation might have exercised and possessed if present. The Board of Directors

may, by resolution, from time to time confer like powers upon any other person or persons.

4.4

Chief Executive Officer. Subject to the provisions of these Bylaws and to the direction of the Board of Directors, the Chief Executive

Officer shall have ultimate authority for decisions relating to the general management and control of the affairs and business of the

Corporation and shall perform such other duties and exercise such other powers which are or from time to time may be delegated to him

or her by the Board of Directors or these Bylaws, all in accordance with basic policies as established by and subject to the oversight

of the Board of Directors.

4.5

President. At the request of the Chief Executive Officer, or in the absence of the Chief Executive Officer, or in the event of

his, her or her inability or refusal to act, the President shall perform the duties of the Chief Executive Officer, and when so acting,

shall have all the powers of and be subject to all the restrictions upon such office. The President shall perform such other duties and

have such other powers as the Board of Directors from time to time may prescribe.

4.6

Chief Financial Officer. The Chief Financial Officer shall have general supervision, direction and control of the financial affairs

of the Corporation and shall perform such other duties and exercise such other powers which are or from time to time may be delegated

to him or her by the Board of Directors or these Bylaws, all in accordance with basic policies as established by and subject to the oversight

of the Board of Directors. In the absence of a named Treasurer, the Chief Financial Officer shall also have the powers and duties of

the Treasurer as hereinafter set forth and shall be authorized and empowered to sign as Treasurer in any case where such officer’s

signature is required.

4.7

Vice Presidents. At the request of the Chief Executive Officer or the President, or in the absence of the President, or in the

event of his or her inability or refusal to act, the Vice President or the Vice Presidents if there is more than one (in the order designated

by the Board of Directors) shall perform the duties of the President, and when so acting, shall have all the powers of and be subject

to all the restrictions upon such office. Each Vice President shall perform such other duties and have such other powers as the Board

of Directors from time to time may prescribe. If there be no Vice President, the Board of Directors shall designate the officer of the

Corporation who, in the absence of the President or in the event of the inability or refusal of such officer to act, shall perform the

duties of such office, and when so acting, shall have all the powers of and be subject to all the restrictions upon such office.

4.8

Secretary. The Secretary shall attend all meetings of the Board of Directors and all meetings of stockholders and record all the

proceedings thereat in a book or books to be kept for that purpose; the Secretary shall also perform like duties for the standing committees

when required. The Secretary shall give, or cause to be given, notice of all meetings of the stockholders and special meetings of the

Board of Directors, and shall perform such other duties as may be prescribed by the Board of Directors or the Chief Executive Officer,

under whose supervision the Secretary shall be. If the Secretary shall be unable or shall refuse to cause to be given notice of all meetings

of the stockholders and special meetings of the Board of Directors, then any Assistant Secretary shall perform such actions. If there

be no Assistant Secretary, then the Board of Directors or the Chief Executive Officer may choose another officer to cause such notice

to be given. The Secretary shall have custody of the seal of the Corporation and the Secretary or any Assistant Secretary, if there be

one, shall have authority to affix the same to any instrument requiring it and when so affixed, it may be attested by the signature of

the Secretary or by the signature of any such Assistant Secretary. The Board of Directors may give general authority to any other officer

to affix the seal of the Corporation and to attest the affixing by his or her signature. The Secretary shall see that all books, reports,

statements, certificates and other documents and records required by law to be kept or filed are properly kept or filed, as the case

may be.

4.9

Treasurer. The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts

of receipts and disbursements in books belonging to the Corporation and shall deposit all moneys and other valuable effects in the name

and to the credit of the Corporation in such depositories as may be designated by the Board of Directors. The Treasurer shall disburse

the funds of the Corporation as may be ordered by the Board of Directors, taking proper vouchers for such disbursements, and shall render

to the Chief Executive Officer, President and the Board of Directors, at its regular meetings, or when the Board of Directors so requires,

an account of all his or her transactions as Treasurer and of the financial condition of the Corporation. If required by the Board of

Directors, the Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall be satisfactory to the

Board of Directors for the faithful performance of the duties of his or her office and for the restoration to the Corporation, in case

of his or her death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever

kind in his or her possession or under his or her control belonging to the Corporation.

4.10

Assistant Secretaries. Except as may be otherwise provided in these Bylaws, Assistant Secretaries, if there be any, shall perform

such duties and have such powers as from time to time may be assigned to them by the Board of Directors, the Chief Executive Officer,

the President, any Vice President, if there be one, or the Secretary, and in the absence of the Secretary or in the event of his or her

disability or refusal to act, shall perform the duties of the Secretary, and when so acting, shall have all the powers of and be subject

to all the restrictions upon the Secretary.

4.11

Assistant Treasurers. Assistant Treasurers, if there be any, shall perform such duties and have such powers as from time to time

may be assigned to them by the Board of Directors, the Chief Executive Officer, the President, any Vice President, if there be one, or

the Treasurer, and in the absence of the Treasurer or in the event of his or her disability or refusal to act, shall perform the duties

of the Treasurer, and when so acting, shall have all the powers of and be subject to all the restrictions upon the Treasurer. If required

by the Board of Directors, an Assistant Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall

be satisfactory to the Board of Directors for the faithful performance of the duties of his or her office and for the restoration to

the Corporation, in case of his or her death, resignation, retirement or removal from office, of all books, papers, vouchers, money and

other property of whatever kind in his or her possession or under his or her control belonging to the Corporation.

4.12

Controller. The Controller shall establish and maintain the accounting records of the Corporation in accordance with generally

accepted accounting principles applied on a consistent basis, maintain proper internal control of the assets of the Corporation and shall

perform such other duties as the Board of Directors, the Chief Executive Officer, the President or any Vice President of the Corporation

may prescribe.

4.13

Other Officers. Such other officers as the Board of Directors may choose shall perform such duties and have such powers as from

time to time may be assigned to them by the Board of Directors. The Board of Directors may delegate to any other officer of the Corporation

the power to choose such other officers and to prescribe their respective duties and powers.

4.14

Vacancies. The Board of Directors shall have the power to fill any vacancies in any office occurring from whatever reason.

4.15

Resignations. Any officer may resign at any time by submitting his or her written resignation to the Corporation. Such resignation

shall take effect at the time of its receipt by the Corporation, unless another time be fixed in the resignation, in which case it shall

become effective at the time so fixed. The acceptance of a resignation shall not be required to make it effective.

4.16

Removal. Subject to the provisions of any employment agreement approved by the Board of Directors, any officer of the Corporation

may be removed at any time, with or without cause, by the Board of Directors.

ARTICLE

CAPITAL

STOCK

5.1

Form of Certificates. The shares of stock in the Corporation may be certificated or uncertificated, subject to the sole discretion

of the Board of Directors and the requirements of Delaware General Corporate Law (the “DGCL”). Stock certificates

shall be in such forms as the Board of Directors may prescribe and signed by the Chairman of the Board, the Chief Executive Officer,

President or a Vice President and by the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant Secretary of the Corporation.

5.2

Signatures. Any or all of the signatures on a stock certificate may be a facsimile, including, but not limited to, signatures

of officers of the Corporation and countersignatures of a transfer agent or registrar. In case an officer, transfer agent or registrar

who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or

registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such person were such officer,

transfer agent or registrar at the date of issue.

5.3

Lost Certificates. The Board of Directors may direct a new stock certificate or certificates to be issued in place of any stock

certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen or destroyed, upon the making of

an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen or destroyed. When authorizing such issue

of a new stock certificate, the Board of Directors may, in its discretion and as a condition precedent to the issuance thereof, require

the owner of such lost, stolen or destroyed certificate, or his or her legal representative, to advertise the same in such manner as

the Board of Directors shall require and/or to give the Corporation a bond in such sum as it may direct as indemnity against any claim

that may be made against the Corporation with respect to the certificate alleged to have been lost, stolen or destroyed.

5.4

Transfers. Stock of the Corporation shall be transferable in the manner prescribed by law and in these Bylaws. Transfers of certificated

stock shall be made on the books of the Corporation only by the person named in the certificate or by such person’s attorney lawfully

constituted in writing and upon the surrender of the certificate therefor, which shall be canceled before a new certificate shall be

issued. Transfers of uncertificated stock shall be made on the books of the Corporation only by the person then registered on the books

of the Corporation as the owner of such shares or by such person’s attorney lawfully constituted in writing and written instruction

to the Corporation containing such information as the Corporation or its agents may prescribe. No transfer of uncertificated stock shall

be valid as against the Corporation for any purpose until it shall have been entered in the stock records of the Corporation by an entry

showing from and to whom transferred. The Corporation shall have no duty to inquire into adverse claims with respect to any stock transfer

unless (a) the Corporation has received a written notification of an adverse claim at a time and in a manner which affords the Corporation

a reasonable opportunity to act on it prior to the issuance of a new, reissued or re-registered share certificate, in the case of certificated

stock, or entry in the stock record books of the Corporation, in the case of uncertificated stock, and the notification identifies the

claimant, the registered owner and the issue of which the share or shares is a part and provides an address for communications directed

to the claimant; or (b) the Corporation has required and obtained, with respect to a fiduciary, a copy of a will, trust, indenture, articles

of co-partnership, Bylaws or other controlling instruments, for a purpose other than to obtain appropriate evidence of the appointment

or incumbency of the fiduciary, and such documents indicate, upon reasonable inspection, the existence of an adverse claim. The Corporation

may discharge any duty of inquiry by any reasonable means, including notifying an adverse claimant by registered or certified mail at

the address furnished by him or, if there be no such address, at his or her residence or regular place of business that the security

has been presented for registration of transfer by a named person, and that the transfer will be registered unless within thirty days

from the date of mailing the notification, either (a) an appropriate restraining order, injunction or other process issues from a court

of competent jurisdiction; or (b) an indemnity bond, sufficient in the Corporation’s judgment to protect the Corporation and any

transfer agent, registrar or other agent of the Corporation involved from any loss which it or they may suffer by complying with the

adverse claim, is filed with the Corporation.

5.5

Fixing Record Date. In order that the Corporation may determine the stockholders entitled to notice or to vote at any meeting

of stockholders or any adjournment thereof, or to express consent to corporate action in writing without a meeting, or entitled to receive

payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change,

conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record

date shall not precede the date upon which the resolution fixing the record is adopted by the Board of Directors, and which record date

shall not be more than sixty (60) nor less than ten (10) days before the date of such meeting, nor more than ten (10) days after the

date upon which the resolution fixing the record date of action with a meeting is adopted by the Board of Directors, nor more than sixty

(60) days prior to any other action. If no record date is fixed:

(a)

The record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business

on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding

the day on which the meeting is held.

(b)

The record date for determining stockholders entitled to express consent to corporate action in writing without a meeting, when no prior

action by the Board of Directors is necessary, shall be the first date on which a signed written consent is delivered to the Corporation.

(c)

The record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board of

Directors adopts the resolution relating thereto.

determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment

of the meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.

5.6

Registered Stockholders. Prior to due presentment for transfer of any share or shares, the Corporation shall treat the registered

owner thereof as the person exclusively entitled to vote, to receive notifications and to all other benefits of ownership with respect

to such share or shares, and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the

part of any other person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of the

State Delaware.

ARTICLE

NOTICES

6.1

Form of Notice. Notices to directors and stockholders other than notices to directors of special meetings of the board of Directors

which may be given by any means stated in Section 3.4, shall be in writing and delivered personally or mailed to the directors or stockholders

at their addresses appearing on the books of the corporation. Notice by mail shall be deemed to be given at the time when the same shall

be mailed. Notice to directors may also be given by telegram.

6.2

Waiver of Notice. Whenever any notice is required to be given under the provisions of law or the Certificate of Incorporation

or by these Bylaws of the Corporation, a written waiver, signed by the person or persons entitled to notice, whether before or after

the time stated therein, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice

of such meeting, except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the

transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the

purpose of, any regular, or special meeting of the stockholders, Directors, or members of a committee of Directors need be specified

in any written waiver of notice unless so required by the Certificate of Incorporation.

ARTICLE

VII

INDEMNIFICATION

OF DIRECTORS AND OFFICERS

7.1

Actions by Third Parties. The Corporation shall indemnify any person who was or is a party or is threatened to be made a party

to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than

an action by or in the right of the Corporation) by reason of the fact that he or her is or was a director, officer, employee or agent

of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation,

partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts

paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he or her acted in good

faith and in a manner he or her reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect

to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The termination of any action,

suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself,

create a presumption that the person did not act in good faith and in a manner which he or her reasonably believed to be in or not opposed

to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that

his or her conduct was unlawful.

7.2

Actions by or in Right of the Company. The Corporation shall indemnify any person who was or is a party, or is threatened to be

made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its

favor by reason of the fact that he or her is or was a director, officer, employee or agent of the Corporation, or is or was serving

at the request of the Corporation as a director, officer, employee or agent of another Corporation, partnership, joint venture, trust

or other enterprise against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection with the

defense or settlement of such action or suit if he or her acted in good faith and in a manner he or her reasonably believed to be in

or not opposed to the best interests of the Corporation and except that no indemnification shall be made in respect of any claim, issue

or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court

of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of

liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses

which the Court of Chancery or such other court shall deem proper.

7.3

Success on the Merits. To the extent that a director, officer, employee or agent of the Corporation has been successful on the

merits or otherwise in defense of any action, suit or proceeding referred to in Sections 1 or 2 of this Article, or in defense of any

claim, issue or matter therein, he shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred

by him or her in connection therewith.

7.4

Standard of Conduct Determination. Any indemnification under Sections 7.1 or 7.2 (unless ordered by a court) shall be made by

the Corporation only as authorized in the specific case upon a determination that indemnification of the director, officer, employee

or agent is proper in the circumstances because he or her has met the applicable standard of conduct set forth in such section. Such

determination shall be made:

(a)

by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to such action, suit or proceeding,

(b)

if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested directors so directs, by independent legal counsel

in a written opinion, or

(c)

by the stockholders.

7.5

Expenses. Expenses (including attorneys’ fees) incurred by an officer or director in defending any civil, criminal, administrative

or investigative action, suit or proceeding may be paid by the Corporation in advance of the final disposition of such action, suit or

proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be

determined that he is not entitled to be indemnified by the Corporation as authorized in this Section. Such expenses (including attorneys’

fees) incurred by other employees and agents may be so paid upon such terms and conditions, if any, as the Board of Directors deems appropriate.

7.6

Non-Exclusive Rights. The indemnification and advancement of expenses provided by, or granted pursuant to the other sections of

this Article shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may

be entitled under the Certificate of Incorporation, any bylaw, agreement, vote of stockholders or disinterested directors or otherwise,

both as to action in his or her official capacity and as to action in another capacity while holding such office.

7.7

Insurance. The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director,

officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee

or agent of another Corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him and

incurred by him in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power

to indemnify him against such liability under the provisions of this Article.

7.8

Defined Terms.

(a)

For purposes of this Article, references to “the Corporation” shall include, in addition to the resulting Corporation, any

constituent Corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence

had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who

is or was a director, officer employee or agent of such constituent Corporation, or is or was serving at the request of such constituent

Corporation as a director, officer, employee or agent of another Corporation, partnership, joint venture, trust or other enterprise,

shall stand in the same position under this Article with respect to the resulting or surviving Corporation as he would have with respect

to such constituent Corporation of its separate existence had continued.

(b)

For purposes of this Article, references to “other enterprises” shall include employee benefit plans; references to “fines”

shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to “serving at the

request of the Corporation” shall include any service as a director, officer, employee or agent of the Corporation which imposes

duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan, its participants

or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to be in the interest of the participants

and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the

Corporation” as referred to in this Article.

7.9

Continuation of Rights. The indemnification and advancement of expenses provided by, or granted pursuant to, this Article shall,

unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or

agent and shall inure to the benefit of the heirs, executors and administrators of such a person.

7.10

Limitation of Liability. No director or officer of the Corporation shall be personally liable to the Corporation or to any stockholder

of the Corporation for monetary damages for breach of fiduciary duty as a director or officer, except to the extent such exemption from

liability or limitation thereof is not permitted under the DGCL, as it presently exists or may hereafter be amended from time to time.

ARTICLE

VIII

GENERAL

PROVISIONS

8.1

Reliance on Books and Records. Each Director, each member of any committee designated by the Board of Directors, and each officer

of the Corporation, shall, in the performance of his or her duties, be fully protected in relying in good faith upon the books of account

or other records of the Corporation, including reports made to the Corporation by any of its officers, by an independent certified public

accountant, or by an appraiser selected with reasonable care.

8.2

Maintenance and Inspection of Records.

(a)

The Corporation shall, either at its principal executive office or at such place or places as designated by the Board of Directors, keep

a record of its stockholders listing their names and addresses and the number and class of shares held by each stockholder, a copy of

these by-laws, as may be amended to date, minute books, accounting books and other records.

(b)

Any such records maintained by the Corporation may be kept on, or by means of, or be in the form of, any information storage device or

method, provided that the records so kept can be converted into clearly legible paper form within a reasonable time. The Corporation

shall so convert any records so kept upon the request of any person entitled to inspect such records pursuant to the provisions of the

Delaware General Corporation Law. When records are kept in such manner, a clearly legible paper form produced from or by means of the

information storage device or method shall be admissible in evidence, and accepted for all other purposes, to the same extent as an original

paper form accurately portrays the record.

(c)

Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under oath stating the purpose thereof,

have the right during the usual hours for business to inspect for any proper purpose the Corporation’s stock ledger, a list of

its stockholders, and its other books and records and to make copies or extracts therefrom. A proper purpose shall mean a purpose reasonably

related to such person’s interest as a stockholder. In every instance where an attorney or other agent is the person who seeks

the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other writing that authorizes the

attorney or other agent to so act on behalf of the stockholder. The demand under oath shall be directed to the Corporation at its registered

office in Delaware or at its principal executive office.

8.3

Inspection by Directors. Any director shall have the right to examine the Corporation’s stock ledger, a list of its stockholders,

and its other books and records for a purpose reasonably related to his or her position as a director.

8.4

Dividends. Subject to the provisions of the Certificate of Incorporation, if any, dividends upon the capital stock of the Corporation

may be declared by the Board of Directors at any regular or special meeting, pursuant to law. Dividends may be paid in cash, in property,

or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation. Before payment of any dividend, there

may be set aside out of any funds of the Corporation available for dividends such sum or sums as the Directors from time to time, in

their absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing

or maintaining any property of the Corporation, or for such other purpose as the Directors shall think conducive to the interest of the

Corporation, and the Directors may modify or abolish any such reserve in the manner in which it was created.

8.5

Checks. All checks or demands for money and notes of the Corporation shall be signed by such officer or officers or such other

persons as the Board of Directors may from time to time designate.

8.6

Fiscal Year. The fiscal year of the Corporation shall be as determined by the Board of Directors. If the Board of Directors shall

fail to do so, the Chief Executive Officer shall fix the fiscal year.

8.7

Seal. The corporate seal shall have inscribed thereon the name of the Corporation, the year of its organization and the words

“Corporate Seal, Delaware”. The seal may be used by causing it or a facsimile thereof to be impressed or affixed or in any

manner reproduced.

8.8

Amendments. Subject to any limitations in the Certificate of Incorporation, the original or other Bylaws may be adopted, amended

or repealed by the stockholders entitled to vote thereon at any regular or special meeting or, if the Certificate of Incorporation so

provides, by the Board of Directors. The fact that such power has been so conferred upon the Board of Directors shall not divest the

stockholders of the power nor limit their power to adopt, amend or repeal Bylaws, subject to any limitations in the Certificate of Incorporation.

8.9

Interpretation of Bylaws. All words, terms and provisions of these Bylaws shall be interpreted and defined by and in accordance

with the General Corporation Law of the State of Delaware, as amended, and as amended from time to time hereafter.

EX-10.1

Filename: ex10-1.htm · Sequence: 4

Exhibit

10.1

JOINDER

AGREEMENT

This

JOINDER (this “Joinder”) to the Lock-Up Agreement, dated as of September 15, 2025, by and among Boost Run Inc.

(the “Company”) and the other parties identified therein (as the same has been and may be amended, supplemented or

modified from time to time, the “Agreement”), is made and entered into as of May 8, 2026 (the “Joinder Date”),

by the undersigned hereto (the “Investor”).

WHEREAS,

the Investor desires to acknowledge that, upon execution of this Joinder and effective as of the Joinder Date, such Investor shall be

party to, and bound by all of the terms and conditions of the Agreement; and

NOW

THEREFORE, in consideration of the mutual promises and covenants set forth herein, and other good and valuable consideration, the

receipt of which is hereby acknowledged, intending to be legally bound hereby, the parties to this Joinder agree as follows:

1. Definitions.

Capitalized terms used herein but not otherwise defined herein shall have the respective

meanings set forth in the Agreement.

2. Agreement

to be Bound. The Investor hereby (a) acknowledges that the Investor has received and

reviewed a complete copy of the Agreement and (b) agrees that upon execution of this Joinder,

the Investor shall become a party to the Agreement and shall be fully bound by, and subject

to, all of the applicable terms, conditions, representations and warranties and other provisions

of the Agreement with all attendant rights, benefits, duties, restrictions and obligations

stated therein as though an original party.

3. Effectiveness.

This Joinder shall take effect and shall become a part of the Agreement as of the Joinder

Date immediately upon the execution hereof.

4. Counterparts.

This Joinder may be executed in two or more counterparts, each of which shall be deemed an

original, but all of which together shall constitute one and the same instrument.

5. Governing

Law. This Joinder shall be governed by, and construed in accordance with, the laws of

the State of Delaware, without regard to principles of choice of law or conflicts of law

to the extent that such principles would result in the application of the laws of another

jurisdiction.

6. Headings.

The headings contained in this Joinder are for purposes of convenience only and shall not

affect the meaning or interpretation of this Joinder.

WITNESS WHEREOF, the undersigned have executed this Joinder as of the date set forth above.

JOINING PARTY:

[●]

EX-10.2

Filename: ex10-2.htm · Sequence: 5

Exhibit

10.2

AMENDED

AND RESTATED REGISTRATION RIGHTS AGREEMENT

THIS

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 8, 2026, is made and

entered into by and among Willow Lane Acquisition Corp., a Cayman Islands exempted company (together with its successors, the “Company”),

Boost Run Inc., a Delaware corporation (“Pubco”), Willow Lane Sponsor, LLC, a Delaware limited liability company

(the “Sponsor”), BTIG, LLC (“BTIG”), Craig-Hallum Capital Group, LLC (“Craig-Hallum”),

and certain members of Boost Run Holdings, LLC, a Delaware limited liability company (the “Target Company”)

listed on the signature pages hereto (such members, the “Boost Run Holders” and, together with the Sponsor,

BTIG, Craig-Hallum and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement,

a “Holder” and collectively the “Holders”). Capitalized terms used and not otherwise

defined herein shall have the meanings set forth in the Business Combination Agreement (defined below).

RECITALS

WHEREAS,

the Company has 4,628,674 Class B ordinary shares, par value $0.0001 per share (including the shares of Pubco Common Stock issued or

issuable upon the conversion of any such ordinary shares or that are issued in exchange for such ordinary shares in the SPAC Merger,

the “Founder Shares”), issued and outstanding;

WHEREAS,

the Founder Shares are convertible into Class A ordinary shares of the Company, par value $0.0001 per share, on the terms and conditions

provided in the Company’s amended and restated memorandum and articles of association;

WHEREAS,

the Company, Sponsor, BTIG and Craig-Hallum are parties to that certain Registration Rights Agreement, dated November 7, 2024 (as amended,

the “Original Registration Rights Agreement”);

WHEREAS,

on November 7, 2024, the Company and the Sponsor entered into that certain Private Placement Warrants Purchase Agreement (the “Warrant

Subscription Agreement”), pursuant to which the Sponsor purchased an aggregate of 4,007,222 redeemable warrants (the “Private

Placement Warrants”) in a private placement transaction occurring simultaneously with the closing of the Company’s

initial public offering;

WHEREAS,

on November 7, 2024, the Company, BTIG and Craig-Hallum entered into that certain Private Placement Warrants Purchase Agreement (the

“Underwriters Warrant Subscription Agreement”), pursuant to which BTIG and Craig-Hallum purchased an aggregate

of 1,138,500 Private Placement Warrants in a private placement transaction occurring simultaneously with the Closing of the Company’s

initial public offering;

WHEREAS,

in order to finance the Company’s transaction costs in connection with its initial business combination, the Sponsor, its affiliates

or any of the Company’s officers and directors may loan to the Company funds as the Company may require, of which up to $1,500,000

of such loans may be convertible into additional warrants (such warrants, including any Pubco warrants issued in the SPAC Merger in exchange

for such private placement equivalent warrants, the “Working Capital Warrants”) at a price of $1.00 per Working

Capital Warrant at the option of the lender;

WHEREAS,

on September 15, 2025, the Company, Pubco, the Target Company, Benchmark Merger Sub I Inc., a Delaware corporation and a wholly-owned

subsidiary of Pubco (“SPAC Merger Sub”), and Benchmark Merger Sub II LLC, a Delaware limited liability company

and a wholly-owned subsidiary of Pubco (“Company Merger Sub”) George Peng, solely as a representative of the

SPAC shareholders (the “SPAC Representative”) and Andrew Karos, solely as a representative of the Sellers (the

“Seller Representative”), entered into that certain Business Combination Agreement (as amended from time to

time, the “Business Combination Agreement”);

WHEREAS,

pursuant to the Business Combination Agreement, subject to the terms and conditions thereof, among other matters, the Company shall de-register

by way of continuation out of the Cayman Islands and re-register into the State of Delaware so as to become a Delaware corporation pursuant

to the Companies Act (as Revised) of the Cayman Islands (the “Act”) and the applicable provisions of the Delaware

General Corporation Law (“DGCL”) and, upon the consummation of the transactions contemplated by the Business

Combination Agreement (the “Closing”): (a) SPAC Merger Sub will merge with and into the Company, with the Company

continuing as the surviving entity (the “SPAC Merger”) and each issued and outstanding security of the SPAC

immediately prior to the effective time of the SPAC Merger shall no longer be outstanding and shall automatically be cancelled, in exchange

for the issuance to the holder thereof of a substantially equivalent Pubco security; (b) Company Merger Sub will merge with and into

the Target Company, with the Target Company continuing as the surviving entity (the “Company Merger,” and together

with the SPAC Merger, the “Mergers”) and each issued and outstanding security of the Target Company immediately

prior to the effective time of the Company Merger shall no longer be outstanding and shall automatically be cancelled, in exchange for

the issuance to the holder thereof of shares of common stock, par value $0.0001 per share, of Pubco (“Pubco Common Stock”);

and (c) as a result of which Mergers, among other matters, the Company and the Target Company will become wholly-owned subsidiaries of

Pubco and Pubco will become a publicly traded company, all in accordance with the applicable provisions of the DGCL and the Act;

WHEREAS,

on September 15, 2025, the Sponsor, Goodrich ILMJS LLC, a Delaware limited liability company (“SPV” and, together

with the Sponsor, the “Designated Earnout Recipients”), and Pubco entered into an Agreement (the “Earnout

Agreement”) with respect to certain earnout shares to be issued on a contingent basis to the Designated Earnout Recipients

(such shares, the “Designated Earnout Shares”);

WHEREAS,

pursuant to the Business Combination Agreement, certain earnout shares are to be awarded to recipients designated by Pubco (the “Pubco-Designated

Earnout Shares” and, together with the Designated Earnout Shares, the “Earnout Shares”);

WHEREAS,

on September 15, 2025, (i) Sellers entered into Lock-Up Agreements with the Company and Pubco (each a “Lock-Up Agreement”),

and (ii) the Company, the Sponsor, Pubco, the IPO Underwriter and the other “Insiders” named therein entered into an amendment

to letter agreement, dated as of November 7, 2024, by and among the Company, the Sponsor and each of the Company’s officers and

directors (as amended, the “Insider Letter”);

WHEREAS,

pursuant to Section 5.5 of the Original Registration Rights Agreement, the provisions, covenants and conditions set forth therein may

be amended or modified upon the written consent of the Company and the holders of at least a majority-in-interest of the Registrable

Securities (as defined in the Original Registration Rights Agreement) at the time in question, and the Sponsor is holder of at least

a majority-in-interest of the Registrable Securities (as defined in the Original Registration Rights Agreement) as of the date hereof;

and

WHEREAS,

the Company and the Sponsor desire to amend and restate the Original Registration Rights Agreement and enter into this Agreement, pursuant

to which Pubco shall grant the Holders certain registration rights with respect to certain securities of Pubco, as set forth in this

Agreement.

NOW,

THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable

consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby

agree as follows:

Article

DEFINITIONS

1.1

Definitions. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective

meanings set forth below:

“Adverse

Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment

of the Chief Executive Officer or principal financial officer of Pubco, after consultation with counsel to Pubco, (i) would be required

to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain

any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case

of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii)

would not be required to be made at such time if the Registration Statement were not being filed, and (iii) Pubco has a bona fide business

purpose for not making such information public.

“Agreement”

shall have the meaning given in the Preamble.

“Board”

shall mean the Board of Directors of Pubco.

“BTIG”

shall have the meaning given in the Preamble.

“Business

Combination Agreement “ shall have the meaning given in the Recitals hereto.

“Commission”

shall mean the United States Securities and Exchange Commission.

“Company”

shall have the meaning given in the Preamble.

“Craig-Hallum”

shall have the meaning given in the Preamble.

“Demand

Registration” shall have the meaning given in subsection 2.1.1.

“Demanding

Boost Run Holder” shall have the meaning given in subsection 2.1.1.

“Demanding

Sponsor Holder” shall have the meaning given in subsection 2.1.1.

“Demanding

Underwriters Holder” shall have the meaning given in subsection 2.1.1.

“Demanding

Holder” shall have the meaning given in subsection 2.1.1.

“Designated

Earnout Recipients” shall have the meaning given in the Recitals hereto.

“Designated

Earnout Shares” shall have the meaning given in the Recitals hereto.

“Earnout

Agreement” shall have the meaning given in the Recitals hereto.

“Earnout

Shares” shall have the meaning given in the Recitals hereto.

“Exchange

Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

“Form

S-1” shall have the meaning given in subsection 2.1.1.

“Form

S-3” shall have the meaning given in subsection 2.3.

“Founder

Shares” shall have the meaning given in the Recitals hereto.

“Founder

Shares Lock-up Period” shall mean the applicable lock-up period in the Insider Letter, as amended.

“Boost

Run Holders” shall have the meaning given in the Recitals hereto.

“Holders”

shall have the meaning given in the Preamble.

“Insider

Letter” shall have the meaning given in the Recitals hereto.

“Lock-Up

Agreement” shall have the meaning given in the Preamble.

“Lock-up

Period” shall mean (i) with respect to the Sponsor Holders, the Founder Shares Lock-up Period and Private Placement Lock-Up

Period specified in the Insider Letter, as amended, and (ii) with respect to the Boost Run Holders, the lock-up period specified in the

Lock-up Agreements.

“Maximum

Number of Securities” shall have the meaning given in subsection 2.1.4.

“Misstatement”

shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement

or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light

of the circumstances under which they were made) not misleading.

“Original

Registration Rights Agreement” shall have the meaning given in the Recitals hereto.

“Permitted

Transferees” shall mean (a) with respect to the Sponsor Holders and their respective Permitted Transferees, (i) prior to

the expiration of the applicable Lock-up Period, any person or entity to whom such Holder of Registrable Securities is permitted to transfer

such Registrable Securities prior to the expiration of the applicable Lock-up Period pursuant to the Insider Letter, as amended, and

(ii) after the expiration of the applicable Lock-up Period, any person or entity to whom such Holder is permitted to transfer such Registrable

Securities, subject to and in accordance with any applicable agreement between such Holder and/or their respective Permitted Transferees

and Pubco and any transferee thereafter; (b) with respect to the Boost Run Holders and their respective Permitted Transferees, (i) prior

to the expiration of the applicable Lock-up Period, any person or entity to whom such Holder is permitted to transfer such Registrable

Securities prior to the expiration of the applicable Lock-up Period pursuant to the Lock-Up Agreement and (ii) after the expiration of

the applicable Lock-up Period, any person or entity to whom such Holder is permitted to transfer such Registrable Securities, subject

to and in accordance with any applicable agreement between such Holder and/or their respective Permitted Transferees and Pubco and any

transferee thereafter; and (c) with respect to all other Holders and their respective Permitted Transferees, any person or entity to

whom such Holder of Registrable Securities is permitted to transfer such Registrable Securities, subject to and in accordance with any

applicable agreement between such Holder and/or their respective Permitted Transferees and Pubco and any transferee thereafter.

“Piggyback

Registration” shall have the meaning given in subsection 2.2.1.

“Private

Placement Lock-up Period” shall mean the applicable lock-up period in the Insider Letter, as amended.

“Private

Placement Warrants” shall have the meaning given in the Recitals hereto.

“Pro

Rata” shall have the meaning given in subsection 2.1.4.

“Prospectus”

shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended

by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

“Pubco”

shall have the meaning given in the Preamble.

“Pubco

Common Stock” shall have the meaning given in the Recitals hereto.

“Pubco-Designated

Earnout Shares” shall have the meaning given in the Recitals hereto.

“Registrable

Security” shall mean (a) the shares of Pubco Common Stock issued as Aggregate Stock Consideration in the Company Merger,

including any Earnout Shares, (b) the Founder Shares (including the shares of Pubco Common Stock issued or issuable upon the conversion

of any Founder Shares or that are issued in exchange for such Founder Shares in the SPAC Merger), (c) the Private Placement Warrants

and the shares of Pubco Common Stock issuable on exercise of the Private Placement Warrants, (d) any outstanding shares of Pubco Common

Stock or any other equity security (including the shares of Pubco Common Stock issued or issuable upon the exercise of any other equity

security) of Pubco held by a Sponsor Holder as of the date of this Agreement, (e) any Working Capital Warrants and shares of Pubco Common

Stock issuable on exercise of the Working Capital Warrants, (f) any warrants, shares of capital stock or other securities of Pubco issued

as a dividend or other distribution with respect to or in exchange for or in replacement of Company Ordinary Shares and (g) any other

equity security of Pubco issued or issuable with respect to any such shares of Pubco Common Stock by way of a stock capitalization or

stock split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided,

however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a

Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities

shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall

have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been

delivered by Pubco and subsequent public distribution of such securities shall not require registration under the Securities Act; (C)

such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated

under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or

limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other

public securities transaction.

“Registration”

shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements

of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

“Registration

Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

(A)

all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority,

Inc.) and any securities exchange on which the shares of Pubco Common Stock are then listed;

(B)

fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters

in connection with blue sky qualifications of Registrable Securities);

(C)

printing, messenger, telephone and delivery expenses;

(D)

reasonable fees and disbursements of counsel for Pubco;

(E)

reasonable fees and disbursements of all independent registered public accountants of Pubco incurred specifically in connection with

such Registration; and(F) reasonable fees and expenses of one (1) legal counsel selected by the holders of a majority-in-interest of

the Sponsor Demanding Holders initiating a Demand Registration to be registered for offer and sale in the applicable Registration.

“Registration

Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this

Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements

to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

“Requesting

Holder” shall have the meaning given in subsection 2.1.1.

“Securities

Act” shall mean the Securities Act of 1933, as amended from time to time.

“Seller

Representative” shall have the meaning given in the Recitals hereto.

“SPAC

Representative” shall have the meaning given in the Recitals hereto.

“Sponsor”

shall have the meaning given in the Recitals hereto.

“Sponsor

Holders” shall mean the Sponsor and its Permitted Transferees who hold Registrable Securities.

“SPV”

shall have the meaning given in the Recitals hereto.

“Underwriter”

shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such

dealer’s market-making activities.

“Underwriters

Holders” shall mean BTIG, Craig-Hallum and their Permitted Transferees.

“Underwriters

Warrant Subscription Agreement” shall have the meaning given in the Recitals hereto.

“Underwritten

Registration” or “Underwritten Offering” shall mean a Registration in which securities of Pubco

are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

“Warrant

Subscription Agreement” shall have the meaning given in the Recitals hereto.

“Working

Capital Warrants” shall have the meaning given in the Recitals hereto.

Article

REGISTRATIONS

2.1

Demand Registration.

2.1.1

Request for Registration. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and

from time to time after the date hereof, (i) the Holders of a majority-in-interest of the then outstanding Registrable Securities held

by the Sponsor Holders (the “Demanding Sponsor Holders”), (ii) the Holders of a majority-in-interest of the

then outstanding Registrable Securities held by the Underwriters Holders (the “Demanding Underwriters Holders”)

or (iii) the Holders of a majority-in-interest of the then outstanding Registrable Securities held by the Boost Run Holders (the “Demanding

Boost Run Holders”) (any of the Demanding Sponsor Holders, the Demanding Underwriters Holders or the Demanding Boost Run

Holders being in such case, a “Demanding Holder”) may make a written demand for Registration of all or part

of their Registrable Securities, which written demand shall describe the amount and type of securities to be included in such Registration

and the intended method(s) of distribution thereof (such written demand a “Demand Registration”). Pubco shall,

within ten (10) days of Pubco’s receipt of the Demand Registration, notify, in writing, all other Holders of Registrable Securities

of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable

Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all or a portion of such Holder’s

Registrable Securities in such Registration, a “Requesting Holder”) shall so notify Pubco, in writing, within

five (5) days after the receipt by the Holder of the notice from Pubco. Upon receipt by Pubco of any such written notification from a

Requesting Holder(s) to Pubco, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a Registration

pursuant to a Demand Registration and Pubco shall effect, as soon thereafter as practicable, but not more than forty five (45) days immediately

after Pubco’s receipt of the Demand Registration, the Registration of all Registrable Securities requested by the Demanding Holder(s)

and Requesting Holder(s) pursuant to such Demand Registration, including by filing a Registration Statement relating thereto as soon

as practicable. Under no circumstances shall Pubco be obligated to effect more than an aggregate of three (3) Registrations pursuant

to a Demand Registration under this subsection 2.1.1 with respect to any or all Registrable Securities, provided, however,

that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement that may

be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested

by the Requesting Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance

with Section 3.1 of this Agreement.

2.1.2

Effective Registration. Notwithstanding the provisions of subsection 2.1.1 above or any other part of this Agreement, a

Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement filed

with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and

(ii) Pubco has complied with all of its obligations under this Agreement with respect thereto; provided, further, that

if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to

a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any

other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective,

unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of

the Demanding Holders initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly

notify Pubco in writing, but in no event later than five (5) days, of such election; and provided, further, that Pubco

shall not be obligated or required to file another Registration Statement until the Registration Statement that has been previously filed

with respect to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.

2.1.3

Underwritten Offering. Subject to the provisions of subsection 2.1.4 and Section 2.4 hereof, if a majority-in-interest

of the Demanding Holders so advise Pubco as part of their Demand Registration that the offering of the Registrable Securities pursuant

to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder

(if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such

Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided

herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection

2.1.3 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering

by the majority-in-interest of the Demanding Holders initiating the Demand Registration.

2.1.4

Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a

Demand Registration, in good faith, advises Pubco, the Demanding Holders and the Requesting Holders (if any) in writing that the dollar

amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together

with all other shares of Pubco Common Stock or other equity securities that Pubco desires to sell and the shares of Pubco Common Stock,

if any, as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by

any other stockholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold

in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability

of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum

Number of Securities”), then Pubco shall include in such Underwritten Offering, as follows: (i) first, the Registrable

Securities of the Demanding Holders and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities

that each Demanding Holder and Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate

number of Registrable Securities that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration

(such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number

of Securities; (ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i),

the Registrable Securities of Holders (Pro Rata, based on the respective number of Registrable Securities that each Holder has so requested)

exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, without exceeding the Maximum

Number of Securities; (iii) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses

(i) and (ii), the shares of Pubco Common Stock or other equity securities that Pubco desires to sell, which can be sold without exceeding

the Maximum Number of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached under the

foregoing clauses (i), (ii) and (iii), the shares of Pubco Common Stock or other equity securities of other persons or entities that

Pubco is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can

be sold without exceeding the Maximum Number of Securities.

2.1.5

Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders initiating a Demand Registration or a majority-in-interest

of the Requesting Holders (if any), pursuant to a Registration under subsection 2.1.1 shall have the right to withdraw from a

Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to Pubco and the Underwriter

or Underwriters (if any) of their intention to withdraw from such Registration prior to the effectiveness of the Registration Statement

filed with the Commission with respect to the Registration of their Registrable Securities pursuant to such Demand Registration. Notwithstanding

anything to the contrary in this Agreement, Pubco shall be responsible for the Registration Expenses incurred in connection with a Registration

pursuant to a Demand Registration prior to its withdrawal under this subsection 2.1.5.

2.2

Piggyback Registration.

2.2.1

Piggyback Rights. If, at any time on or after the Closing Date, Pubco proposes to file a Registration Statement under the Securities

Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible

into equity securities, for its own account or for the account of shareholders of Pubco (or by Pubco and by the shareholders of Pubco

including, without limitation, pursuant to Section 2.1 hereof), other than a Registration Statement (i) filed in connection with

any employee share option or other benefit plan, (ii) for an exchange offer or offering of securities solely to Pubco’s existing

shareholders, (iii) for an offering of debt that is convertible into equity securities of Pubco or (iv) for a dividend reinvestment plan,

then Pubco shall give written notice of such proposed filing to all of the Holders of Registrable Securities as soon as practicable but

not less than ten (10) days before the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount

and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing

Underwriter or Underwriters, if any, in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity

to register the sale of such number of Registrable Securities as such Holders may request in writing within five (5) days after receipt

of such written notice (such Registration a “Piggyback Registration”). Pubco shall, in good faith, cause such

Registrable Securities to be included in such Piggyback Registration and shall use its best efforts to cause the managing Underwriter

or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection

2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any similar securities of Pubco included in

such Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s)

of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under

this subsection 2.2.1 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten

Offering by Pubco.

2.2.2

Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be

a Piggyback Registration, in good faith, advises Pubco and the Holders of Registrable Securities participating in the Piggyback Registration

in writing that the dollar amount or number of the shares of Pubco Common Stock that Pubco desires to sell, taken together with (i) the

shares of Pubco Common Stock, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements

with persons or entities other than the Holders of Registrable Securities hereunder (ii) the Registrable Securities as to which registration

has been requested pursuant to Section 2.2 hereof, and (iii) the shares of Pubco Common Stock, if any, as to which Registration

has been requested pursuant to separate written contractual piggy-back registration rights of other stockholders of Pubco, exceeds the

Maximum Number of Securities, then:

(a)

If the Registration is undertaken for Pubco’s account, Pubco shall include in any such Registration (A) first, the shares of Pubco

Common Stock or other equity securities that Pubco desires to sell, which can be sold without exceeding the Maximum Number of Securities;

(B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable

Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof (pro

rata based on the respective number of Registrable Securities that such Holder has requested be included in such Registration), which

can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has

not been reached under the foregoing clauses (A) and (B), the shares of Pubco Common Stock, if any, as to which Registration has been

requested pursuant to written contractual piggy-back registration rights of other shareholders of Pubco, which can be sold without exceeding

the Maximum Number of Securities;

(b)

If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then Pubco shall

include in any such Registration (A) first, the shares of Pubco Common Stock or other equity securities, if any, of such requesting persons

or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities;

(B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable

Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.2.1, pro rata

based on the respective number of Registrable Securities that each Holder has requested be included in such Registration and the aggregate

number of Registrable Securities that the Holders have requested to be included in such Registration, which can be sold without exceeding

the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing

clauses (A) and (B), the shares of Pubco Common Stock or other equity securities that Pubco desires to sell, which can be sold without

exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached

under the foregoing clauses (A), (B) and (C), the shares of Pubco Common Stock or other equity securities for the account of other persons

or entities that Pubco is obligated to register pursuant to separate written contractual arrangements with such persons or entities,

which can be sold without exceeding the Maximum Number of Securities.

2.2.3

Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration

for any or no reason whatsoever upon written notification to Pubco and the Underwriter or Underwriters (if any) of his, her or its intention

to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with

respect to such Piggyback Registration. Pubco (whether on its own good faith determination or as the result of a request for withdrawal

by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection

with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the

contrary in this Agreement, Pubco shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration

prior to its withdrawal under this subsection 2.2.3.

2.2.4

Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof

shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.1 hereof.

2.3

Registrations on Form S-3. The Holders of Registrable Securities may at any time, and from time to time, request in writing that

Pubco, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale

of any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such

time (“Form S-3”); provided, however, that Pubco shall not be obligated to effect such request

through an Underwritten Offering. Within five (5) days of the Pubco’s receipt of a written request from a Holder or Holders of

Registrable Securities for a Registration on Form S-3, Pubco shall promptly give written notice of the proposed Registration on Form

S-3 to all other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or

a portion of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify Pubco, in writing, within five

(5) days after the receipt by the Holder of the notice from Pubco. As soon as practicable thereafter, but not more than twelve (12) days

after Pubco’s initial receipt of such written request for a Registration on Form S-3, Pubco shall register all or such portion

of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of Registrable

Securities of any other Holder or Holders joining in such request as are specified in the written notification given by such Holder or

Holders; provided, however, that Pubco shall not be obligated to effect any such Registration pursuant to Section 2.3

hereof if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities, together with the Holders

of any other equity securities of Pubco entitled to inclusion in such Registration, propose to sell the Registrable Securities and such

other equity securities (if any) at any aggregate price to the public of less than $10,000,000.

2.4

Restrictions on Registration Rights. If (A) during the period starting with the date sixty (60) days prior to Pubco’s good

faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of, Pubco

initiated Registration and provided that Pubco has delivered written notice to the Holders prior to receipt of a Demand Registration

pursuant to subsection 2.1.1 and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable

Registration Statement to become effective; (B) the Holders have requested an Underwritten Registration and Pubco and the Holders are

unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board such Registration

would be seriously detrimental to Pubco and the Board concludes as a result that it is essential to defer the filing of such Registration

Statement at such time, then in each case Pubco shall furnish to such Holders a certificate signed by the Chairman of the Board stating

that in the good faith judgment of the Board it would be seriously detrimental to Pubco for such Registration Statement to be filed in

the near future and that it is therefore essential to defer the filing of such Registration Statement. In such event, Pubco shall have

the right to defer such filing for a period of not more than thirty (30) days. Notwithstanding anything to the contrary contained in

this Agreement, Pubco shall not be required to effect or permit any Registration or cause any Registration Statement to become effective,

with respect to any Registrable Securities held by any Holder, until after the expiration of the applicable Lock-Up Period.

Article

III

PUBCO

PROCEDURES

3.1

General Procedures. If at any time on or after the date hereof Pubco is required to effect the Registration of Registrable Securities,

Pubco shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the

intended plan of distribution thereof, and pursuant thereto Pubco shall, as expeditiously as possible:

3.1.1

prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and

use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities

covered by such Registration Statement have been sold;

3.1.2

prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements

to the Prospectus, as may be requested by a majority in interest of the Holders with Registrable Securities registered on such Registration

Statement or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to

the registration form used by Pubco or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective

until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution

set forth in such Registration Statement or supplement to the Prospectus;

3.1.3

prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters,

if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such

Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including

all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including

each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such

Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities

owned by such Holders;

3.1.4

prior to any public offering of Registrable Securities, use its best efforts to (i) register or qualify the Registrable Securities covered

by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the

Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may request

and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with

or approved by such other governmental authorities as may be necessary by virtue of the business and operations of Pubco and do any and

all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration

Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that Pubco

shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or

take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then

otherwise so subject;

3.1.5

cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities

issued by Pubco are then listed;

3.1.6

provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective

date of such Registration Statement;

3.1.7

advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance

of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any

proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal

if such stop order should be issued;

3.1.8

at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration

Statement furnish a copy thereof to each seller of such Registrable Securities and its counsel, including, without limitation, providing

copies promptly upon receipt of any comment letters received with respect to any such Registration Statement or Prospectus;

3.1.9

notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities

Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes

a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;

3.1.10

permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters,

if any, and any attorney or accountant retained by such Holders or Underwriters to participate, at each such person’s own expense,

in the preparation of the Registration Statement, and cause Pubco’s officers, directors and employees to supply all information

reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided,

however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory

to Pubco, prior to the release or disclosure of any such information; and provided further, Pubco may not include the name of

any Holder or Underwriter or any information regarding any Holder or Underwriter in any Registration Statement or Prospectus, any amendment

or supplement to such Registration Statement or Prospectus, any document that is to be incorporated by reference into such Registration

Statement or Prospectus, or any response to any comment letter, without the prior written consent of such Holder or Underwriter, such

consent not to be unreasonably withheld, and providing each such Holder or Underwriter a reasonable amount of time to review and comment

on such applicable document, which comments Pubco shall include unless contrary to applicable law;

3.1.11

obtain a “cold comfort” letter from Pubco’s independent registered public accountants in the event of an Underwritten

Registration, in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the

managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

3.1.12

on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel

representing Pubco for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the

Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as

the Holders, placement agent, sales agent, or Underwriters may reasonably request and as are customarily included in such opinions and

negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;

3.1.13

in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary

form, with the managing Underwriter of such offering;

3.1.14

make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve

(12) months beginning with the first day of Pubco’s first full calendar quarter after the effective date of the Registration Statement

which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated

thereafter by the Commission);

3.1.15

if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $25,000,000, use its reasonable

efforts to make available senior executives of Pubco to participate in customary “road show” presentations that may be reasonably

requested by the Underwriters in any Underwritten Offering; and

3.1.16

otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in

connection with such Registration.

3.2

Registration Expenses. The Registration Expenses of all Registrations shall be borne by Pubco. It is acknowledged by the Holders

that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’

commissions and discounts, brokerage fees, Underwriters’ marketing costs and, other than as set forth in the definition of “Registration

Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.

3.3

Requirements for Participation in Underwritten Offerings. No person may participate in any Underwritten Offering for equity securities

of Pubco pursuant to a Registration initiated by Pubco hereunder unless such person (i) agrees to sell such person’s securities

on the basis provided in any underwriting arrangements approved by Pubco and (ii) completes and executes all customary questionnaires,

powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required

under the terms of such underwriting arrangements.

3.4

Suspension of Sales; Adverse Disclosure. Upon receipt of written notice from Pubco that a Registration Statement or Prospectus

contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until he, she or it has

received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that Pubco hereby covenants

to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until he, she or it is advised

in writing by Pubco that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration

Statement in respect of any Registration at any time would require Pubco to make an Adverse Disclosure or would require the inclusion

in such Registration Statement of financial statements that are unavailable to Pubco for reasons beyond Pubco’s control, Pubco

may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of,

such Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith by

Pubco to be necessary for such purpose. In the event Pubco exercises its rights under the preceding sentence, the Holders agree to suspend,

immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection

with any sale or offer to sell Registrable Securities. Pubco shall immediately notify the Holders of the expiration of any period during

which it exercised its rights under this Section 3.4.

3.5

Reporting Obligations. As long as any Holder shall own Registrable Securities, Pubco, at all times while it shall be a reporting

company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace

period) all reports required to be filed by Pubco after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange

Act and to promptly furnish the Holders with true and complete copies of all such filings. Pubco further covenants that it shall take

such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell

shares of Pubco Common Stock held by such Holder without registration under the Securities Act within the limitation of the exemptions

provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission), including

providing any legal opinions. Upon the request of any Holder, Pubco shall deliver to such Holder a written certification of a duly authorized

officer as to whether it has complied with such requirements.

3.6

Limitations on Registration Rights. Notwithstanding anything herein to the contrary, BTIG and Craig-Hallum or their respective

designees or Permitted Transferees may not exercise their rights, if any, under Sections 2.1 and 2.2 hereunder after five (5) and seven

(7) years from the commencement of sales in the Company’s initial public offering, respectively.

3.7

Requirements for Participation in Underwritten Offerings and Limitations on Registration Rights. No person may participate in

any Underwritten Offering for equity securities of Pubco pursuant to a registration initiated by Pubco hereunder unless such person (i)

agrees to sell such person’s securities on the basis provided in any underwriting arrangements approved by Pubco and (ii) completes

and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary

documents as may be reasonably required under the terms of such underwriting arrangements.

Article

INDEMNIFICATION

AND CONTRIBUTION

4.1

Indemnification.

4.1.1

Pubco agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and each

person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses

(including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration Statement,

Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material

fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused

by or contained in any information furnished in writing to Pubco by such Holder expressly for use therein. Pubco shall indemnify the

Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities Act)

to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

4.1.2

In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish

to Pubco in writing such information and affidavits as Pubco reasonably requests for use in connection with any such Registration Statement

or Prospectus and, to the extent permitted by law, shall indemnify Pubco, its directors and officers and agents and each person who controls

Pubco (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation

reasonable attorneys’ fees) resulting from any untrue statement of material fact contained in the Registration Statement, Prospectus

or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein

or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained

in any information or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that

the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability

of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from

the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the

Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the Securities Act) to

the same extent as provided in the foregoing with respect to indemnification of Pubco.

4.1.3

Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect

to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification

hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s

reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit

such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense

is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its

consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume

the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus local counsel) for all parties

indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict

of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying

party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot

be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such

settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified

party of a release from all liability in respect to such claim or litigation.

4.1.4

The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or

on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer

of securities. Pubco and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are

reasonably requested by any indemnified party for contribution to such party in the event Pubco’s or such Holder’s indemnification

is unavailable for any reason.

4.1.5

If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless

an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party,

in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of

such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying

party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party

and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or

alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information

supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative

intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the

liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such Holder

in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities

referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3

above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.

The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined

by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to

in this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the

Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such

fraudulent misrepresentation.

Article

MISCELLANEOUS

5.1

Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail,

addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person

or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, telecopy, telegram or

facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently

given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed

and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time

as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused

by the addressee upon presentation. Any notice or communication under this Agreement must be addressed, if to Pubco, to: 5 Revere Drive,

Northbrook, IL 60062, Attention: Chief Executive Officer, with copy to: Winston & Strawn LLP, 35 W. Wacker Drive Chicago, IL 60601-9703

, Attention: Peter Clarke, and, if to any Holder, at such Holder’s address or contact information as set forth in Pubco’s

books and records. Any party may change its address for notice at any time and from time to time by written notice to the other parties

hereto, and such change of address shall become effective thirty (30) days after delivery of such notice as provided in this Section

5.1.

5.2

Assignment; No Third Party Beneficiaries.

5.2.1

This Agreement and the rights, duties and obligations of Pubco hereunder may not be assigned or delegated by Pubco in whole or in part.

5.2.2

Prior to the expiration of the applicable Lock-up Period, no Holder may assign or delegate such Holder’s rights, duties or obligations

under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder to a Permitted

Transferee but only if such Permitted Transferee agrees to become bound by the transfer restrictions set forth in this Agreement. After

the expiration of the applicable Lock-up Period, the Holder may assign or delegate such Holder’s rights, duties or obligations

under this Agreement, in whole or in part, to any transferee.

5.2.3

This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors

and the permitted assigns of the Holders, which shall include Permitted Transferees.

5.2.4

This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth

in this Agreement and Section 5.2 hereof.

5.2.5

No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate Pubco

unless and until Pubco shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii) the

written agreement of the assignee, in a form reasonably satisfactory to Pubco, to be bound by the terms and provisions of this Agreement

(which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as

provided in this Section 5.2 shall be null and void.

5.3

Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which

shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.

5.4

Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES

EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS

AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS

OF SUCH JURISDICTION. ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED

HEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED STATES OR THE COURTS OF THE STATE OF NEW YORK IN EACH CASE LOCATED IN THE

CITY OF NEW YORK, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING.

5.5

Amendments and Modifications. Upon the written consent of Pubco, the Sponsor and the Holders of at least a majority in interest

of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this

Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however,

that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its

capacity as a holder of the capital shares of Pubco, in a manner that is materially different from the other Holders (in such capacity)

shall require the consent of the Holder so affected. No course of dealing between any Holder or Pubco and any other party hereto or any

failure or delay on the part of a Holder or Pubco in exercising any rights or remedies under this Agreement shall operate as a waiver

of any rights or remedies of any Holder or Pubco. No single or partial exercise of any rights or remedies under this Agreement by a party

shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.

5.6

Other Registration Rights. Pubco represents and warrants that no person, other than a Holder of Registrable Securities, has any

right to require Pubco or the Company to register any securities of Pubco or the Company for sale or to include such securities of Pubco

or the Company in any Registration filed by Pubco or the Company for the sale of securities for its own account or for the account of

any other person. Further, Pubco represents and warrants that this Agreement supersedes any other registration rights agreement or agreement

with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms

of this Agreement shall prevail.

5.7

Term. This Agreement shall terminate upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date

as of which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable

period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by

the Commission)) or (B) the Holders of all Registrable Securities are permitted to sell the Registrable Securities without registration

pursuant to Rule 144 (or any similar provision) under the Securities Act with no volume or other restrictions or limitations. The provisions

of Section 3.5 and Article IV shall survive any termination.

5.8

Termination of Business Combination Agreement. This Agreement shall be binding upon each party upon such party’s execution

and delivery of this Agreement, but this Agreement shall only become effective upon the Closing. In the event that the Business Combination

Agreement is validly terminated in accordance with its terms prior to the Closing, this Agreement shall automatically terminate and become

null and void and be of no further force or effect, and the parties shall have no obligations hereunder and the provisions of the Original

Registration Rights Agreement shall be automatically reinstated and in effect.

[Signature

Page Follows]

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

COMPANY:

WILLOW

LANE ACQUISITION CORP., a Cayman Islands exempted company

By:

/s/

Luke Weil

Name:

Luke Weil

Title:

Chief

Executive Officer

PUBCO:

BOOST

RUN INC., a Delaware corporation

By:

/s/

Andrew Karos

Name:

Andrew Karos

Title:

Chief Executive Officer

HOLDERS:

WILLOW

LANE SPONSOR, LLC, a Delaware limited liability company

By:

/s/

Luke Weil

Name:

Luke Weil

Title:

Managing Member

BTIG, LLC

By:

/s/

Paul Wood

Name:

Paul Wood

Title:

Managing Director

CRAIG-HALLUM CAPITAL GROUP, LLC

By:

/s/

Rick Hartfiel

Name:

Rick Hartfiel

Title:

Managing Partner, Head of Investment Banking

[Signature

Page to Registration Rights Agreement]

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

BOOST RUN HOLDERS:

ANDREW KAROS

/s/ Andrew Karos

Andrew Karos

Address for Notice:

Address: 352 Sunrise Cir. Glencoe, IL 60022

Email: ak@boostrun.com

Phone: (847) 745-8579

RYAN

BURKE

/s/

Ryan Burke

Ryan

Burke

Address for Notice:

Address:

7114 East Stetson Drive, Suite 400, Scottsdale, AZ 85251

Email:

ryan@rainypartners.com

Phone:

917-862-2297

Goodrich

ILMJS LLC

By:

/s/

Sean Goodrich

Name:

Sean

Goodrich

Title:

Managing

Member

Address

for Notice:

Address:

4020 Hardie Ave

Miami, Fl 33133

Email: sg@boostrun.com

Phone: 917-239-2997

A23

Revocable Trust No.1, dated January 26, 2026

By:

/s/

Harilaos Georgakopoulos

Name:

Harilaos

Georgakopoulos

Title:

Trustee

Address for Notice:

Address: 2827 N. Elm Ln, Arlington Heights, IL 60004

Email: hgeorgako@hotmail.com

Phone: 847-651-8434

[Signature

Page to Registration Rights Agreement]

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

HOLDERS (for entities):

[HOLDER]

By:

Name:

Title:

Address for Notice:

Address:

Facsimile No.:

Telephone No.:

Email:

HOLDERS (for individuals):

[HOLDER]

By:

Name:

Address for Notice:

Address:

Facsimile

No.:

Telephone

No.:

Email:

EX-10.3

Filename: ex10-3.htm · Sequence: 6

Exhibit

10.3

INDEMNITY

AGREEMENT

This

INDEMNITY AGREEMENT (this “Agreement”) is made as of May 8, 2026, by and between Boost Run Inc., a Delaware

corporation (the “Company”), and each of the undersigned (each, an “Indemnitee”).

RECITALS

WHEREAS,

highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities

unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and

actions against them arising out of their service to and activities on behalf of such corporations;

WHEREAS,

the board of directors of the Company (the “Board”) has determined that, in order to attract and retain qualified

individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving

the Company and its subsidiaries from certain liabilities;

WHEREAS,

directors, officers, and other persons in service to corporations or business enterprises are being increasingly subjected to expensive

and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company

or business enterprise itself;

WHEREAS,

the Amended and Restated Certificate of Formation (the “Charter”) and the Amended and Restated Bylaws (the

“Bylaws”) of the Company require indemnification of the officers and directors of the Company. Indemnitee may

also be entitled to indemnification pursuant to applicable provisions of Delaware General Corporate Law (“DGCL”).

The Charter, Bylaws and DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate

that contracts may be entered into between the Company and members of the Board, officers, and other persons with respect to indemnification,

hold harmless, exoneration, advancement, and reimbursement rights;

WHEREAS,

the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

WHEREAS,

the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests

of the Company’s stockholders and that the Company should act to assure such persons that there will be increased certainty of

such protection in the future;

WHEREAS,

it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate, and

advance expenses on behalf of such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve

the Company free from undue concern that they will not be so protected against liabilities;

WHEREAS,

this Agreement is a supplement to and in furtherance of the Charter and Bylaws and any resolutions adopted pursuant thereto, and shall

not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; and

WHEREAS,

Indemnitee may not be willing to serve as an officer or director, advisor, or in another capacity without adequate protection, and the

Company desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service

for or on behalf of the Company on the condition that Indemnitee be so indemnified.

NOW,

THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and

agree as follows:

TERMS

AND CONDITIONS

SERVICES TO THE COMPANY. Indemnitee will serve or continue to serve as an officer, director, advisor, key employee, or in any

other capacity of the Company, as applicable, for so long as Indemnitee is duly elected or appointed or retained or until Indemnitee

tenders Indemnitee’s resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement shall continue in

full force and effect after Indemnitee has ceased to serve as a director, officer, advisor, key employee, or in any other capacity of

the Company, in each case as provided in Section 16. This Agreement, however, shall not impose any obligation on Indemnitee or the Company

to continue Indemnitee’s service to the Company beyond any period otherwise required by law or by other agreements or commitments

of the parties, if any.

DEFINITIONS. As used in this Agreement:

(a)

“agent” shall mean any person who is or was a director, officer, or employee of the Company or a subsidiary

of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a

director, officer, employee, fiduciary, or other official of another corporation, partnership, limited liability company, joint venture,

trust, or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of

the Company.

(b)

“Beneficial Owner” and “Beneficial Ownership” shall have the meanings set forth in

Rule 13d-3 promulgated under the Exchange Act (as defined below) as in effect on the date hereof.

(c)

“Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of

any of the following events:

(i)

Acquisition of Stock by Third Party. Other than Pelican Sponsor LLC (the “Sponsor”) or any of its affiliates,

any Person (as defined below) is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing fifteen

percent (15%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote generally in the

election of directors, unless (1) the change in the relative Beneficial Ownership of the Company’s securities by any Person results

solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors,

or (2) such acquisition was approved in advance by the Continuing Directors (as defined below) and such acquisition would not constitute

a Change in Control under part (iii) of this definition;

(ii)

Change in Board of Directors. Individuals who, as of the date hereof, constitute the Board, and any new director whose election

by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two thirds of the directors

then still in office who were directors on the date hereof or whose election for nomination for election was previously so approved (collectively,

the “Continuing Directors”), cease for any reason to constitute at least a majority of the members of the Board;

(iii)

Corporate Transactions. The effective date of a merger, capital stock exchange, asset acquisition, stock purchase, reorganization,

or similar business combination involving the Company and one or more businesses (a “Business Combination”),

in each case unless, following such Business Combination: (1) all or substantially all of the individuals and entities who were the Beneficial

Owners of securities entitled to vote generally in the election of directors immediately prior to such Business Combination beneficially

own, directly or indirectly, more than 51% of the combined voting power of the then outstanding

securities of the Company entitled to vote generally in the election of directors resulting from such Business Combination (including,

without limitation, a corporation that as a result of such transaction owns the Company or all or substantially all of the Company’s

assets either directly or through one or more Subsidiaries (as defined below)) in substantially the same proportions as their ownership

immediately prior to such Business Combination, of the securities entitled to vote generally in the election of directors; (2) other

than an affiliate of the Sponsor, no Person (excluding any corporation resulting from such Business Combination) is the Beneficial Owner,

directly or indirectly, of fifteen percent (15%) or more of the combined voting power of the then outstanding securities entitled to

vote generally in the election of directors of the surviving corporation except to the extent that such ownership existed prior to the

Business Combination; and (3) at least a majority of the Board of Directors of the corporation resulting from such Business Combination

were Continuing Directors at the time of the execution of the initial agreement, or of the action of the Board of Directors, providing

for such Business Combination;

(iv)

Liquidation. The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement or series

of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring

the Company’s current receivables or escrows due (or, if such stockholder approval is not required, the decision by the Board to

proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions); or

(v)

Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule

14A of Regulation 14A (or any successor rule) (or a response to any similar item on any similar schedule or form) promulgated under the

Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.

(d)

“Corporate Status” means the status of a person who is or was

a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of the Company or of any other

Enterprise (as defined below) that such person is or was serving at the request of the Company.

(e)

“Delaware Court” shall mean the Delaware Court of Chancery, or if the Delaware Court of Chancery lacks subject

matter jurisdiction, any other state court of the State of Delaware or the federal courts for the District of Delaware.

(f)

“Disinterested Director” shall mean a director of the Company who is not

and was not a party to the Proceeding (as defined below) in respect of which indemnification is sought by Indemnitee.

(g)

“Enterprise” shall mean the Company and any other corporation, constituent corporation (including any constituent

of a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited

liability company, partnership, joint venture, trust, employee benefit plan, or other enterprise which Indemnitee is or was serving at

the request of the Company as a director, officer, trustee, manager, general partner, managing member, fiduciary, employee, or agent.

(h)

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

(i)

“Expenses” shall include all direct and indirect costs, fees, and expenses of

any type or nature whatsoever, including, without limitation, all reasonable attorneys’ fees and costs, retainers, court

costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating

costs, printing and binding costs, telephone charges, postage, delivery service fees, fax transmission charges, secretarial services,

and all other disbursements, obligations, or expenses in connection with prosecuting, defending, preparing to prosecute or defend, investigating,

being or preparing to be a witness in, settlement or appeal of, or otherwise participating in, a Proceeding (as defined below), including

reasonable compensation for time spent by Indemnitee for which he or she is not otherwise compensated by the Company or any third party.

Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding (as defined below), including

without limitation the principal, premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal

bond or its equivalent. “Expenses,” however, shall not include amounts paid in settlement by Indemnitee or the amount of

judgments or fines against Indemnitee.

(j)

“fines” shall include any excise tax assessed on Indemnitee with respect to any employee benefit plan.

(k)

“Independent Counsel” shall mean a law firm or a member of a law firm that has significant experience in matters

of corporate law and that neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee

in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other

indemnitees under similar indemnification agreements); or (ii) any other party to the Proceeding (as defined below) giving rise to a

claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any

person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing

either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.

(l)

“Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on

the date hereof; provided, however, that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries (as defined below)

of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of any corporation

owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of

the Company; and (iv) any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary

(as defined below) of the Company or of a corporation owned directly or indirectly by the stockholders of the Company in substantially

the same proportions as their ownership of stock of the Company.

(m)

“Proceeding” shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate

dispute resolution mechanism, investigation, inquiry, administrative hearing, or any other actual, threatened or completed proceeding,

whether brought in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims),

criminal, administrative, or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or otherwise

by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action (or failure to act) taken

by Indemnitee or of any action (or failure to act) on Indemnitee’s part while acting as a director or officer of the Company, or

by reason of the fact that Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner,

manager, managing member, fiduciary, employee, or agent of any other Enterprise, in each case whether or not serving in such capacity

at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided

under this Agreement.

(n)

“serving at the request of the Company” shall include any service as a director, officer, employee, agent or

fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent, or fiduciary with

respect to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee

reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be

deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this

Agreement.

(o)

“Subsidiary,” with respect to any Person, shall mean any corporation, limited liability company, partnership,

joint venture, trust, or other entity of which a majority of the voting power of the voting equity securities or equity interest is owned,

directly or indirectly, by that Person.

INDEMNITY IN THIRD-PARTY PROCEEDINGS. To the fullest extent permitted by applicable law, the Company shall indemnify, hold harmless,

and exonerate Indemnitee in accordance with the provisions of this Section 3 if Indemnitee was, is, or is threatened to be made, a party

to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the right of the Company

to procure a judgment in its favor by reason of Indemnitee’s Corporate Status (which is addressed in Section 4). Pursuant to this

Section 3, Indemnitee shall be indemnified, held harmless, and exonerated against all Expenses, judgments, liabilities, fines,

penalties, and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection

with or in respect of such Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement) actually, and reasonably

incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue, or matter therein, if

Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company

and, in the case of a criminal Proceeding, had no reasonable cause to believe that Indemnitee’s conduct was unlawful.

INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY. To the fullest extent

permitted by applicable law, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of

this Section 4 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise)

in any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate Status.

Pursuant to this Section 4, Indemnitee shall be indemnified, held harmless, and exonerated against all Expenses actually and reasonably

incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee

acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company. No indemnification,

hold harmless, or exoneration for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee

shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that any court in which the Proceeding

was brought or the Delaware Court shall determine upon application that, despite the adjudication of liability but in view of all the

circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless, or to exoneration.

INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL. Notwithstanding

any other provisions of this Agreement, to the extent that Indemnitee was or is, by reason of Indemnitee’s Corporate Status, a

party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue, or

matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law, indemnify, hold harmless,

and exonerate Indemnitee against all Expenses actually and reasonably incurred by Indemnitee in connection therewith. If Indemnitee is

not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues,

or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and exonerate

Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with each

successfully resolved claim, issue, or matter. If Indemnitee is not wholly successful in such Proceeding, the Company also shall, to

the fullest extent permitted by applicable law, indemnify, hold harmless, and exonerate Indemnitee against all Expenses reasonably incurred

in connection with a claim, issue, or matter related to any claim, issue, or matter on which Indemnitee was successful. For purposes

of this Section and without limitation, the termination of any claim, issue, or matter in such a Proceeding by dismissal, with or without

prejudice, shall be deemed to be a successful result as to such claim, issue, or matter.

INDEMNIFICATION FOR EXPENSES OF A WITNESS. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee

is, by reason of Indemnitee’s Corporate Status, a witness or deponent in any Proceeding to which

Indemnitee was or is not a party or threatened to be made a party, Indemnitee shall, to the fullest extent permitted by applicable

law, be indemnified, held harmless, and exonerated against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s

behalf in connection therewith.

ADDITIONAL INDEMNIFICATION, HOLD HARMLESS

AND EXONERATION RIGHTS. Notwithstanding any limitation in Sections 3, 4 or 5,

this Section 7 is intended to provide Indemnitee with additional contractual indemnification, hold harmless, and exoneration rights to

the fullest extent permitted by applicable law, beyond the specific indemnification rights set forth in Sections 3, 4 and 5. Accordingly,

the Company shall, to the fullest extent permitted by applicable law, indemnify, hold harmless and exonerate Indemnitee if Indemnitee

is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure

a judgment in its favor) against all Expenses, judgments, liabilities, fines, penalties, and amounts paid in settlement (including all

interest, assessments, and other charges paid or payable in connection with or in respect of such Expenses, judgments, liabilities, fines,

penalties, and amounts paid in settlement) actually and reasonably incurred by Indemnitee in connection with the Proceeding. No indemnification,

hold harmless, or exoneration rights shall be available under this Section 7 on account of Indemnitee’s conduct that constitutes

a breach of Indemnitee’s duty of loyalty to the Company or its stockholders or is an act or omission not in good faith or that

involves intentional misconduct or a knowing violation of law.

CONTRIBUTION IN THE EVENT OF JOINT LIABILITY.

(a)

To the fullest extent permissible under applicable law, if the indemnification, hold harmless and/or exoneration rights provided for

in this Agreement are unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying,

holding harmless, or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for

judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding

without requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution

it may have at any time against Indemnitee.

(b)

The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be

if joined in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

(c)

The Company hereby agrees to fully indemnify, hold harmless, and exonerate Indemnitee from any claims for contribution which may be brought

by officers, directors, or employees of the Company other than Indemnitee who may be jointly liable with Indemnitee.

ADVANCES OF EXPENSES; DEFENSE OF CLAIM.

(a)

Notwithstanding any provision of this Agreement to the contrary, and to the fullest extent not prohibited by applicable law, the Company

shall pay the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee within three months)

in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement or statements requesting such

advances from time to time, prior to the final disposition of any Proceeding. Advances shall, to the fullest extent permitted by law,

be unsecured and interest free. Advances shall, to the fullest extent permitted by law, be made without regard to Indemnitee’s

ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to be indemnified, held harmless, or exonerated

under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing a Proceeding to

enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances

claimed. To the extent required by applicable law, such payments of Expenses in advance of the final disposition of the Proceeding shall

be made only upon the Company’s receipt of (i) a written affirmation by Indemnitee of Indemnitee’s good faith belief that

Indemnitee has met the applicable standard of conduct necessary for indemnification under applicable law and (ii) an undertaking, by

or on behalf of Indemnitee, to repay the advanced amounts to the extent that it is ultimately determined that Indemnitee is not entitled

to be indemnified by the Company.

(b)

The Company will be entitled to participate in the Proceeding at its own expense.

(c)

The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, liability,

fine, penalty or limitation on Indemnitee without Indemnitee’s prior written consent.

10.

PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION.

(a)

Indemnitee agrees to notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment,

information or other document relating to any Proceeding, claim, issue, or matter therein that may be subject to indemnification, hold

harmless, or exoneration rights, or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall

not relieve the Company of any obligation that it may have to Indemnitee under this Agreement, or otherwise.

(b)

Indemnitee may deliver to the Company a written application to indemnify, hold harmless, or exonerate Indemnitee in accordance with this

Agreement. Such application(s) may be delivered from time to time and at such time(s) as Indemnitee deems appropriate in his or her sole

discretion. Following such a written application for indemnification by Indemnitee, Indemnitee’s entitlement to indemnification

shall be determined according to Section 11(a) of this Agreement.

11.

PROCEDURE UPON APPLICATION FOR INDEMNIFICATION.

(a)

A determination, if required by applicable law, with respect to Indemnitee’s entitlement

to indemnification shall be made in the specific case by one of the following methods:

(i) if

no Change in Control has occurred

(x) by

a majority vote of the Disinterested Directors, even though less than a quorum of the Board,

(y) by

a committee of Disinterested Directors, even though less than a quorum of the Board, or

(z) if

there are no Disinterested Directors, or if such Disinterested Directors so direct, by Independent

Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee;

(ii) if

a Change in Control has occurred, by Independent Counsel in a written opinion to the Board,

a copy of which shall be delivered to Indemnitee.

The

Company will advise Indemnitee promptly in writing with respect to any determination that Indemnitee is or is not entitled to indemnification,

including a description of any reason or basis for which indemnification has been denied.

If it is determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten

(10) days after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination

with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons, or entity upon reasonable

advance request any documentation or information that is not privileged or otherwise protected from disclosure and that is reasonably

available to Indemnitee and reasonably necessary to such determination. Any costs or Expenses (including

reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons, or entity

making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification)

and the Company hereby agrees to indemnify and to hold Indemnitee harmless therefrom.

(b)

If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 11(a) hereof, the Independent

Counsel shall be selected as provided in this Section 11(b). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee

shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising it of the identity

of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent

Counsel” as defined in Section 2 of this Agreement. If the Independent Counsel is selected by the Board, the Company shall give

written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected and certifying that the Independent

Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. In either

event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such

written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection

to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel selected does

not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set

forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act

as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel selected may not serve as Independent

Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without

merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant to Section 10(b)

hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Delaware

Court for resolution of any objection that shall have been made by the Company or Indemnitee to the other’s selection of Independent

Counsel and/or for the appointment as Independent Counsel of a person selected by the Delaware Court, and the person with respect to

whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 11(a) hereof. Upon the

due commencement of any judicial proceeding or arbitration pursuant to Section 13(a) of this Agreement, Independent Counsel shall be

discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then

prevailing).

(c)

The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent

Counsel against any and all Expenses, claims, liabilities, and damages arising out of or relating to this Agreement or its engagement

pursuant hereto.

12.

PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS.

(a)

In making a determination with respect to entitlement to indemnification hereunder, the person, persons, or entity making such determination

shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification

in accordance with Section 10(b) of this Agreement, and the Company shall have the burden of proof to overcome that presumption in connection

with the making by any person, persons, or entity of any determination contrary to that presumption. Neither the failure of the Company

(including by the Disinterested Directors or Independent Counsel) to have made a determination prior to the commencement of any action

pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of

conduct, nor an actual determination by the Company (including by the Disinterested Directors or Independent Counsel) that Indemnitee

has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met

the applicable standard of conduct.

(b)

If the person, persons, or entity empowered or selected under Section 11 of this Agreement to determine whether Indemnitee is entitled

to indemnification shall not have made a determination within thirty (30) days after receipt by the Company of the request therefor,

the requisite determination of entitlement to indemnification shall, to the fullest extent permitted by law, be deemed to have been made

and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission

of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification,

or (ii) a final judicial determination that any or all such indemnification is expressly prohibited under applicable law; provided, however,

that such 30-day period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person, persons,

or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the

obtaining or evaluating of documentation and/or information relating thereto.

(c)

The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea

of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect

the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee

reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee

had reasonable cause to believe that Indemnitee’s conduct was unlawful.

(d)

For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action

is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee

by the directors, trustees, general partners, managers, or managing members of the Enterprise in the course of their duties, or on the

advice of legal counsel for the Enterprise, its Board, any committee of the Board, or any director, trustee, general partner, manager,

or managing member of the Enterprise, or on information or records given or reports made to the Enterprise, its Board, any committee

of the Board or any director, trustee, general partner, manager, or managing member of the Enterprise, by an independent certified public

accountant or by an appraiser or other expert selected by the Enterprise, its Board, any

committee of the Board, or any director, trustee, general partner, manager, or managing member. The provisions of this Section 12(d)

shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have

met the applicable standard of conduct set forth in this Agreement.

(e)

The knowledge and/or actions, or failure to act of any other director, officer, trustee, partner, manager, managing member, fiduciary,

agent, or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under

this Agreement.

13.

REMEDIES OF INDEMNITEE.

(a)

If (i) a determination is made pursuant to Section 11 of this Agreement that Indemnitee is not entitled to indemnification under this

Agreement, (ii) advancement of Expenses, to the fullest extent permitted by applicable law, is not timely made pursuant to Section 9

of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 11(a) of this Agreement

within thirty (30) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made

pursuant to Section 5, 6, 7 or the last sentence of Section 11(a) of this Agreement within ten

(10) days after receipt by the Company of a written request therefor, (v) a contribution payment is not made in a timely manner

pursuant to Section 8 of this Agreement, (vi) payment of indemnification pursuant to Sections 3 or 4 of this Agreement is not made within

ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vii) payment to Indemnitee pursuant

to any hold harmless or exoneration rights under this Agreement or otherwise is not made in accordance with this Agreement, Indemnitee

shall be entitled to an adjudication by the Delaware Court to such indemnification, hold harmless, exoneration, contribution, or advancement

rights. Alternatively, Indemnitee, at Indemnitee’s option, may seek an award in arbitration to be conducted by a single arbitrator

pursuant to the Commercial Arbitration Rules and Mediation Procedures of the American Arbitration Association. Except as set forth herein,

the provisions of Delaware law (without regard to its conflict of laws rules) shall apply to any such arbitration. The Company shall

not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.

(b)

In the event that a determination shall have been made pursuant to Section 11(a) of this Agreement that Indemnitee is not entitled to

indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 13 shall be conducted in all respects as a

de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.

(c)

In any judicial proceeding or arbitration commenced pursuant to this Section 13, Indemnitee shall be presumed to be entitled to be indemnified,

held harmless, and exonerated and to receive advancement of Expenses under this Agreement and the Company shall have the burden of proving

Indemnitee is not entitled to be indemnified, held harmless, and exonerated and to receive advancement of Expenses, as the case may be,

and the Company may not refer to or introduce into evidence any determination pursuant to Section 11(a) of this Agreement adverse to

Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section 13, Indemnitee shall

not be required to reimburse the Company for any advances pursuant to Section 9 until a final determination is made with respect to Indemnitee’s

entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

(d)

If a determination shall have been made pursuant to Section 11(a) of this Agreement that Indemnitee is entitled to indemnification, the

Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 13, absent

(i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement

not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable

law.

(e)

The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 13 that the

procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before

any such arbitrator that the Company is bound by all the provisions of this Agreement.

(f)

The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by law against all Expenses and, if requested

by Indemnitee, shall (within ten (10) days after the Company’s receipt of such written request) pay to Indemnitee, to the fullest

extent permitted by applicable law, such Expenses which are incurred by Indemnitee in connection with any judicial proceeding or arbitration

brought by Indemnitee: (i) to enforce his or her rights under, or to recover damages for breach of, this Agreement or any other indemnification,

hold harmless, exoneration, advancement, or contribution agreement or provision of the Charter, or the Bylaws now or hereafter in effect;

or (ii) for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless of the

outcome and whether Indemnitee ultimately is determined to be entitled to such indemnification, hold harmless, or exoneration right,

advancement, contribution, or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought

by Indemnitee in good faith).

(g)

Interest shall be paid by the Company to Indemnitee at the legal rate under Delaware law for amounts that the Company indemnifies, holds

harmless, or exonerates, or advances, or is obliged to indemnify, hold harmless, or exonerate or advance for the period commencing with

the date on which Indemnitee requests indemnification, to be held harmless, exonerated, or seeks contribution, reimbursement, or advancement

of any Expenses and ending with the date on which such payment is made to Indemnitee by the Company.

14.

SECURITY. Notwithstanding anything herein to the contrary, to the extent requested by Indemnitee and approved by the Board, the

Company may at any time and from time to time provide security to Indemnitee for the Company’s obligations hereunder through an

irrevocable bank line of credit, funded trust, or other collateral. Any such security, once provided to Indemnitee, may not be revoked

or released without the prior written consent of Indemnitee.

15.

NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; SUBROGATION.

(a)

The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any

time be entitled under applicable law, the Charter, the Bylaws, any agreement, a vote of stockholders, or a resolution of directors,

or otherwise. No amendment, alteration, or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee

under this Agreement in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) or

claim, issue or matter therein arising out of, or related to, any action taken or omitted by such Indemnitee in Indemnitee’s Corporate

Status prior to such amendment, alteration, or repeal. To the extent that a change in applicable law, whether by statute or judicial

decision, permits greater indemnification, hold harmless, or exoneration rights or advancement of Expenses than would be afforded currently

under the Charter, the Bylaws or this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement

the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or

remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or

hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall

not prevent the concurrent assertion or employment of any other right or remedy.

(b)

DGCL, the Charter, and the Bylaws permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements

including, but not limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification Arrangements”)

on behalf of Indemnitee against any liability asserted against Indemnitee or incurred by or on behalf of Indemnitee or in such capacity

as a director, officer, employee, or agent of the Company, or arising out of Indemnitee’s status as such, whether or not the Company

would have the power to indemnify Indemnitee against such liability under the provisions of this Agreement or under DGCL, as it may then

be in effect. The purchase, establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit or affect

the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution

and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations of the Company

or the other party or parties thereto under any such Indemnification Arrangement.

(c)

In the event of any payment under this Agreement, the Company, to the fullest extent permitted by law, shall be subrogated to the extent

of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to

secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

(d)

The Company’s obligation to indemnify, hold harmless, exonerate, or advance Expenses hereunder to Indemnitee who is or was serving

at the request of the Company as a director, officer, trustee, partner, manager, managing member, fiduciary, employee, or agent of any

other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless, or exoneration payments

or advancement of expenses from such Enterprise. Notwithstanding any other provision of this Agreement to the contrary, (i) Indemnitee

shall have no obligation to reduce, offset, allocate, pursue, or apportion any indemnification, hold harmless, exoneration, advancement,

contribution, or insurance coverage among multiple parties possessing such duties to Indemnitee prior to the Company’s satisfaction

and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement

without regard to whether Indemnitee holds, may pursue, or has pursued any indemnification, advancement, hold harmless, exoneration,

contribution, or insurance coverage rights against any person or entity other than the Company.

16.

DURATION OF AGREEMENT. All agreements and obligations of the Company contained herein

shall continue during the period Indemnitee serves as a director or officer of the Company or as a director, officer, trustee, partner,

manager, managing member, fiduciary, employee, or agent of any other corporation, partnership, joint venture, trust, employee benefit

plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so long as Indemnitee shall

be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant to

Section 13 of this Agreement) by reason of Indemnitee’s Corporate Status, whether or not Indemnitee is acting in any such capacity

at the time any liability or expense is incurred for which indemnification or advancement can be provided under this Agreement. Without

limiting the foregoing, this Agreement shall apply to and cover any and all acts or omissions occurring, or alleged to have occurred,

prior to, at, or in connection with any Business Combination or other Change in Control transaction involving the Company, including

the negotiation, approval, financing, disclosure, or consummation thereof and any related filings or disclosure documents.

17.

SEVERABILITY. If any provision or provisions of this Agreement shall be held to be invalid, illegal, or unenforceable for any

reason whatsoever, (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation,

each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal, or unenforceable,

that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable

to the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform

to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions

of this Agreement (including, without limitation, each portion of any Section, paragraph, or sentence of this Agreement containing any

such provision held to be invalid, illegal, or unenforceable, that is not itself invalid, illegal, or unenforceable) shall be construed

so as to give effect to the intent manifested thereby.

18.

ENFORCEMENT AND BINDING EFFECT.

(a)

The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in

order to induce Indemnitee to serve as a director, officer, or key employee of the Company, and the Company acknowledges that Indemnitee

is relying upon this Agreement in serving as a director, officer, or key employee of the Company.

(b)

Without limiting any of the rights of Indemnitee under the Charter or Bylaws as in

effect from time to time to the extent not inconsistent with this Agreement, this Agreement

constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior

agreements and understandings, oral, written, or implied, between the parties hereto with

respect to the subject matter hereof.

(c)

The indemnification, hold harmless, exoneration, and advancement of expenses rights provided by or granted pursuant to this Agreement

shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect

successor by purchase, merger, consolidation, or otherwise to all or substantially all of the business and/or assets of the Company),

shall continue as to an Indemnitee who has ceased to be a director, officer, employee, or agent of the Company or a director, officer,

trustee, general partner, manager, managing member, fiduciary, employee, or agent of any other Enterprise at the Company’s request,

and shall inure to the benefit of Indemnitee and Indemnitee’s spouse, assigns, heirs, devisees, executors, and administrators and

other legal representatives.

(d)

The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation, or otherwise) to all,

substantially all, or a substantial part of the business and/or assets of the Company, by written agreement in form and substance satisfactory

to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would

be required to perform if no such succession had taken place, including, without limitation, the obligations set forth in Section 27

with respect to the procurement, maintenance, and payment for any directors’ and officers’ liability insurance, runoff coverage,

and tail policy required thereunder.

(e)

The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable

and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree

that Indemnitee may, to the fullest extent permitted by law, enforce this Agreement by seeking, among other things, injunctive relief

and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive

relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which Indemnitee

may be entitled. The Company and Indemnitee further agree that Indemnitee shall, to the fullest extent permitted by law, be entitled

to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions, and permanent injunctions,

without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of

a waiver, a bond or undertaking may be required of Indemnitee by a court of competent jurisdiction. The Company hereby waives any such

requirement of such a bond or undertaking to the fullest extent permitted by law.

(f)

The Company hereby covenants and agrees that it shall not adopt, amend, modify, alter, or repeal any provision of its Charter or Bylaws,

or adopt any new provision of its Charter or Bylaws, in any manner that would limit, restrict, impair, defeat, supersede, or adversely

affect any right, protection, undertaking, or obligation set forth in this Agreement. Any such adoption, amendment, modification, alteration,

repeal, or new provision shall constitute a breach of this Agreement, and Indemnitee shall be entitled to seek all remedies available

at law or in equity, including specific performance and injunctive relief, in addition to any other rights or remedies available under

this Agreement.

19.

MODIFICATION AND WAIVER. No supplement, modification, or amendment of this Agreement shall be binding unless executed in writing

by the Company and Indemnitee. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any

other provisions of this Agreement nor shall any waiver constitute a continuing waiver.

20.

NOTICES. All notices, requests, demands, and other communications under this Agreement shall be in writing and shall be deemed

to have been duly given if (i) delivered by hand and receipted for by the party to whom

said notice or other communication shall have been directed on such delivery, or (ii) mailed by certified or registered mail with postage

prepaid, on the third (3rd) business day after the date on which it is so mailed:

(a)

If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide

in writing to the Company.

(b)

If to the Company, to:

Boost

Run Inc.

Revere Drive, Suite 200

Northbrook,

IL 60062

Attention:

Andrew Karos, Chief Executive Officer

to any other address as may have been furnished to Indemnitee in writing by the Company.

21.

APPLICABLE LAW AND CONSENT TO JURISDICTION. This Agreement and the legal relations

among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard

to its conflict-of-laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 13(a) of this Agreement,

to the fullest extent permitted by law, the Company and Indemnitee hereby irrevocably and unconditionally: (a) agree that any action

or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court and not in any other state

or federal court in the United States of America or any court in any other country; (b) consent to submit to the exclusive jurisdiction

of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement; (c) waive any objection

to the laying of venue of any such action or proceeding in the Delaware Court; and (d) waive, and agree not to plead or to make, any

claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum, or is subject

(in whole or in part) to a jury trial. To the fullest extent permitted by law, the parties hereby agree that the mailing of process and

other papers in connection with any such action or proceeding in the manner provided by Section 20 or in such other manner as may be

permitted by law, shall be valid and sufficient service thereof.

22.

IDENTICAL COUNTERPARTS. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed

to be an original but all of which together shall constitute one and the same Agreement.

Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of

this Agreement.

23.

MISCELLANEOUS. Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate. The headings

of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or

to affect the construction thereof.

24.

PERIOD OF LIMITATIONS. No legal action shall be brought and no cause of action shall be asserted by or in the right of the Company

against Indemnitee, Indemnitee’s spouse, heirs, executors, or personal or legal representatives after the expiration of two years

from the date of accrual of such cause of action, and any claim or cause of action of the Company shall be extinguished and deemed released

unless asserted by the timely filing of a legal action within such two-year period; provided, however, that if any shorter period of

limitations is otherwise applicable to any such cause of action such shorter period shall govern.

25.

ADDITIONAL ACTS. If for the validation of any of the provisions in this Agreement any act, resolution, approval, or other procedure

is required to the fullest extent permitted by law, the Company undertakes to cause such act, resolution, approval, or other procedure

to be effected or adopted in a manner that will enable the Company to fulfill its obligations under this Agreement.

26.

MAINTENANCE OF INSURANCE; TAIL COVERAGE.

(a)

The Company shall maintain in effect, at its sole cost and expense, one or more policies of directors’ and officers’ liability

insurance with reputable insurers providing coverage for wrongful acts and omissions of the directors and officers of the Company, in

such amounts and on such terms as are customary and commercially reasonable for similarly situated publicly traded companies, for the

entire period for which the Company may be obligated to indemnify, hold harmless, exonerate, or advance Expenses to Indemnitee under

this Agreement.

(b)

To the extent that the Company maintains any insurance policy or policies providing liability insurance for directors, officers, trustees,

partners, managers, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise that such person serves

at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with their terms to the maximum extent

of the coverage available for any such person under such policy or policies, and in no event shall the rights and benefits available

to Indemnitee thereunder be less favorable than those accorded to the most favorably insured of the Company’s directors and officers.

(c)

If, at the time the Company receives notice from any source of a Proceeding as to which Indemnitee is a party or participant, the Company

has directors’ and officers’ liability insurance in effect, the Company shall give prompt notice of such Proceeding to the

applicable insurers in accordance with the procedures set forth in the applicable policies and shall thereafter take all necessary or

desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance

with the terms of such policies.

(d)

Without limiting the foregoing, in connection with any Change in Control, Business Combination, merger, consolidation, reorganization,

liquidation, dissolution, or similar transaction, the Company shall, or shall cause its successor to, obtain and fully pay for a prepaid

non-cancellable runoff or tail policy providing directors’ and officers’ liability insurance coverage for a period of not

less than six (6) years after the effective time of such transaction with respect to claims arising from facts, events, acts, or omissions

occurring or alleged to have occurred at or prior to the effective time of such transaction, with coverage, limits, retentions, scope,

and terms that are no less favorable in the aggregate to Indemnitee than the coverage in effect immediately prior to such transaction.

[Signature

Page Follows]

WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed as of the day and year first above written.

BOOST

RUN INC.

By:

Name:

Andrew

Karos

Title:

Chief

Executive Officer

INDEMNITEE

By:

Name:

[Signature

Page to Indemnity Agreement]

EX-10.6

Filename: ex10-6.htm · Sequence: 7

Exhibit

10.6

EMPLOYMENT

AGREEMENT

THIS

EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 8, 2026 by and between Andrew Karos (“Executive”)

and Boost Run Inc., a Delaware corporation (collectively with its direct or indirect subsidiaries, the “Company”).

WHEREAS,

the Company, Willow Lane Acquisition Corp, Benchmark Merger Sub I Inc., Benchmark Merger Sub II LLC, Boost Run Holdings, LLC and the

other parties named thereto have entered into a Business Combination Agreement and intend to effectuate the transactions contemplated

thereby (the “Merger”);

WHEREAS,

the Company desires to employ Executive as its Chief Executive Officer pursuant to the terms and conditions set forth in this Agreement

following the closing of the Merger (the date on which such closing occurs, the “Closing Date”), subject to and contingent

upon the closing of the Merger, and effective upon the date immediately following the Closing Date (such date on which this Agreement

becomes effective, the “Effective Date”), and Executive is willing and able to render such services and desires to

do so on the terms and conditions hereinafter set forth herein.

NOW,

THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto

agree as follows:

1. Employment.

The Company shall employ Executive as the Chief Executive Officer under this Agreement (such period of employment, the “Term”).

In this capacity, Employee shall have the duties and roles commensurate with that of a chief executive officer. Executive shall perform

such other duties as are customarily performed by other persons in similar positions, including other duties as may arise from time-to-time

and as may be reasonably assigned by the Board of Directors of the Company (the “Board”).

2. Employment

Duties. Executive shall perform assigned duties and responsibilities in a professional manner, in good faith, and to the best of

Employee’s skills, abilities, talents and experience.

3. Compensation.

During the Term, the Company shall pay Executive a base salary at an annual rate of $1.00, payable in accordance with the Company’s

normal payroll practices for employees as in effect from time to time. Executive’s annual base salary, as in effect from time to

time, is hereinafter referred to as the “Base Salary.” The Base Salary shall be subject to annual review by the Board

(or a duly authorized committee thereof).

4. Work

Location. Executive will primarily perform his employment services in Illinois.

5. Benefits.

During the Term, Executive and Executive’s eligible dependents shall be eligible to participate in the Company’s benefit

plans provided to similarly situated senior executives, subject to the terms of such plans. The Company reserves the right to amend any

employee benefit plan, policy, program or arrangement from time to time, or to terminate such plan, policy, program or arrangement, consistent

with the terms thereof at any time and for any reason without providing Executive with notice.

6. Expenses.

Executive may from time-to-time be required to travel in connection with the performance of Executive’s services, as determined

by the Board. Executive shall be entitled to reimbursement for all reasonable and necessary out-of-pocket business and travel expenses

incurred by Executive in connection with the performance of Executive’s duties hereunder during the Term in accordance with the

Company’s expense reimbursement policies and procedures.

7. Termination.

The Company may terminate Executive’s employment with immediate effect at any time and for any reason in accordance with applicable

local, state, and federal labor laws. Executive may terminate this Agreement and the employment at any time and for any reason in accordance

with applicable local, state, and federal labor laws. At the time of termination, Employee agrees to return all Company property, including

but not limited to computers, cell-phones, and any other electronic devices. The rights and obligations of the parties set forth in Confidentiality,

Non-Disparagement, Inventions, and Miscellaneous Agreement are intended to survive termination, and will survive termination of this

Agreement.

8. Confidentiality;

Assignment of Inventions; Non-Disparagement.

(a) Confidential

and Proprietary Information. Executive agrees that all materials and items produced or developed by Executive for the Company or

any entity that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with,

the Company (each such entity, an “Affiliate” and collectively, the “Company Group”) or obtained

by Executive from the Company Group either directly or indirectly pursuant to this Agreement, shall be and remains the property of the

Company Group. Executive acknowledges that Executive will, during Executive’s association with the Company, acquire, or be exposed

to, or have access to, materials, data and information that constitute valuable, Confidential and Proprietary Information of the Company

Group, including, without limitation, any or all of the following: business plans, practices and procedures, pricing information, sales

figures, profit or loss figures, this Agreement and its terms, information relating to customers, clients, intellectual property, suppliers,

technology, sources of supply and customer lists, research, technical data, trade secrets or know-how, software, developments, inventions,

processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, policies, training

manuals and similar materials used by the Company in conducting its business operations, personnel information of any Person employed

by the Company, potential business combinations, and such other information or material as the Company may designate as confidential

and/or proprietary from time to time (collectively hereinafter, the “Confidential and Proprietary Information”). Notwithstanding

the foregoing, “Confidential and Proprietary Information” does not include information that is or becomes publicly available,

other than information made publicly available by Executive or another person in violation of Executive’s obligations in this Section

8(a).

(b) Confidentiality

Obligations. During Executive’s employment with the Company and at all times thereafter, Executive shall not, directly or indirectly,

use, misuse, misappropriate, disclose or make known, without the prior written approval of the Board, to any party, firm, corporation,

association or other entity, any such Confidential and Proprietary Information for any reason or purpose whatsoever, except as may be

required in the course of Executive’s performance of Executive’s duties hereunder. In consideration of the unique nature

of the Confidential and Proprietary Information, all obligations pertaining to the confidentiality and nondisclosure thereof shall remain

in effect until the Company Group have released such information; provided that the provisions of this Section 8(b) shall

not apply to the disclosure of Confidential and Proprietary Information to the Company’s Affiliates together with each of their

respective shareholders, directors, officers, accountants, lawyers, and other representatives or agents, in furtherance of Executive’s

duties hereunder, nor to a Protected Activity as defined in Section 8(c) below. In addition, it shall not be a breach of the confidentiality

obligations hereof if Executive is required by applicable law to disclose any Confidential and Proprietary Information; provided

that in such case, Executive shall (i) give the Company the earliest notice possible that such disclosure is or may be required and (ii)

cooperate with the Company, at the Company’s expense, in protecting to the maximum extent legally permitted, the confidential or

proprietary nature of the Confidential and Proprietary Information which must be so disclosed. Upon termination of Executive’s

employment, Executive agrees that all Confidential and Proprietary Information, directly or indirectly, in Executive’s possession

that is in writing or other tangible form (together with all duplicates thereof) will promptly (and in any event within ten (10) days

following such termination) be returned to the Company and will not be retained by Executive or furnished to any person, either by sample,

facsimile, film, audio or video cassette, electronic data, oral communication, or any other means of communication.

Activities. This Agreement shall not be construed or applied in a manner that limits or interferes with Executive’s right to

discuss or disclose information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that

employees have reason to believe is unlawful, and, without notice to or authorization of the Company, (i) to communicate and cooperate

in good faith with any self-regulatory organization or U.S. federal, state, or local governmental or law enforcement branch, agency,

commission, or entity (collectively, a “Government Entity”) for the purpose of (A) reporting a possible violation

of any U.S. federal, state, or local law or regulation, (B) participating in any investigation or proceeding that may be conducted or

managed by any Government Entity, including by providing documents or other information, or (C) filing a charge or complaint with a Government

Entity, provided that in each case, such communications, participation, and disclosures are consistent with applicable law, or

(ii) to engage counsel to pursue enforcement and/or interpretation of this Agreement.

(d) Defend

Trade Secrets Act. Pursuant to the Defend Trade Secrets Act of 2016, Executive shall not be held criminally or civilly liable under

any federal or state trade secret law for the disclosure of a trade secret that is made (i) in confidence to a federal, state, or local

government official, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or (ii) in

a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. If Executive files a lawsuit

for retaliation by the Company Group for reporting a suspected violation of law, Executive may disclose the trade secret to the Executive’s

attorney and use the trade secret information in the court proceeding, if Executive files any document containing the trade secret under

seal and does not disclose the trade secret, except pursuant to court order. All disclosures and other conduct permitted under this Section

8(d) are herein referred to as “Protected Activities.” Notwithstanding the foregoing, under no circumstance will

Executive be authorized to disclose any Confidential and Proprietary Information as to which the Company may assert protections from

disclosure under the attorney-client privilege or the attorney work product doctrine, without prior written consent of the Company’s

General Counsel or other authorized officer designated by the Company, except to the extent disclosure of such privileged information

to a Government Entity is permitted under applicable law, regulation or state attorney conduct rules. Additionally, this Agreement does

not interfere with Executive’s right to disclose information regarding Executive’s compensation and benefits to Executive’s

spouse, accountants, counsel, financial advisors and lenders with a need to know such information, it being understood that Executive

will advise such persons of their confidentiality obligations with respect thereto, and ensure that such persons are bound by obligations

of confidentiality reasonably comparable to those imposed in this Agreement.

(e) Nondisparagement.

Executive agrees that Executive shall refrain from making, directly or indirectly, any disparaging or defamatory comments concerning

the Company, any of its Affiliates, or any of the Company’s or its Affiliates’ respective businesses, products or services,

or their respective current or former directors, officers, agents, partners, shareholders or employees, either publicly or privately.

Notwithstanding the foregoing, nothing in this Agreement is intended to or should be construed to prevent Executive from (i) fully and

truthfully responding to a subpoena or other legal process or request by a governmental or regulatory body, (ii) testifying fully and

truthfully in any action, proceeding, or regulatory matter, (iii) exercising protected rights to the extent that such rights cannot be

waived by agreement, (iv) reporting any allegations of unlawful conduct to federal, state, or local officials for investigation, including,

but not limited to, alleged criminal conduct or unlawful employment practices under federal or Illinois law, or (v) otherwise reporting

in good faith any violation of law or regulations to any governmental agency or entity or making disclosures that are protected under

whistleblower law.

(f) Inventions.

(i) Executive

acknowledges and agrees that all patentable inventions that are made or conceived by Executive, solely or jointly with others, during

the Term, either while performing Executive’s duties with the Company or on Executive’s own time, but only insofar as such

inventions are related to Executive’s work as an employee or other service provider to the Company (the “Inventions”),

shall belong exclusively to the Company (or its designee), whether or not patent applications are filed thereon. Executive will keep

full and complete written records (the “Records”), in the manner prescribed by the Company, of all Inventions, and

will promptly disclose all Inventions completely and in writing to the Company. The Records shall be the sole and exclusive property

of the Company and Executive will surrender them upon the termination of the Term, or upon the Company’s request. Executive hereby

assigns to the Company the Inventions and all patents that may be issued thereon in any and all countries, whether prior to, during or

subsequent to the Term, together with the right to file, in Executive’s name or in the name of the Company (or its designee), applications

for patents and equivalent rights (the “Applications”). Executive will, at any time during and subsequent to the Term,

make such applications, sign such papers, take all rightful oaths, and perform all acts as may be requested from time to time by the

Company with respect to the Inventions. Executive will also execute assignments to the Company (or its designee), of the Applications,

and give the Company and its attorneys all reasonable assistance (including the giving of testimony) to obtain the Inventions for its

benefit, all without additional compensation to Executive from the Company but entirely at the Company’s expense.

(ii) In

addition, the Inventions will be deemed Work for Hire, as such term is defined under the copyright law of the United States, on behalf

of the Company, and Executive agrees that the Company will be the sole owner of the Inventions and all underlying rights therein, in

all media now known or hereinafter devised, throughout the universe and in perpetuity, without any further obligations to Executive.

If the Inventions, or any portion thereof, are deemed not to be Work for Hire, Executive hereby irrevocably conveys, transfers and assigns

to the Company all rights, in all media now known or hereinafter devised, throughout the universe and in perpetuity, in and to the Inventions,

including, without limitation, all of Executive’s right, title and interest in the copyrights (and all renewals, revivals and extensions

thereof) to the Inventions, including, without limitation, all rights of any kind or any nature now or hereafter recognized, including,

without limitation, the unrestricted right to make modifications, adaptations and revisions to the Inventions, to exploit and allow others

to exploit the Inventions and all rights to sue at law or in equity for any infringement or other unauthorized use or conduct in derogation

of the Inventions, known or unknown, prior to the date hereof, including, without limitation, the right to receive all proceeds and damages

therefrom. In addition, Executive hereby waives any so-called “moral rights” with respect to the Inventions. Executive hereby

waives any and all currently existing and future monetary rights in and to the Inventions and all patents that may be issued thereon,

including, without limitation, any rights that would otherwise accrue to Executive’s benefit by virtue of Executive being an employee

of or other service provider to the Company.

(i) Subject

to Section 8(a) above, nothing in this Section 8(f) will restrict Executive from use of concepts, ideas or methods that

are generally known by others in the industry, nor shall Executive be restricted from using the general know-how or experience obtained

during employment with the Company. In accordance with the Illinois Employee Patent Act or any other similar, applicable law, this Section

8(f) does not apply to any invention for which no equipment, supplies, facilities, or trade secret information of the Company Group

is used, and which is developed entirely on Executive’s own time, unless: (i) the invention relates to either the business of the

Company Group or its actual or demonstrably anticipated research or development; or (ii) the invention results from any work performed

by Executive for the Company Group.

(iii) Notwithstanding

any other provision in this Section 8(f), “Inventions” shall not include the patents and other assets set forth

on Exhibit A hereto. Executive hereby represents and warrants that the patents and other assets owned by Executive set forth on

Exhibit A are not related in any way to the Company Group, except as stated therein.

(g) Duty

of Loyalty. Executive acknowledges and agrees that during the Term, Executive owes a fiduciary duty of loyalty, fidelity and allegiance

to act in the best interests of the Company and to do no act that would materially injure the business, interests or reputation of the

Company or any member of the Company Group. In keeping with these duties, during the Term, Executive shall make full disclosure to the

Company of all business opportunities pertaining to the Company’s business and shall not appropriate for Executive’s own

benefit business opportunities concerning the subject matter of the fiduciary relationship.

(h) Relief.

The parties hereto further agree that Executive’s expertise in the business of the Company is of a special, unique, unusual, extraordinary,

and intellectual character, which gives Executive’s expertise a peculiar value. Consequently, Executive acknowledges and agrees

that the Company Group will suffer irreparable harm from a breach of Section 8 by Executive and that money damages or the remedy

at law available to the Company Group for breach of Executive’s obligations under this Agreement may be inadequate and will not

be a reasonable or adequate remedy for any such breach. Therefore, in addition to any other rights or remedies that the Company Group

may have at law or in equity, in the event of a breach or threatened breach of this Agreement, the Company Group shall be entitled to

(without limitation) specific performance and/or temporary and permanent injunctive relief in any proceeding that may be brought to enforce

any provision of this Agreement, injunctive or other equitable relief (including a restraining order) from a court of competent jurisdiction

in order to enforce, or prevent any violations of, the provisions hereof, in each case, without (i) the necessity of proof of actual

damage or adequacy of remedies at law, (ii) being required to post bond or other security and (iii) an award of their reasonable attorneys’

fees incurred in enforcing their rights under this Agreement. Any and all remedies herein expressly conferred upon a party will be deemed

cumulative with and not exclusive of any other remedy conferred hereby, or by applicable law or equity upon such party, and the exercise

by a party of any one remedy will not preclude the exercise of any other remedy.

(i) Reasonableness.

Executive acknowledges that due to the proprietary nature of the business of the Company, Executive’s obligations under this Agreement

are reasonable (including as to duration, geographical area and scope) in light of the circumstances as they exist on the date of this

Agreement and in the context of the injuries likely to be sustained by the Company Group if Executive were to violate such obligations

and are necessary to ensure the preservation, protection and continuity of such business, Confidential and Proprietary Information, trade

secrets and goodwill of the Company Group. Executive further acknowledges that this Agreement is made in consideration of and is adequately

supported by the agreement of the Company to perform its obligations under this Agreement, which Executive acknowledges constitutes good,

valuable and sufficient consideration. Executive acknowledges and agrees that Executive has either reviewed the provisions of this Agreement

with Executive’s legal counsel or had the opportunity to do so and willingly declined that opportunity. Executive further agrees

and acknowledges that Executive has been provided with at least fourteen (14) days to consider this Agreement, including the restricted

covenants set forth in this Agreement, or has voluntarily elected to execute this Agreement prior to the expiration of such fourteen

(14) day period.

(j) Tolling.

In the event of any violation of the provisions of this Section 8, Executive acknowledges and agrees that the post-termination

restrictions contained in this Section 8 shall be extended by a period of time equal to the period of such violation, it being

the intention of the parties hereto that the running of the applicable post-termination restriction period shall be tolled during any

period of such violation.

9. Miscellaneous.

(a) Entire

Agreement and Amendment. This Agreement constitutes the entire agreement between the Parties and supersedes all prior understandings

of the Parties. No supplement, modification or amendment of this Agreement will be binding unless executed in writing by both of the

Parties.

(b) Notices.

Any notice or other communication given or made to either Party under this Agreement shall be in writing and delivered by hand, sent

by overnight courier service or sent by certified or registered mail, return receipt requested, to the address stated above or to another

address as that party may subsequently designate by notice and shall be deemed given on the date of delivery.

Neither party shall be deemed to have waived any provision of this Agreement or the exercise of any rights held under this Agreement

unless such waiver is made expressly and in writing. Waiver by either Party of a breach or violation of any provision of this Agreement

shall not constitute a waiver of any subsequent or other breach or violation.

(d) Further

Assurances. At the request of one party, the other party shall execute and deliver such other documents and take such other actions

as may be reasonably necessary to give effect the terms of this Agreement.

(e) Severability.

If any provision of this Agreement is held to be invalid, illegal or unenforceable in whole or in part, the remaining provisions shall

not be affected and shall continue to be valid, legal and enforceable as though the invalid, illegal or unenforceable parts had not been

included in this Agreement.

(f) No

Assignment. This Agreement is personal to the Executive and shall not be assigned by the Executive.

(g) Governing

Law. This Agreement will be governed by and construed in accordance with the laws of the State of Illinois, without giving effect

to any choice of law or conflict of law provision or rule. Executive expressly consents to the personal and exclusive jurisdiction and

venue of the state and federal courts located in Illinois. for any proceeding relating to or arising in any way from this Agreement.

(h) AS

A SPECIFICALLY BARGAINED INDUCEMENT FOR EACH OF THE PARTIES TO ENTER INTO THIS AGREEMENT (EACH PARTY HAVING HAD OPPORTUNITY TO CONSULT

COUNSEL), EACH PARTY EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY TO THE FULLEST EXTENT PERMITTED BY LAW IN ANY PROCEEDING RELATING TO

OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED IN THIS AGREEMENT.

[signature

page follows]

WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

BOOST

RUN INC.

By:

/s/

Andrew Karos

Name:

Andrew

Karos

Title:

Chief

Executive Officer

EXECUTIVE

/s/

Andrew Karos

Andrew

Karos

EXHIBIT

EXCLUDED

INVENTIONS

have no inventions.

The

following is a complete list of all Inventions relative to the subject matter of my employment with the Company that have been created

by me, alone or jointly with others, prior to the Effective Date, which might relate to the Company Group’s present business:

Additional

sheets attached.

Executive

Signature:

Date:

EX-10.7

Filename: ex10-7.htm · Sequence: 8

Exhibit

10.7

EMPLOYMENT

AGREEMENT

THIS

EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 8, 2026 by and between Erik K. Guckel (“Executive”)

and Boost Run Inc., a Delaware corporation (collectively with its direct or indirect subsidiaries, the “Company”).

WHEREAS,

the Company, Willow Lane Acquisition Corp, Benchmark Merger Sub I Inc., Benchmark Merger Sub II LLC, Boost Run Holdings, LLC (the “Predecessor”)

and the other parties named thereto have entered into a Business Combination Agreement and intend to effectuate the transactions contemplated

thereby (the “Merger”);

WHEREAS,

the Company desires to employ Executive as its Chief Financial Officer pursuant to the terms and conditions set forth in this Agreement

following the closing of the Merger (the date on which such closing occurs, the “Closing Date”), subject to and contingent

upon the closing of the Merger, and effective upon the date immediately following the Closing Date (such date on which this Agreement

becomes effective, the “Effective Date”), and Executive is willing and able to render such services and desires to

do so on the terms and conditions hereinafter set forth herein.

NOW,

THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto

agree as follows:

Employment Term. This Agreement shall govern the terms and conditions of Executive’s employment with the Company from and

after the Effective Date and supersedes and replaces any prior offer letter or agreement between the Company and Executive as of the

Effective Date, including, without limitation, that certain offer letter, dated as of July 31, 2025, by and between Executive and Boost

Run LLC (the “Prior Agreement”), other than with respect to the restrictive covenants set forth in Appendix B thereto.

Executive’s employment with the Company shall commence on the Effective Date and continue until terminated in accordance with Section

7 and Section 8 (such period of employment, the “Term”).

Employment Duties.

(a)

During the Term, Executive shall have the title of Chief Financial Officer of the Company and shall have such duties, authorities and

responsibilities as are consistent with such position. Executive shall report to the Chief Executive Officer of the Company. Executive’s

role will be located in Illinois. Executive shall devote Executive’s full working time and attention and Executive’s best

efforts to Executive’s employment and service with the Company and shall perform Executive’s services in a capacity and in

a manner consistent with Executive’s position for the Company; provided that this Section 2 shall not be interpreted

as prohibiting Executive from (i) managing Executive’s personal investments (so long as such investment activities are of a passive

nature), (ii) engaging in charitable or civic activities, or (iii) participating on boards of directors or similar bodies of non-profit

organizations, in each case of (i) – (iii), so long as such activities do not, individually or in the aggregate, (A) materially

interfere with the performance of Executive’s duties and responsibilities hereunder, (B) create a fiduciary conflict, or (C) result

in a violation of Section 12 of this Agreement. If requested, Executive shall also serve as an executive officer and/or member

of the board of directors (or similar governing body) of any entity that directly, or indirectly through one or more intermediaries,

controls, is controlled by, or is under common control with, the Company (an “Affiliate”) without any additional compensation.

Executive acknowledges and agrees that Executive will be subject to and shall comply with all Company policies, including, without limitation,

the Company’s insider trading policy, conflict of interest policy, stock ownership guidelines and compensation clawback policies,

as in effect from time to time.

(b)

Executive shall support the Board of Directors of the Company (the “Board”), its committees and the Company’s

governance systems as reasonably requested from time to time. Without limiting the generality of the foregoing, it is anticipated that

Executive will provide governance support to the Board’s investor relations and audit and compliance committees. Subject to and

at the invitation of the Board, Executive may attend meetings of the Board (and any committees thereof) in a non-voting observer capacity.

Executive will receive all materials provided to the Board at the same time as the Board (subject to customary exclusions for privileged

or conflict of interest materials, as determined by the Board in its discretion), and shall at all times maintain the confidentiality

of all such materials. The Board shall determine in its discretion whether to nominate Executive for appointment to the Board following

the Effective Date (subject to approval by the Company’s shareholders).

Base Salary. During the Term, the Company shall pay Executive a base salary at an annual rate of $400,000 (Four Hundred Thousand

Dollars), payable in accordance with the Company’s normal payroll practices for employees as in effect from time to time. Executive’s

annual base salary, as in effect from time to time, is hereinafter referred to as the “Base Salary.” The Base Salary

shall be subject to annual review by the Board or its compensation committee (the “Committee”).

Annual Bonus/Long-Term Incentives.

(a)

Annual Bonus. With respect to each fiscal year during the Term, Executive shall be eligible to earn an annual cash bonus (the

“Annual Bonus”), with an initial target of seventy-five percent (75%) of Base Salary (the “Target Bonus”)

with the ability to earn between 0%–150% of such Target Bonus in any given year, based upon the achievement of Company and individual

performance metrics that are determined in the first quarter of each fiscal year by the Board or the Committee in consultation with management.

Company performance metrics may include consideration of revenue, revenue growth, ARR growth, EBITDA, EBITDA margin, cash flow, timeliness

of reporting, investor relations and team development and audit governance, among other criteria, as determined by the Board or Committee

for each fiscal year. All determinations as to whether any Annual Bonus is earned and payable, and the form in which any Annual Bonus

is paid, will be made by the Board or the Committee in its or their sole discretion. For the avoidance of doubt, if the Board or Committee

approves the payment of an Annual Bonus to Executive for a fiscal year, such Annual Bonus (i) shall not create a contractual entitlement

or expectation to an Annual Bonus or similar level of Annual Bonus in future years; and (ii) shall be subject to the terms of any bonus

plans, programs, agreements or arrangements of the Company that may be in place from time to time (including any clawback or similar

policy). In any year in which an Annual Bonus is payable to Executive by the Company, Executive must be employed with the Company on

the payment date in order to receive such Annual Bonus (except as otherwise provided in Section 8). In the event that an Annual

Bonus is payable by the Company in a given year, such Annual Bonus will generally be paid in the first regularly scheduled payroll date

after the approval and certification of the Company’s performance results by the Board or the Committee, as applicable, but in

no event later than seventy-five (75) days following the end of the applicable fiscal year to which the Annual Bonus relates.

(b)

Equity Awards. The Executive shall be eligible to receive a one-time long-term incentive award under the Company’s 2026

Omnibus Incentive Plan (the “Plan”), as amended from time to time, as soon as reasonably practicable following the

Effective Date (the “One-Time Award”). The One-Time Award shall be comprised of 1,156,304 time-based restricted stock

units (“RSUs”), 722,691 performance-based RSUs, and a nonqualified option to purchase 1,011,766 shares of Company

common stock, and shall be subject to the terms and conditions of the Plan and the applicable award agreements. The Executive shall be

eligible to participate in the Plan and receive subsequent annual long-term incentive awards thereunder. The Board or the Committee will

determine in its discretion the terms of any equity award in accordance with the terms of the Plan as in effect from time to time.

Benefits. During the Term, Executive shall be provided the opportunity to participate in all standard employee benefit programs

made available by the Company to the Company’s senior executive employees generally, in accordance with the terms and conditions

of such plans, including the eligibility and participation provisions of such plans and programs, as such plans or programs may be in

effect from time to time. The Company reserves the right to amend any employee benefit plan, policy, program or arrangement from time

to time, or to terminate such plan, policy, program or arrangement, consistent with the terms thereof at any time and for any reason

without providing Executive with notice.

Travel and Expense Reimbursement. Executive may from time-to-time be required to travel in connection with the performance of

Executive’s services, as determined by the Board. Executive shall be entitled to reimbursement for all reasonable and necessary

out-of-pocket business and travel expenses incurred by Executive in connection with the performance of Executive’s duties hereunder

during the Term in accordance with the Company’s expense reimbursement policies and procedures.

Termination of Employment. Executive’s employment during the Term may be terminated as follows:

(a)

Automatically in the event of the death of Executive;

(b)

At the option of the Company, by written notice to Executive or Executive’s personal representative in the event of the Disability

of Executive. As used herein, the term “Disability” shall mean Executive’s inability, with or without reasonable

accommodation, to perform the essential duties, responsibilities, and functions of Executive’s position with the Company as a result

of any mental or physical disability or incapacity for a length of time that the Company determines is sufficient to satisfy such obligations

as it may have to provide leave under applicable family and medical leave laws and/or “reasonable accommodation” under applicable

federal, state or local disability laws. Family and medical leave or disability leave provided under federal, state or local law may

be unpaid as per the requirements of such laws; provided, however, that Executive shall be entitled to such payments and

benefits under the Company’s vacation, sick leave or disability leave programs as per the terms of such programs. The Company may

terminate Executive’s active employment because of a Disability by giving written notice to Executive at any time effective at

or within twenty (20) days after the end of the period of leave as may be required under the family and medical leave laws or under federal,

state or local disability laws, but the Company shall retain Executive as an inactive employee if necessary to maintain Executive’s

eligibility for any disability leave benefits. A reassignment, reduction or elimination of the duties defined in Section 2 because

of Executive’s inability to perform such duties during any period of a disability leave or during the period Executive is designated

as an inactive employee, or the appointment of a temporary or permanent replacement for Executive during any disability leave, shall

not constitute Good Reason under Section 9(b) below.

(c)

At the option of the Company for Cause, by delivering prior written notice to Executive;

(d)

At the option of the Company at any time without Cause, by delivering written notice of its determination to terminate to Executive;

(e)

At the option of Executive for Good Reason; or

(f)

At the option of Executive without Good Reason, upon thirty (30) days’ prior written notice to the Company (which the Company may,

in its sole discretion, make effective earlier than the termination date provided in such notice; provided, however, that

in such event, the Company shall have no obligation to pay Executive any compensation or benefits for any portion of the notice period

following the accelerated termination date).

For

the avoidance of doubt, the expiration of the Term as a result of either party providing a timely notice of non-renewal in accordance

with Section 1 shall not, in and of itself, constitute a termination by the Company without Cause or a resignation by Executive

for Good Reason under this Agreement, and no severance or other termination-related benefits shall be payable solely as a result thereof.

Payments Upon Termination of Employment.

(a)

Termination by the Company Without Cause or by Executive For Good Reason other than in connection with a Change in Control. If

Executive’s employment is terminated during the Term by the Company without Cause (excluding for death or Disability) or by Executive

for Good Reason other than in connection with a Change in Control (as defined in the Plan), subject to Section 8(d) of this Agreement

and all applicable withholdings and deductions, Executive shall be entitled to the following payments and benefits (collectively, the

“Severance Benefits”):

(i)

(A) within thirty (30) days following such termination (or such earlier date as required by applicable law), payment of Executive’s

accrued and unpaid Base Salary through the date of termination, (B) reimbursement of expenses in accordance with Section 6 of

this Agreement, and (C) all other vested employee benefits in accordance with the Company’s benefit plans, programs or policies

(other than severance) and as required under law (the “Accrued Amounts”);

(ii)

an amount equal to Executive’s Base Salary, as in effect immediately prior to Executive’s date of termination, payable in

substantially equal installments in accordance with the Company’s regular payroll practices as in effect from time to time for

twelve (12) months (the “Severance Period”) following such termination, with the first payment to be made on the first

regularly scheduled payroll date following the expiration of the applicable revocation period for the release of claims required in connection

with such severance (as described in Section 8(d) herein), and such first payment shall include payment of any amounts that would

otherwise be due prior thereto;

(iii)

an amount equal to Executive’s target Annual Bonus (if any) earned for the fiscal year immediately preceding the year in which

termination occurs, to the extent such bonus has been earned but not yet paid, payable in a lump sum at the same time such Annual Bonus

would be due under Section 4(a) if Executive had remained employed with the Company through such payment date;

(iv)

a pro-rata portion of the Annual Bonus for the year in which Executive’s termination occurs based on actual performance and the

number of days during the fiscal year of termination during which Executive was employed with the Company, payable in a lump sum at the

same time such prorated Annual Bonus would be due under Section 4(a) if Executive had remained employed with the Company through such

payment date; and

(v)

any equity granted to Executive under the Plan shall be treated in accordance with the terms set forth in the Plan and the applicable

award agreement.

(b)

Termination by the Company Without Cause or by Executive For Good Reason Following a Change in Control. If Executive’s employment

is terminated during the Term by the Company without Cause (excluding for death or Disability) or by Executive for Good Reason on or

within twelve (12) months following the consummation of a Change in Control, then, in lieu of the Severance Benefits provided under Section

8(a) and subject to Section 8(d) of this Agreement and all applicable withholdings and deductions, Executive shall be entitled

to the following payments and benefits:

(i)

(A) within thirty (30) days following such termination (or such earlier date as required by applicable law), payment of the Accrued Amounts;

(ii)

an amount equal to eighteen (18) months of Executive’s Base Salary, as in effect immediately prior to Executive’s date of

termination, payable in a single lump sum within thirty (30) days following the expiration of the applicable revocation period for the

release of claims required in connection with such severance (as described in Section 8(d) herein);

(iii)

an amount equal to Executive’s target Annual Bonus (if any) earned for the fiscal year immediately preceding the year in which

termination occurs, to the extent such bonus has been earned but not yet paid, payable in a lump sum at the same time such Annual Bonus

would be due under Section 4(a) if Executive had remained employed with the Company through such payment date;

(iv)

an amount equal to one hundred percent (100%) of the higher of (A) Executive’s Target Bonus as in effect for the fiscal year in

which the Change in Control occurs or (B) Executive’s actual Annual Bonus for the fiscal year immediately preceding the year in

which Executive’s termination of employment occurs; and

(v)

acceleration of one hundred percent (100%) of Executive’s outstanding unvested equity awards on the date of Executive’s termination;

provided, however, that if an outstanding equity award is to vest and/or the amount of the equity award to vest is to be determined based

on the achievement of performance criteria, then the equity award will vest as to one hundred percent (100%) of the amount of the equity

award assuming the performance criteria had been achieved at target levels for the relevant performance period(s), unless otherwise provide

in the applicable award agreement.

(c)

Other Terminations. If Executive’s employment is terminated at any time (i) by the Company for Cause (as defined herein),

(ii) by Executive due to a voluntary resignation (other than for Good Reason), or (iii) due to Executive’s death or Disability,

then Executive (or Executive’s estate, if applicable) shall be entitled solely to receive the Accrued Amounts.

(d)

Conditions to Payment. All payments and benefits due to Executive under this Section 8 other than the Accrued Amounts shall

be payable only if Executive executes and delivers to the Company a separation agreement and general release of claims in a form provided

by the Company, and such release is no longer subject to revocation (to the extent applicable), in each case, within sixty (60) days

following termination of employment. Failure to timely execute and return such release or the revocation of such release during the revocation

period shall be a waiver by Executive of Executive’s right to severance (which, for the avoidance of doubt, shall not include any

amounts required by law to be paid). In addition, severance shall be conditioned on Executive’s compliance with Sections 10,

11, 12 and 13 of this Agreement.

(e)

No Other Severance. Executive hereby acknowledges and agrees that, other than the severance payments described in this Section

8, upon the effective date of the termination of Executive’s employment, Executive shall not be entitled to any other severance

payments or benefits of any kind under any Company benefit plan, severance policy generally available to the Company’s employees

or otherwise and all other rights of Executive to compensation under this Agreement shall end as of such date.

Definitions.

(a)

“Cause” shall mean any of the following, as reasonably determined by the Board or the Chief Executive Officer: (i)

Executive’s material failure to perform such duties as are reasonably requested by the Board and that are consistent with Executive’s

role, which is not cured within fifteen (15) days of Executive’s receipt of written notice detailing the same from the Board; (ii)

Executive’s material failure to observe any material policy of the Company and its Affiliates generally applicable to executives

of the Company and its Affiliates of which Executive has notice, which is not cured within fifteen (15) days of Executive’s receipt

of written notice detailing the same from the Board; (iii) Executive’s gross negligence or willful misconduct in the performance

of Executive’s duties or Executive’s willful disregard of Executive’s duties; (iv) Executive’s commission of

any act which results in Executive’s conviction, or plea of guilty or no contest to, a felony or other crime involving moral turpitude,

fraud or theft; (v) Executive’s material breach of Executive’s fiduciary duties with respect to the Company or any of its

Affiliates; (vi) Executive’s material breach of any restrictive covenant with the Company or any of its Affiliates, including any

restrictive covenant set forth in Section 12, which is not cured within fifteen (15) days of Executive’s receipt of written notice

detailing the same from the Board; or (vii) Executive’s acts of dishonesty intended to result in Executive’s or any other

person’s substantial enrichment, at the Company’s expense.

(b)

“Good Reason” shall mean, without Executive’s prior written consent, the occurrence of any of the following

events: (i) a material diminution in Executive’s duties or responsibilities that is inconsistent with Executive’s position

as described herein or (ii) any material reduction in Executive’s Base Salary or Target Bonus opportunity (other than an across

the board reduction that applies to all other senior executives of the Company); provided, that no event shall constitute Good

Reason unless (A) Executive has given the Company written notice of the termination, setting forth the conduct of the Company that is

alleged to constitute Good Reason, within thirty (30) days following the occurrence of such event, (B) Executive has provided the Company

at least sixty (60) days following the date on which such notice is provided to cure such conduct and the Company has failed to do so,

and (C) Executive resigns from employment for Good Reason within thirty (30) days following the expiration of such cure period.

10.

Return of Company Property. Within ten (10) days following the effective date of Executive’s termination of employment for

any reason, Executive or Executive’s personal representative shall return all property of the Company or any of its Affiliates

in Executive’s possession, including, but not limited to, all Company-owned computer equipment (hardware and software), telephones,

facsimile machines, tablet computers and other communication devices, credit cards, keys, security access cards or fobs, badges, identification

cards and all copies (including drafts) of any documentation or information (however stored) relating to the business of the Company

or any of its Affiliates, the Company’s or any of its Affiliates’ customers and clients or their respective prospective customers

or clients.

11.

Resignation as Officer or Fiduciary. Upon the effective date of any termination of Executive’s employment, Executive shall

be deemed to have resigned from Executive’s position and, to the extent applicable, as an officer of the Company or any of its

Affiliates and as a fiduciary of any Company benefit plan. On or immediately following the effective date of any such termination of

Executive’s employment, Executive shall confirm the foregoing by submitting to the Company in writing a confirmation of Executive’s

resignation(s).

12.

Confidentiality; Intellectual Property Assignment; Non-Competition; Non-Solicitation.

(a)

Confidential and Proprietary Information. Executive agrees that all materials and items produced or developed by Executive for

the Company and its affiliates (collectively, the “Company Group”) or obtained by Executive from the Company Group

either directly or indirectly pursuant to this Agreement, shall be and remains the property of the Company Group. Executive acknowledges

that Executive will, during Executive’s association with the Company, acquire, or be exposed to, or have access to, materials,

data and information that constitute valuable, Confidential and Proprietary Information of the Company Group, including, without limitation,

any or all of the following: business plans, practices and procedures, pricing information, sales figures, profit or loss figures, this

Agreement and its terms, information relating to customers, clients, intellectual property, suppliers, technology, sources of supply

and customer lists, research, technical data, trade secrets or know-how, software, developments, inventions, processes, formulas, technology,

designs, drawings, engineering, hardware configuration information, marketing, finances, policies, training manuals and similar materials

used by the Company in conducting its business operations, personnel information of any Person employed by the Company, potential business

combinations, and such other information or material as the Company may designate as confidential and/or proprietary from time to time

(collectively hereinafter, the “Confidential and Proprietary Information”). Notwithstanding the foregoing, “Confidential

and Proprietary Information” does not include information that is or becomes publicly available, other than information made publicly

available by Executive or another person in violation of Executive’s obligations in this Section 12(a).

(b)

During Executive’s employment with the Company and at all times thereafter, Executive shall not, directly or indirectly, use, misuse,

misappropriate, disclose or make known, without the prior written approval of the Board, to any party, firm, corporation, association

or other entity, any such Confidential and Proprietary Information for any reason or purpose whatsoever, except as may be required in

the course of Executive’s performance of Executive’s duties hereunder. In consideration of the unique nature of the Confidential

and Proprietary Information, all obligations pertaining to the confidentiality and nondisclosure thereof shall remain in effect until

the Company Group have released such information; provided that the provisions of this Section 12(b) shall not apply to

the disclosure of Confidential and Proprietary Information to the Company’s Affiliates together with each of their respective shareholders,

directors, officers, accountants, lawyers and other representatives or agents in furtherance of Executive’s duties hereunder, nor

to a Protected Activity as defined in Section 12(c) below. In addition, it shall not be a breach of the confidentiality obligations

hereof if Executive is required by applicable law to disclose any Confidential and Proprietary Information; provided that in such

case, Executive shall (i) give the Company the earliest notice possible that such disclosure is or may be required and (ii) cooperate

with the Company, at the Company’s expense, in protecting to the maximum extent legally permitted, the confidential or proprietary

nature of the Confidential and Proprietary Information which must be so disclosed. Upon termination of Executive’s employment,

Executive agrees that all Confidential and Proprietary Information, directly or indirectly, in Executive’s possession that is in

writing or other tangible form (together with all duplicates thereof) will promptly (and in any event within ten (10) days following

such termination) be returned to the Company and will not be retained by Executive or furnished to any person, either by sample, facsimile,

film, audio or video cassette, electronic data, verbal communication or any other means of communication.

(c)

Protected Activities. This Agreement shall not be construed or applied in a manner that limits or interferes with Executive’s

right to discuss or disclose information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct

that employees have reason to believe is unlawful, and, without notice to or authorization of the Company, (i) to communicate and cooperate

in good faith with any self-regulatory organization or U.S. federal, state, or local governmental or law enforcement branch, agency,

commission, or entity (collectively, a “Government Entity”) for the purpose of (A) reporting a possible violation

of any U.S. federal, state, or local law or regulation, (B) participating in any investigation or proceeding that may be conducted or

managed by any Government Entity, including by providing documents or other information, or (C) filing a charge or complaint with a Government

Entity, provided that in each case, such communications, participation, and disclosures are consistent with applicable law, or

(ii) to engage counsel to pursue enforcement and/or interpretation of this Agreement.

(d)

Defend Trade Secrets Act. Pursuant to the Defend Trade Secrets Act of 2016, Executive shall not be held criminally or civilly

liable under any federal or state trade secret law for the disclosure of a trade secret that is made (i) in confidence to a federal,

state, or local government official, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of

law, or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. If Executive

files a lawsuit for retaliation by the Company Group for reporting a suspected violation of law, Executive may disclose the trade secret

to the Executive’s attorney and use the trade secret information in the court proceeding, if Executive files any document containing

the trade secret under seal and does not disclose the trade secret, except pursuant to court order. All disclosures and other conduct

permitted under this Section 12(d) are herein referred to as “Protected Activities.” Notwithstanding the foregoing,

under no circumstance will Executive be authorized to disclose any Confidential and Proprietary Information as to which the Company may

assert protections from disclosure under the attorney-client privilege or the attorney work product doctrine, without prior written consent

of the Company’s General Counsel or other authorized officer designated by the Company, except to the extent disclosure of such

privileged information to a Government Entity is permitted under applicable law, regulation or state attorney conduct rules. Additionally,

this Agreement does not interfere with Executive’s right to disclose information regarding Executive’s compensation and benefits

to Executive’s spouse, accountants, counsel, financial advisors and lenders with a need to know such information, it being understood

that Executive will advise such persons of their confidentiality obligations with respect thereto, and ensure that such persons are bound

by obligations of confidentiality reasonably comparable to those imposed in this Agreement.

(e)

Non-Solicitation. Executive agrees that (i) for the period commencing on the Effective Date and ending on the twelve (12) month

anniversary of the date on which Executive’s employment with the Company is terminated for any reason (such period shall be referred

to as the “Restricted Period”), Executive will not, without written consent of the Company directly or indirectly

Solicit, recruit, induce or encourage to leave employment or association with the Company or other Company Group Member, or to become

employed by, become associated with or consult for, any Person other than the Company Group, or hire, attempt to hire, employ or engage

(whether as an employee, consultant, agent, independent contractor, director, equity holder, member, manager, general or limited partner

or in any other capacity), any Person who or which is or was employed or engaged by the Company Group at the time of such solicitation,

recruitment, inducement, or encouragement or the one-year period preceding such activity (each such Person, a “Specified Individual”),

or (ii) during the Restricted Period, directly or indirectly induce or encourage any customer, client or supplier of the Company Group

to cease to engage the services of the Company Group; provided, however, that (A) the foregoing shall not apply with respect

to Executive causing to be placed any general advertisements in newspapers and/or other media of general circulation (including advertisements

posted on the Internet or social media) that are not targeted specifically at the Company Group or its respective employees or consultants,

provided that in no event shall a Specified Individual be hired or otherwise retained as a result of such general advertisement,

in each case, with actual knowledge of Executive and (B) during Executive’s employment, Executive may not engage in the foregoing

activities with respect to any Person who was employed or engaged by the Company Group at any time during the Restricted Period. “Person”

means an individual, a partnership, a corporation, an association, a limited liability company, a joint stock company, a trust, a joint

venture, an unincorporated organization or a governmental entity or any department, agency or political subdivision thereof. “Solicit”

shall mean making any direct or indirect communication of any kind, regardless of who initiates it, or engaging in any conduct that in

any way invites, advises, encourages, or requests any Person to take or refrain from taking any action.

(f)

Non-Competition.

(i)

Executive has had and/or will have access to and is familiar with the trade secrets related to the Restricted Business (as defined below)

and the Company, and with other Confidential Information concerning the Restricted Business and the Company, including all (A) inventions,

technology and research and development related to the Restricted Business and the Company, (B) suppliers, distributors, customers, third

party payors, vendors, contractors, or other business relations, including, without limitation lists identifying such Persons, (C) products

(including products under development) and services related to the Restricted Business and the Company and related costs and pricing

structures, (D) accounting and business methods and practices related to the Restricted Business and the Company, and (E) similar and

related Confidential Information and trade secrets related to the Restricted Business and the Company. Executive acknowledges and agrees

that the Company would be irreparably damaged if Executive were to directly or indirectly provide services to any Person competing with

the Restricted Business or the Company or engaging in a similar business and that such direct or indirect competition by Executive would

result in a significant loss of goodwill by the Company.

(ii)

In order to protect the Confidential Information and goodwill of the Company and to maintain the value of the Restricted Business and

for such other consideration, the receipt and sufficiency of which are hereby acknowledged and agreed, Executive hereby agrees that during

the Restricted Period, Executive will not, directly or indirectly, individually or on behalf of any Person, whether for compensation

or otherwise, (A) engage in or assist others in engaging in the Restricted Business anywhere in the Restricted Area; (B) have an interest

in any Person that engages directly or indirectly in the Restricted Business in any capacity, including as a partner, shareholder, member,

lender, employee, principal, agent, trustee or consultant; or (C) interfere with the business relationships (whether formed prior to

or after the date of this Agreement) between the Company Group and any client, customer, vendor or supplier of the Company Group. However,

the acquisition of up to 1% for passive investment purposes of any class of the outstanding equity, debt securities, or other equity

interests of any person, corporation, partnership, or other business entity or enterprise shall not, in and of itself, be construed as

a breach of this Section 12(f). “Restricted Business” means the business of owning or operating bare metal

graphics processing unit servers within data centers and/or any other material business or enterprise of the Company Group that occurs

during the Term or the Restricted Period. The “Restricted Area” means anywhere in the United States or in any other

market in which the Company Group is engaged, or is actively contemplating becoming engaged, in the Restricted Business during the Restricted

Period.

(g)

Nondisparagement. Executive agrees that Executive shall refrain from making, directly or indirectly, any disparaging or defamatory

comments concerning the Company, any of its Affiliates, or any of the Company’s or its Affiliates’ respective businesses,

products or services, or their respective current or former directors, officers, agents, partners, shareholders or employees, either

publicly or privately. Notwithstanding the foregoing, nothing in this Agreement is intended to or should be construed to prevent Executive

from (i) fully and truthfully responding to a subpoena or other legal process or request by a governmental or regulatory body, (ii) testifying

fully and truthfully in any action, proceeding, or regulatory matter, (iii) exercising protected rights to the extent that such rights

cannot be waived by agreement, (iv) reporting any allegations of unlawful conduct to federal, state, or local officials for investigation,

including, but not limited to, alleged criminal conduct or unlawful employment practices under federal or Illinois law, or (v) otherwise

reporting in good faith any violation of law or regulations to any governmental agency or entity or making disclosures that are protected

under whistleblower law.

(h)

Inventions.

(i)

Executive acknowledges and agrees that all patentable inventions that are made or conceived by Executive, solely or jointly with others,

during the Term, either while performing Executive’s duties with the Company or on Executive’s own time, but only insofar

as such inventions are related to Executive’s work as an employee or other service provider to the Company (the “Inventions”),

shall belong exclusively to the Company (or its designee), whether or not patent applications are filed thereon. Executive will keep

full and complete written records (the “Records”), in the manner prescribed by the Company of all Inventions and will

promptly disclose all Inventions completely and in writing to the Company. The Records shall be the sole and exclusive property of the

Company and Executive will surrender them upon the termination of the Term, or upon the Company’s request. Executive hereby assigns

to the Company the Inventions and all patents that may be issued thereon in any and all countries, whether prior to, during or subsequent

to the Term, together with the right to file, in Executive’s name or in the name of the Company (or its designee), applications

for patents and equivalent rights (the “Applications”). Executive will, at any time during and subsequent to the Term,

make such applications, sign such papers, take all rightful oaths, and perform all acts as may be requested from time to time by the

Company with respect to the Inventions. Executive will also execute assignments to the Company (or its designee), of the Applications,

and give the Company and its attorneys all reasonable assistance (including the giving of testimony) to obtain the Inventions for its

benefit, all without additional compensation to Executive from the Company but entirely at the Company’s expense.

(ii)

In addition, the Inventions will be deemed Work for Hire, as such term is defined under the copyright law of the United States, on behalf